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Abstract 
Right ventricular (RV) size and function are prognostic in congenital and 
acquired heart disease. Two-dimensional echocardiography (2DE) is the 
most readily available modality for RV assessment, but is limited by its 
complex shape. Furthermore, biventricular function is intimately related 
through a shared septum and pericardium. The simplest metric of left 
ventricular (LV) function is ejection fraction (LVEF). However, LVEF is 
often maintained in pulmonary hypertension (PH), for example. Therefore 
better indicators of LV function are required to identify patients at risk of 
deterioration. In this thesis, novel imaging techniques for assessing 
cardiac function in right heart disease are investigated. 
 
The first experiment tested the hypothesis that single-beat three-
dimensional echocardiography (3DE) accurately and reproducibly 
quantifies RV volumes. 3DE traditionally acquires sub-volumes over 
consecutive heartbeats, whereas novel 3DE transducers can acquire 
datasets in a single cardiac cycle. Single-beat 3DE was compared 
against CMRI in 100 subjects including patients with PH and carcinoid 
heart disease. Single-beat 3DE was feasible and accurate for RV 
volumetric quantification, but with limitations of test-retest reproducibility. 
 
The second experiment tested the hypothesis that 2D knowledge-based 
reconstruction (2DKBR) accurately and reproducibly quantifies RV 
volumes. 2DKBR involves 2DE-acquired RV coordinates localized in 3D 
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space and connected by reference to a disease-specific RV catalogue. 
This was validated against CMRI in 28 PH patients, and test-retest 
reproducibility was assessed. 2DKBR was feasible and accurate for RV 
volumetric quantification in PH, and more reproducible than conventional 
2DE. 
 
The final experiment tested the hypothesis that multi-directional 
myocardial velocities could be assessed in PH by CMRI. A tissue phase 
mapping sequence was utilized in 40 PH patients and 20 healthy 
volunteers. Over a median follow-up period of 20 months, LV early 
diastolic wave velocities were the only independent predictors of 
functional capacity and clinical worsening in a model that includes 
conventional metrics of biventricular function. 
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1.1 Introduction 
Quantification of right ventricular (RV) size and function is prognostic in 
congenital and acquired heart disease[1-4]. However, this has proven 
challenging throughout history, and remains so in modern day cardiology. 
1.1.1 The right ventricle: a historical perspective 
The Greek philosopher Aristotle (384 – 322 B.C.) was the first to 
characterize the anatomy of the heart and circulation[5]. He described the 
right and left ventricles as part of a three-chambered model, with the right 
atrium separately identified as a morphological venous lake. Galen (129 – 
c. 200/c. 217 A.D.), a Greek physician, surgeon and philosopher, instead 
suggested that the right ventricle (RV) directly pulled in blood that had 
been created in the liver[6]. This theory of cardiac structure persisted 
throughout medieval Europe until the Renaissance revival of anatomy. 
Leonardo Da Vinci (1452 – 1519 A.D.) was the first person to accurately 
recognize the heart as a four-chambered structure. He was also credited 
for identifying the moderator band of the RV, albeit suggesting its function 
was to moderate the size of the RV by preventing its over-distension 
(Figure 1-1)[6-8]. Sir William Harvey in 1616 was the first person to 
correctly describe the function of the RV, stating that, “the right ventricle 
may be said to be made for the sake of transmitting blood through the 
lungs, not for nourishing them”[9, 10]. 
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Figure 1-1: Drawings of the RV by Leonardo da Vinci. 
From Quaderni d'Anatomia II ( left) and IV (right). Reproduced from 
Leonardo da Vinci on movement of the heart and blood, K. D. Keele, 1952.  
  
 
Importantly, Da Vinci’s anatomical notes consistently refer to the intimate 
relationship between form and function in nature. This is exemplified by 
the anatomy and physiology of the RV: a thin-walled highly compliant 
cardiac chamber, accepting and ejecting blood as part of a low-pressure 
circulation. Da Vinci’s anatomical drawings and notes were not fully 
published though until the early twentieth century, and hence did not 
significantly impact upon the fields of anatomy or physiology for several 
centuries[11]. Similarly, the RV is often described as a “forgotten” or 
“neglected” cardiac chamber, with a lack of awareness of the crucial role 
it plays in cardiac and pulmonary vascular diseases[12, 13]. In the first 
half of the twentieth century, animal studies focused upon the hypothesis 
that circulatory haemodynamics would not be compromised in the 
absence of RV contractile function. Experimental ablation of the RV was 
shown to neither reduce cardiac output nor increase systemic venous 
pressure in open-pericardium canine models[14, 15]. The importance of 
ventricular interdependence was neglected in this model, however, and 
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was only appreciated approximately thirty years later in a closed-chest 
canine model of RV infarction[16, 17]. Furthermore, surgical bypass of 
the RV by the Fontan procedure as a treatment for tricuspid atresia 
initially suggested that this cardiac chamber was functionally close to 
irrelevant[18]. Finally, the absence of any medical treatment for RV 
dysfunction contributed to prevent any serious consideration of investing 
time and money in this area. 
 
The physiological importance of the RV, however, has increasingly been 
recognized in recent decades across a spectrum of congenital and 
acquired heart disease. In patients with left ventricular (LV) dysfunction 
for example, the presence of associated RV dysfunction is an 
independent predictor of worse prognosis[1, 2, 4]. In patients with 
pulmonary hypertension (PH) due to untreated severe mitral stenosis, RV 
failure may be the cause of death in as many as 60% to 70% of 
patients[19]. Heart failure due to RV dysfunction in congenital heart 
disease is both common and closely related to prognosis[20]. In PH, both 
symptom burden and survival are principally determined by the ability of 
the RV to function against raised afterload, rather than the degree of 
elevation of pulmonary arterial pressure itself[21]. The weight of clinical 
evidence concerning the importance of RV dysfunction in cardiac disease 
led the National Heart, Lung, and Blood Institute to recently identify RV 
pathophysiology as a crucial area for research[22]. However, the complex 
anatomy and physiology of the RV make it difficult to functionally assess 
by non-invasive cardiac imaging techniques. 
 
1.1.2 RV anatomy 
The RV is the most anteriorly positioned cardiac chamber, located 
immediately behind the sternum. It is thin-walled, normally 3-5mm in 
health, with prominent trabeculations and a complex geometry. Under 
normal loading conditions, the RV has a triangular shape when viewed 
from the side and a crescentic shape in the sagittal plane, wrapping 
around the conical left ventricle (Figure 1-2). The RV outflow tract is 
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located antero-cephalad to that of the LV, resulting in a crossover 
arrangement of the RV and LV outflow tracts. The RV cavity is divided 
into three components, namely the inlet, apical and outlet portions (Figure 
1-2)[23]. The inlet portion extends from the tricuspid valve annulus, 
delineating the atrioventricular junction, to the insertions of the papillary 
muscles into the RV wall. The apical portion contains muscular 
trabeculations that are coarser than those of the LV. The outlet portion 
extends to the pulmonary valve, the most superiorly located of the cardiac 
valves, and is supported by the muscular subpulmonary infundibulum. 
Unlike the mitral and aortic valves that are in fibrous continuity in the LV, 
the pulmonary valve is separated from the tricuspid valve by the 
ventriculo-infundibular fold. The septomarginal trabeculation on the RV 
side of the interventricular septum is Y-shaped, giving rise to anterior and 
posterior arms that cradle the ventriculo-infundibular fold. The moderator 
band originates from the body of the Y-shaped septomarginal 
trabeculation, and is a structure that identifies the morphological RV. This 
carries a fascicle of the right bundle branch to the parietal wall of the RV.  
 
Figure 1-2: A 3D multi-plane reconstruction of the RV from a balanced SSFP whole 
heart CMR sequence. 
The tripartite model of the RV is demonstrated, with inflow (red), outflow 
(blue), and apical (green) regions. 
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1.1.3 RV function 
The orientation of RV myofibres and their arrangement into layers is 
responsible for the distinct contraction pattern of this chamber[23]. The 
superficial or subepicardial layer is composed of circumferentially 
oriented myofibres, parallel to the direction of the atrioventricular groove. 
The deep or subendocardial myofibres that line the RV cavity are aligned 
longitudinally from base to apex. These layers of differently aligned 
cardiomyocytes are responsible for the peristaltic RV contraction pattern 
starting at the inflow portion and progressing towards the infundibulum 
and outflow tract[24]. The longitudinal motion drawing the base towards 
the apex is accompanied by a bellows effect of inward motion of the free 
wall towards the interventricular septum, which bulges into the RV 
cavity[25].  
 
Pressure-volume loops explain the relationship between RV contractility, 
preload and afterload. Under normal loading conditions the RV displays a 
trapezoidal-shaped pressure-volume loop (Figure 1-3)[26, 27].  
 
Figure 1-3: Normal human LV and RV pressure–volume loops. 
The LV loop is rectangular, whereas the RV is more trapezoidal, with poorly 
defined isovolumic periods. 
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This is in contrast to the rectangular pressure-volume loop of the LV, 
which has well-defined isovolumic phases. Increased RV afterload results 
in a more square-shaped pressure-volume loop, but the RV has a much 
more limited capacity to adjust to these conditions than the LV (Figure 
1-4)[28, 29]. The different embryological origin of RV myocytes from 
those of the LV might account, at least in part, for their differential 
responses when exposed to abnormal loading conditions[30-32]. 
Furthermore, both gene expression implicated in adaptive remodeling 
and the molecular changes in the myocardium in response to raised 
afterload differ between the LV and the RV[33-35]. 
Figure 1-4: The responses of the RV and LV to increases in afterload. 
Reproduced with permission from Haddad et al.[14] 
 
1.1.4 Ventricular interdependence 
Impaired LV performance in primary RV failure is not simply due to 
reduced RV stroke volume delivering lower LV preload via the pulmonary 
circulation. The direct effects of the size, shape and compliance of one 
ventricle on the same parameters of the other ventricle make a crucial 
contribution to the pathophysiology of RV dysfunction[36, 37]. Ventricular 
interdependence is mediated through three principal mechanisms: the 
interventricular septum, shared myocardial fibres, and a common 
pericardial sac. 
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The contribution of a shared septum to ventricular interdependence was 
first described in the early twentieth century. In patients with LV 
hypertrophy, encroachment of the interventricular septum on the RV 
cavity was noted to negatively affect RV filling, referred to as the 
Bernheim effect[38-40]. The “reverse Bernheim effect’ has likewise been 
attributed to the deleterious impact on LV filling of abnormal 
interventricular septal dynamics in RV pressure or volume overload[41-
44]. However, RV dilatation also reduces LV preload through raised LV 
diastolic pressure and increased intrapericardial pressure, manifest as 
pericardial constraint[16]. On the contrary, these haemodynamic 
abnormalities are not observed in open-pericardium animal models of RV 
distension. 
 
Epicardial myofibres run in continuity across both ventricles, through 
which LV contraction in normal hearts can consequently give rise to 
traction of the RV free wall[14]. Chronic abnormalities of RV size, shape 
and contractility can thus result in LV microarchitectural abnormalities. 
Atrophic remodeling of the LV has been demonstrated in RV failure due 
to end-stage idiopathic PH[45], chronic thromboembolic PH[46], 
rheumatic mitral stenosis[47] and end-stage emphysema[48]. 
Furthermore, restoration of LV cavity size, stroke volume and mass has 
been shown to occur following pulmonary thromboendarterectomy, mitral 
valvuloplasty or orthotopic lung transplantation for these latter three 
conditions respectively. 
 
1.2 Non-invasive imaging of the RV 
Progressive developments in echocardiography and CMRI have brought 
these imaging modalities to the forefront of non-invasive RV assessment, 
without the need for ionizing radiation exposure. 
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1.2.1 2D Echocardiography 
Despite the challenges of RV assessment using cardiac ultrasound, 
echocardiography remains the most widely utilized clinical imaging 
modality for this purpose. The American Society of Echocardiography 
recommends that RV size and systolic function should be measured by 
echocardiography in all clinical studies using at least one or a 
combination of the following parameters[49, 50]. 
 
1.2.1.1 2DE linear dimensions 
The complex geometry and shape of the RV coupled with the relative 
paucity of anatomical landmarks confers difficulty for linear 2DE 
quantification of chamber size. Several linear 2DE measures have been 
suggested for assessing RV size[51]. The most reproducible metric is the 
RV basal diameter from an apical 4-chamber window, taken within one-
third of the distance below the tricuspid valve annulus toward the RV 
apex (Figure 1-5)[52]. A basal diameter of >41mm from a RV-focused 
view is taken to indicate RV dilatation, although future work should be 
aimed at indexing these measures to body surface area. Furthermore, 
2DE-derived linear dimensions do not correlate well with 3D-derived RV 
volumes[12, 53]. 
Figure 1-5: RV major and minor axes end-diastolic dimensions measured in the 4-
chamber view on transthoracic echocardiography. 
RVD-1 is the most reproducible 2DE RV dimension. 
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1.2.1.2 Fractional area change (FAC) 
This is obtained by manually tracing the RV endocardial border in the 4-
chamber view at end-diastole and at end-systole from the lateral tricuspid 
annulus along the free wall to the apex and back to medial tricuspid 
annulus, along the interventricular septum (Figure 1-6). The operator 
must include trabeculations, papillary muscles and the moderator band in 
the cavity area. Care must be taken to avoid foreshortening of the RV 
cavity. 
Figure 1-6: RV fractional area change from the 4-chamber view in end-diastole 
(top) and end-systole (bottom) from a 2DE of a patient with PH. 
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FAC is calculated as: 
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Equation 1-1: Fractional area change 
 
RV FAC <35% is indicative of systolic dysfunction. This is a relatively 
easy measurement to acquire and reflects both longitudinal and radial 
components of RV contractility, which is particularly important in raised 
RV afterload[54]. However, this parameter completely neglects the 
contribution of the outflow portion of the RV to ejection, and hence may 
not accurately reflect global RV function. Furthermore, due to LV 
circumferential torsion and the crescentic shape of the RV, the end-
diastolic and end-systolic RV images may be in different tomographic 
planes. 
 
1.2.1.3 Doppler Tissue Imaging (DTI)-derived tricuspid lateral 
annular systolic velocity wave (S’) 
The motion of the lateral tricuspid annulus and the basal free wall 
segment can be reproducibly imaged from the apical 4-chamber window. 
Either pulsed tissue Doppler or colour-coded tissue Doppler can be used 
to measure the peak longitudinal velocity of excursion of the lateral 
tricuspid annulus and basal RV free wall, termed S’. An apical 4-chamber 
window optimized to visualize the RV is imaged, with S’ obtained by one 
of two methods: 
(i) A tissue Doppler mode region of interest is placed over the RV free 
wall. The pulsed Doppler sample volume is placed over the tricuspid 
annulus and the basal segment of the RV free wall (Figure 1-7). The 
peak S’ velocity is taken as the highest systolic velocity, with a value 
<9.5 cm/s indicating RV systolic dysfunction. 
(ii) The alternative approach is to acquire colour-coded tissue Doppler at 
high frame rates to be analyzed offline (Figure 1-8). This 
methodology provides lower velocities, because the encoded data 
represent mean rather than peak velocities.  
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Whilst easy to acquire, S’ only provides a longitudinal measure of 
function, is angle-dependent, and is measured relative to the transducer. 
This parameter may therefore be influenced by overall heart motion. 
Furthermore, S’ assumes that the function of a single RV region is 
representative of the function of the entire chamber. 
Figure 1-7: RV S’ using pulsed tissue Doppler imaging (TDI). 
 
Figure 1-8: Offline analysis of RV colour-coded tissue Doppler. 
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1.2.1.4 Tricuspid Annular Plane Systolic Excursion (TAPSE) 
The longitudinal systolic excursion of the lateral tricuspid annulus is 
visually readily apparent by 2DE. It can be measured by M-mode 
echocardiography with the cursor aligned along the direction of motion of 
the annulus in the apical four-chamber window (Figure 1-9). A cut-off 
value of <17mm indicates RV dysfunction. However, TAPSE is subject to 
translational motion of the RV rather than being reflective of myocardial 
shortening[55]. It is also angle-dependent and only represents the 
longitudinal motion of an isolated RV segment. 
Figure 1-9: RV TAPSE obtained from a zoomed M-mode image. 
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1.2.1.5 RV index of myocardial performance (RIMP) / Tei Index 
RIMP, also known as the Tei index or myocardial performance index 
(MPI), is described as both a global and physiological measure of RV 
function, since it combines information obtained in both systole and 
diastole. The MPI is defined as the proportion of the cardiac cycle 
effectively wasted in isovolumic time relative to the overall ejection time: 
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Equation 1-2: Tei index 
 
The MPI can be obtained by two methods: 
(i) In the pulsed Doppler method, ejection time is measured by pulsed 
wave Doppler of RV outflow (time from the onset to the cessation of 
flow). The time period from tricuspid valve closure to opening is 
measured by pulsed wave Doppler of the tricuspid inflow (from the 
end of the trans-tricuspid A wave to the beginning of the trans-
tricuspid E wave, Figure 1-10). These intervals are measured from 
different cardiac cycles in different echocardiography windows. 
Therefore beats with similar R-R intervals must be used, negating the 
application of this method in patients with arrhythmia. RIMP >0.43 by 
the pulsed wave Doppler method is defined as abnormal. 
(ii) Alternatively, all time intervals can be measured from a single cardiac 
cycle by using pulsed tissue Doppler of the tricuspid annulus (Figure 
1-11). RIMP >0.54 by the DTI method suggests RV dysfunction. 
 
Caution should be applied with RIMP in situations of raised right atrial 
pressure, as the value obtained can be pseudonormalized due to a 
reduced isovolumic relaxation time. 
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Figure 1-10: RV Tei index obtained by the separate acquisition of pulsed-wave 
Doppler of the tricuspid valve inflow (above) and RV outflow (below). 
 
Figure 1-11: RV Tei index obtained by tissue Doppler imaging of the RV lateral 
tricuspid annulus. 
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1.2.1.6 Deformation imaging: strain and strain rate 
Strain and strain rate are deformation parameters reflecting RV 
contractility. Strain is the percentage of systolic myocardial shortening, 
with this change over time measured by strain rate. RV longitudinal strain 
is determined by the percentage of systolic shortening of the free wall 
from base to apex in a RV-focused 4-chamber window (Figure 1-12). RV 
global longitudinal strain may either refer to the average of the RV free 
wall and the septal segments or the RV free wall segments alone, and 
must be considered when comparing studies. 
Figure 1-12: Vector velocity imaging (VVI) speckle tracking echocardiography 
(STE) of the RV of a healthy volunteer. 
The direction and magnitude of the vectors represent myocardial 
deformation. 
 
Deformation parameters can be measured using DTI, accepting the 
inherent limitations of angle dependency and lower signal from the mid-
wall and apical segments. Alternatively, speckle-tracking 
echocardiography (STE) can be used. STE software performs frame-by-
frame tracking of intrinsic myocardial speckles on sequential images 
using an algorithm involving correlation criteria and sums of absolute 
differences. Furthermore, vendor-specific post-processing smoothing 
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algorithms are applied, and in many cases this has been designed for 
application to the LV and later adapted for the RV. 
 
STE requires high temporal resolution for accuracy, and care must be 
taken to avoid algorithmic smoothing compensating for poor quality 2DE 
datasets. Normative reference data are currently heavily weighted 
towards one vendor, and cannot be applied across all vendor platforms. 
However, global longitudinal RV free wall strain > -20% is generally 
regarded as abnormal. 
 
1.2.2 Cardiac Magnetic Resonance Imaging (CMRI) 
CMRI is the ‘gold standard’ imaging modality for assessing cardiac 
volumes[56, 57]. Image acquisition is not limited by windows afforded by 
intercostal rib spaces, body habitus or hyperinflated lungs, as can be the 
case with echocardiography. A contiguous stack of cines is acquired from 
the base to the apex of both ventricles (Figure 1-13). This cross-sectional 
approach also overcomes the complex shape and geometry of the RV 
that hinders 2D imaging approaches, allowing quantification of RV cavity 
volume measurements, stroke volume, ejection fraction and mass. 
Figure 1-13: A short-axis stack (in end-systole) of cines obtained from a healthy 
volunteer using a radial k-t SENSE CMRI sequence. 
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Post-processing entails manual contouring for volumetric analysis. The 
endocardium is manually traced at end-diastole and end-systole for all 
slices in the stack of cines. Mass can also be derived by drawing 
epicardial regions of interest. End-diastolic and end-systolic volumes, 
ejection fraction and mass are then calculated by summation of the 
respective traced regions of interest, termed the disc summation method. 
The main difficulty in RV segmentation is distinguishing the endocardial 
border from the prominent trabeculations. Including RV trabeculations in 
the cavity blood pool volume is more reproducible and requires less post-
processing time[58, 59]. It is clear is that whichever methodology of RV 
segmentation is chosen, consensus training of professionals and 
standardization of post-processing protocols within clinical institutions is 
pivotal to optimizing RV quantification reproducibility by CMRI[60]. 
 
Whilst ideally suited for assessment of the RV, CMRI has well 
documented disadvantages. CMRI is significantly more expensive and 
less readily available than echocardiography[61]. The majority of 
permanent pacemakers and implantable cardiac defibrillators are 
considered a contraindication to MRI by the United States Food and Drug 
Administration (FDA) and by device manufacturers. However, the number 
of patients with an implanted pacing device that are estimated to require 
investigation with MRI has directed the European Society of Cardiology 
(ESC) to issue safety precautions for MRI in these patients[62]. Patients 
who are claustrophobic may also not be able to undergo investigation by 
this modality. Some widely quoted disadvantages of MRI, however, can 
be readily overcome. The conventional approach of acquiring each slice 
with breath-hold cine imaging results in long acquisition times and 
potential problems with multiple breath holds. However, these limitations 
can be overcome with high spatio-temporal resolution real-time MRI[63]. 
Finally, the acquisition of cines by MRI for volumetric analysis does not 
require contrast agents. 
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As with any imaging technique, the reliability of CMRI depends upon 
standardization of image acquisition and post-processing. Overall, 
several studies have reported good and clinically acceptable 
intraobserver, interobserver and interstudy reproducibility metrics for RV 
assessment by CMRI (Table 1-1) [64-66]. Conventional short-axis stacks 
of cines that are more suited to LV volumetric analysis were acquired in 
these studies. Further improvements in reproducibility have been 
reported instead using a transaxial stack of cines specifically for RV 
analysis[67, 68] (Figure 1-14). This is likely due to a number of reasons: 
easier identification of the tricuspid and pulmonary valves; avoidance of 
difficulty identifying the basal slice in the short-axis stack; and eliminating 
inaccuracies in post-processing caused by through-plane longitudinal 
motion of the RV when acquired in the short-axis. Consequently, the 
acquisition of a transaxial stack of cines is recommended for dedicated 
RV volumetric analysis[69]. 
Figure 1-14: A transaxial stack (in end-diastole) of cines for RV volumetric 
analysis obtained from a healthy volunteer using a radial k-t SENSE CMRI 
sequence. 
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1.2.3 RV assessment by 2DE versus CMRI 
CMRI has been used as the reference standard for other modalities to 
quantitatively assess the RV for almost two decades[70]. Given the more 
limited availability and greater expense of this modality, some groups 
have instead attempted to define 2DE thresholds for stratifying those 
patients who may not require further RV assessment by CMRI [71]. 
However, 2DE measures of RV function, including 2D, M-mode, tissue 
Doppler and strain parameters, correlate poorly overall against CMRI-
derived RV ejection fraction (EF) in both congenital and acquired RV 
disease populations[53, 72-79] (Table 1-2). Furthermore, different 2DE 
parameters have a diverse capacity for identifying RV dysfunction[73, 75, 
77-79] (Table 1-3). The overall impression from this literature is that FAC, 
S’ and RV systolic deformation parameters have the most superior profile 
for identifying CMRI-defined thresholds of RV dysfunction. FAC is 
consistently superior to TAPSE, likely due to the integration of radial and 
longitudinal components of motion, and also because the reference 
measure of RV EF by CMRI is similarly a global geometric parameter. 
 
For these reasons, imaging modalities for the quantitative assessment of 
RV size and function should ideally use three-dimensional metrics[26]. 
  
CHAPTER 1 Non-invasive Imaging of the Right Ventricle  
 
 42 
 
 
 
Ta
bl
e 
1-
2:
 2
D
E-
de
riv
ed
 m
et
ric
s 
of
 R
V 
fu
nc
tio
n 
co
rr
el
at
ed
 a
ga
in
st
 C
M
R
I-d
er
iv
ed
 R
VE
F.
 
  
CHAPTER 1 Non-invasive Imaging of the Right Ventricle  
 
 43 
 
 
 
 
Ta
bl
e 
1-
3:
 V
al
ue
 o
f 2
D
E-
de
riv
ed
 m
et
ric
s 
of
 R
V 
fu
nc
tio
n 
to
 id
en
tif
y 
R
V 
dy
sf
un
ct
io
n 
de
fin
ed
 b
y 
C
M
R
I. 
  
CHAPTER 1 Non-invasive Imaging of the Right Ventricle  
 
 44 
1.3 The RV in pressure- and volume-overload states 
The comparison of two distinct imaging modalities is, at least in part, a 
reflection of the homogeneity of the subject cohorts that are studied. 
Acquired primary RV pressure- and volume-overload in vivo is best 
represented by the disease states of pulmonary hypertension (PH) and 
carcinoid heart disease (CHD) respectively. 
 
1.3.1 Pressure-overload of the RV: Pulmonary Hypertension 
The pathologic abnormalities in pulmonary arterial hypertension (PAH) 
constitute vasoconstriction, remodeling and endothelial proliferation of the 
pulmonary arterial tree. This culminates in raised pulmonary vascular 
resistance. The condition carries a high mortality rate of 20% to 40% at 
three years post-diagnosis[17]. However, the degree of raised pulmonary 
pressure is only of modest prognostic significance. It is, rather, the ability 
of the RV to function against this raised afterload that is the key 
determinant of symptoms and mortality[21]. Thus CMRI is ideally placed 
to provide highly prognostic data through RV functional quantification in 
PH[80, 81]. Moreover, interventricular septal dynamics assessed by both 
echocardiography and CMRI are highly revealing of the afterload 
conditions facing the RV[82-85].  
 
PH can be due to a variety of causes, all of which require a tailored 
therapeutic approach (Table 1-4)[86]. Patients with PAH in whom the RV 
is more adapted to working against higher afterload, such as 
Eisenmenger’s syndrome, have a better survival despite higher 
pulmonary pressures than those with a previously normal RV, such as 
idiopathic PAH[87]. Moreover, patients with idiopathic PAH have a better 
survival than those with systemic sclerosis-associated PAH despite 
similar pulmonary pressures[88]. Overall, patients with systemic-sclerosis 
associated PAH have the worst prognosis of all of the underlying disease 
aetiologies[89, 90]. The prognostic heterogeneity related to the cause of 
PAH is most likely due to the nature of RV involvement in the disease 
process. It is suggested that patients with Eisenmenger’s syndrome retain 
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a foetal RV phenotype, whereby RV wall thickness equals that of the LV, 
from infancy to adolescence and adulthood[91]. The ability for the RV to 
offload via a right-to-left shunt may also contribute to the improved 
survival of the Eisenmenger’s syndrome group, akin to the rationale of 
atrial septostomy as an interventional approach for decompensated 
PAH[92]. Patients with systemic sclerosis-associated PAH likely fare 
worst as a result of intrinsic RV systolic dysfunction possibly due to 
replacement fibrosis, further impairing the response to pulmonary 
arteriopathy[88]. 
 
Prior to the advent of medical therapies targeted at the reduction of 
pulmonary pressures, the field of PAH was morbidly referred to as “the 
kingdom of the near-dead”[93]. Pathobiological pathways targeted by 
PAH pharmacotherapy include endothelin, nitric oxide, platelet-derived 
growth factor and prostacyclin pathways (Table 1-5). These are 
introduced as monotherapy or combination therapy in an algorithmic 
approach[94]. Whilst there are no specific medical therapies available for 
the treatment of RV dysfunction, not all pulmonary vasodilator therapies 
are equal in terms of their impact on RV function. For example, sildenafil 
increases RV contractility through direct effects on the RV myocardium 
independent of its pulmonary vasodilator activity in a monocrotaline 
rodent model of PH[95].  
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1 Pulmonary arterial hypertension (PAH) 
 1.1 Idiopathic PAH 
 1.2 Heritable PAH 
 1.3 Drug and toxin induced 
 1.4 Associated with: 
  1.41 Connective tissue disease 
  1.42 Human immunodeficiency virus (HIV) infection 
  1.4.3 Portal hypertension 
  1.4.4 Congenital heart diseases 
  1.4.5 Schistosomiasis 
1’ Pulmonary veno-occlusive disease and/or pulmonary capillary haemangiomatosis 
1’’ Persistent pulmonary hypertension of the newborn (PPHN) 
2 Pulmonary hypertension due to left heart disease 
 2.1 Left ventricular systolic dysfunction 
 2.2 Left ventricular diastolic dysfunction 
 2.3 Valvular disease 
 2.4 Congenital/acquired left heart inflow/outflow tract obstruction and congenital 
cardiomyopathies 
3 Pulmonary hypertension due to lung diseases and/or hypoxia 
 3.1 Chronic obstructive pulmonary disease 
 3.2 Interstitial lung disease 
 3.3 Other pulmonary diseases with mixed restrictive and obstructive pattern 
 3.4 Sleep-disordered breathing 
 3.5 Alveolar hypoventilation disorders 
 3.6 Chronic exposure to high altitude 
 3.7 Developmental lung diseases 
4 Chronic thromboembolic pulmonary hypertension (CTEPH) 
5 Pulmonary hypertension with unclear multifactorial mechanisms 
 5.1 Haematologic disorders: chronic haemolytic anemia, myeloproliferative 
disorders, splenectomy 
 5.2 Systemic disorders: sarcoidosis, pulmonary histiocytosis, 
lymphangioleiomyomatosis 
 5.3 Metabolic disorders: glycogen storage disease, Gaucher disease, thyroid 
disorders 
 5.4 Others: tumoural obstruction, fibrosing mediastinitis, chronic renal failure, 
segmental PH 
Table 1-4: Classification of pulmonary hypertension based upon aetiology. 
Reproduced from 5th World Symposium on pulmonary hypertension (WSPH), Nice 
2013. 
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Pathobiologic pathway targeted Drugs 
Endothelin  
 Endothelin receptor antagonists Ambrisentan, Bosentan, Macitentan 
Nitric Oxide  
 Soluble Guanylate Cyclase 
Stimulators 
Riociguat 
 Phosphodiesterase Type-5 Inhibitors Sildenafil, Tadalafil, Vardenafil 
Platelet-Derived Growth Factor  
 Tyrosine kinase inhibitor Imatinib 
Prostacyclin  
 Prostanoids Beraprost, Epoprostenol, Iloprost, 
Treprostinil 
 Prostacyclin IP-receptor Agonists Selexipag 
Table 1-5: Classes of drugs used to treat pulmonary hypertension. 
 
1.3.2 Volume-overload of the RV: CHD 
Carcinoid is a slow-developing cancer of the neuroendocrine system, 
occurring in approximately 1-2.5 per 100,000 of the population[96]. 
Carcinoid syndrome occurs when the tumour metastasizes to the liver, 
and vasoactive amines and peptides secreted by carcinoid tumour cells 
including 5-hydroxytriptamine (5HT) are able to reach the systemic 
circulation. CHD is present in up to 20% of patients with carcinoid 
syndrome at diagnosis, and is an independent predictor of worse 
prognosis[97]. CHD results from circulating 5HT reaching the right heart, 
causing the endocardial deposition of fibrous plaques on the tricuspid and 
pulmonary valves. Valve leaflets/cusps become thickened, retracted and 
have reduced mobility, eventually becoming fixed[98] (Figure 1-15). 
Functionally a combination of valvular regurgitation and stenosis occurs. 
Many patients are initially asymptomatic despite severe disease, but 
symptoms ultimately result from ensuing right heart volume-overload and 
systolic dysfunction[99]. Without valve replacement surgery, patients with 
RV dilatation have a worse outcome[100]. Valve replacement offers 
symptomatic relief and probable survival advantage, but predicting the 
optimal time to operate remains imprecise[101]. This decision will involve 
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an assessment of the impact of the valvulopathy on RV function, the 
monitoring of which by CMRI has been suggested[102]. 
Figure 1-15: Severe carcinoid heart disease affecting the tricuspid (a-d) and 
pulmonary (e-f) valves. 
Valve leaflets are fixed and retracted, with the valve orif ice open 
throughout the cardiac cycle. This gives rise to free-flowing laminar TR (c-
d) and PR (e-f). The tricuspid valve is visualized fixed open en face by 3DE 
in (a) end-diastole and (b) end-systole. 
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2.1 Introduction 
The most convenient imaging modality for assessing the right ventricle 
(RV) is two-dimensional echocardiography (2DE), but this is limited by the 
crescentic chamber shape and complex geometry, with inflow and outflow 
portions in different planes[12, 23]. Thus cardiac magnetic resonance 
imaging (CMRI) has become the “gold standard” imaging modality for RV 
quantification[103]. The comparative expense and limited availability of 
CMRI as the current reference standard favours the pursuit of novel 
approaches to RV quantification by cardiac ultrasound. 
 
One possibility to overcome the limitations of 2DE is three-dimensional 
echocardiography (3DE). This technique has been previously been 
compared against CMRI in a range of congenital and acquired diseases 
for RV volumetric quantification[104]. 3DE traditionally utilizes the disk 
summation method to reconstruct the RV following sequential slice 
acquisition over consecutive ECG-gated heartbeats[105]. This 3DE 
method, however, is limited by breath holding throughout successive 
cardiac cycles, stitching artifact during acquisition, and difficulties 
identifying inlet and outflow regions in the basal slices during post-
processing[106]. More recently though, ultrasound transducer technology 
has been developed to enable the real-time acquisition of a 90o by 90o full 
volume dataset in a single cardiac cycle[107]. 
 
2.1.1 Aims 
The aims of this study were to: 
  Compare RV volumetric quantification by single-beat full-volume 
3DE against CMRI in homogenous patient populations of acquired 
RV pressure- and volume-overload, namely, PH and CHD, 
respectively. 
  Compare single-beat full-volume 3DE and 2DE functional indices 
in the identification of CMRI-defined RV dysfunction in PH. 
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  Evaluate the test-retest reproducibility of single-beat full-volume 
3DE for both the acquisition and post-processing components of 
the technique. 
 
2.1.2 Personal Contribution 
To fulfill the above aims I have: 
  Obtained ethical approval from the local institutional research 
ethics committee (North West London REC 2) and research and 
development (R&D) approval from the R&D departments at The 
Royal Free Hospital and Great Ormond Street Hospital NHS 
Trusts. 
  Enrolled 100 participants in sinus rhythm with no contraindications 
to magnetic resonance imaging. 
  Performed and post-processed comprehensive 2DE and single-
beat full-volume 3DE studies of the RV for all participants. 
  Repeated the 3DE studies of the RV for a subset of 20 randomly 
selected participants. 
  Post-processed the CMRI studies for all participants to quantify the 
reference standard metrics of RV function. 
 
The results from this work have been published by D. Knight, A. Grasso, 
M. Quail, V. Muthurangu, A. Taylor, C. Toumpanakis, M. Caplin, J. 
Coghlan and J. Davar, in the Journal of the American Society of 
Echocardiography, 2015, 28(3), entitled; “Accuracy and reproducibility of 
right ventricular quantification in patients with pressure and volume 
overload using single-beat three-dimensional echocardiography” [108] 
(see Appendix 1). 
 
2.2 Literature Overview 
In this section, literature on the following areas will be discussed: 
  Benefits of RV functional assessment using 3DE versus 2DE 
  The evolution of 3DE technology 
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  Comparison of MRI versus 3DE in PH for RV volumetric 
quantification 
  Test-retest reproducibility of 3DE for RV volumetric quantification 
 
This overview highlights relevant papers that were found using the 
PubMed search engine. The search terms used included (a combination 
of): 
  Three-dimensional echocardiography 
  Right ventricle 
  Magnetic resonance imaging 
  Test-retest reproducibility 
  Pulmonary hypertension 
When a relevant paper was found, selected referenced papers were 
followed up and any subsequent papers that have cited this paper were 
also followed up. 
 
2.2.1 Benefits of RV functional assessment using 3DE versus 2DE 
The direct comparison of both 2DE and 3DE versus MRI for RV functional 
quantification has only been performed in one study of 120 patients with 
congenital heart disease, 62 (52%) of whom had disease primarily 
affecting the RV[78]. RV dysfunction was defined as any one of an 
indexed EDV >129mL/m2, indexed ESV >58mL/m2, and/or RVEF <48% 
by CMRI. The area under the ROC curve was then defined for both 
traditional 2DE RV functional metrics (FAC, AUC 0.76; TAPSE, AUC 
0.72) and 3DE-derived RVEF (AUC 0.86). RVEF by 3DE was statistically 
significantly superior to TAPSE for identifying RV dysfunction. 2DE-
derived RV FAC and 3DE-derived RV EF were most likely superior to 
TAPSE given that they constitute geometric measures of RV function 
similar to CMRI-derived RVEF. 
 
The importance of 3DE providing global information on systolic function 
over 2DE measures focusing on RV longitudinal function has also been 
demonstrated in the post-cardiac surgery setting[109]. Post-surgical 
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reductions in TAPSE and peak RV systolic velocity are well documented, 
yet global systolic function by 3DE-derived RVEF was shown to be 
unchanged in 40 patients following mitral valve repair. The authors 
concluded that these discordant findings represent a geometric alteration 
in the RV post-operatively rather than true dysfunction, and hence 
surrogate 2DE measures of RV function should be interpreted with 
caution in this context. 
 
2.2.2 The evolution of 3DE technology 
There are two distinct 3DE methods in contemporary practice for the 
acquisition of 3D RV datasets: (i) electrocardiogram (ECG)-gated 
multiple-beat 3DE, and (ii) real-time or live 3DE[105]. 
 
There are also two different commercially available post-processing 
algorithms for 3DE RV datasets: (i) the disk summation method (or 
‘method of disks’), and, more recently (ii) the volumetric semi-automated 
border detection approach[105]. 
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2.2.2.1 ECG-gated multiple-beat 3DE of the RV 
The majority of contemporary in vivo clinical studies utilizing 3DE for the 
evaluation of RV volumes have been performed using multiple-beat gated 
3DE. This technology involves the acquisition of serial sub-volume slices 
of the RV gated to consecutive heartbeats. The sub-volumes are then 
stitched together to form a 3D reconstruction (Figure 2-1). 
Figure 2-1: Schematic of ECG-triggered multiple-beat 3DE data acquisition. 
Narrow pyramidal sub-volumes from four consecutive cardiac cycles are stitched 
together to form a single pyramidal volumetric data set. 
 
The limitations of this technique are inherent to the acquisition of sub-
volumes over several cardiac cycles, usually of the order of 2 to 7 
heartbeats. Patients with arrhythmia or who have difficulty with breath-
holding are prone to stitching artifact, whereby the sub-volumes are 
consequently sub-optimally reconstructed into a volumetric dataset that 
ranges from inaccurate to unusable (Figure 2-2). This can occur with 
arrhythmia due to cavity volumes varying with changes in consecutive R-
R intervals. Stitching artifact with respiratory motion results from changes 
in cardiac position in the thorax with breathing. A further limitation is that 
the volume being acquired can only be inspected after it is obtained, as 
images are not displayed in real-time. 
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Figure 2-2: ECG-gated multiple beat 3DE of the RV. Figure (a) shows a volumetric 
RV data set with no stitching and good image quality on the short-axis slices (b) 
following acquisition. Figure (c) demonstrates stitching artefact (red dotted line) 
caused by breathing during scan acquisition, with stitching visible on 
reconstruction of the sub-volumes in the short-axis slices (d). 
 
Studies using the multiple-gated 3DE technique tended to report an 
underestimation of RV volumes and EF by 3DE when compared against 
CMRI. A meta-analysis was performed of 23 studies including a total of 
807 patients comparing RV volumetric assessment by 3DE versus CMRI 
through May 2010 [104]. All studies that were included were performed 
using multiple-beat gated 3DE acquisition. There was significant bias for 
underestimation of both RV volumes (RVEDV -13.9mL [-17.7, -10.1], 
P<0.00001; RVESV -5.5mL [-7.6, -3.4], P<0.00001) and EF (-0.9% [-1.8, 
-0.1], P=0.03) by 3DE. The factors accounting for a tendency for 
underestimation of RV volumes and EF by 3DE included younger 
participant age (mean age <18 years, P<0.05) and larger RV cavity size 
(EDV >200 mL, P<0.05). 
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A common reason that is cited for underestimation of RV volumes by 3DE 
is the observer tracing further inside the ventricular cavity due to blurred 
endocardial borders resulting from the lower spatial resolution compared 
to 2DE[13]. In an attempt to circumvent this post-processing limitation, it 
has previously been proposed that tracing on the ‘white side’ of the 
endocardial border limits volumetric underestimation by 3DE[110]. Whilst 
noting the findings of the meta-analysis, a small study of 33 patients of 
mixed left heart disease aetiologies comparing 3DE with CMRI has since 
conversely reported more volumetric underestimation for non-dilated 
RVs[111]. This was attributed to easier operator identification of 
trabeculae in dilated RV cavities. 
 
2.2.2.2 Real-time 3DE: single-beat full-volume 3DE of the RV  
More recently, advances in transducer technology have moved away 
from the acquisition of serial sub-volumes. The generation of 
simultaneous multiple ultrasound beams can now allow the acquisition of 
a full-volume dataset in a single heartbeat. This negates the need for 
ECG-gated acquisition, thus avoiding stitching artifact by enabling the 
acquisition of 3D full-volume datasets with irregular R-R intervals. The 
more rapid acquisition times also result in shorter breath-holds. The real-
time nature of obtaining a full-volume dataset also permits the real-time 
display of orthogonal 2D imaging planes prior to and at the time of 
acquisition. This allows the operator to acquire a dataset when satisfied 
that it contains all of the structure(s) being studied. 
 
Two studies have specifically investigated single-beat full-volume 3DE of 
the RV compared with CMRI. The first study investigated the effect of 
long-distance running on RV size and function using both 3DE and CMRI 
in 22 individuals before and after a 30 kilometre run[112]. Whilst 3DE was 
feasible in all subjects, it demonstrated a significant bias for 
underestimation of RV volumes. However, the authors reported a 
tendency to exclude trabeculae from the blood pool volume on 3DE, but 
to include RV trabeculae in the cavity volume on CMRI post-processing. 
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Therefore the post-processing techniques of the two modalities were 
fundamentally different, which could account for this bias. The second 
study of 61 patients of various cardiac disease aetiologies attending for 
same-day CMRI and single-beat 3DE found minimal bias for cavity 
volume quantification between modalities[113]. Notably, this study 
included trabeculae in the RV cavity volume during the post-processing 
stages of both modalities. 
 
2.2.2.3 Commercially available 3DE RV post-processing algorithms 
The disk summation method was the original technique for post-
processing 3DE RV datasets. After allocating the end-diastolic and end-
systolic frames, the operator manually traces the endocardial border in 
the axial plane for serial short-axis slices of a fixed height, usually 7 to 
10mm thick (Figure 2-3). The axial planes can be cross-referenced to 
long-axis images to enable identification of the tricuspid annulus. The RV 
cavity is reconstructed by adding the known areas of the serial axial 
traces, termed disk summation. 
Figure 2-3: The disk summation technique for 3DE RV reconstruction. 
A series of contiguous RV short-axis slices are displayed, corresponding to 
the disks on the 4-chamber view. The endocardial borders are traced 
manually. Reproduced with permission from Morikawa et al .[114] 
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More recently, semi-automated border detection methods have been 
utilized for volumetric analysis. Different semi-automated algorithms have 
been previously described[115, 116]. Commonly, a 3DE-acquired RV 
dataset is imported into the software and manipulated by rotating, 
angulating, and slicing in any of the three displayed orthogonal planes. 
The operator manually traces the endocardial contour for end-diastolic 
and end-systolic frames in sagittal, four-chamber and coronal planes. 
These cross-sectional planes allow visualization of the tricuspid annulus, 
the ventriculo-infundibular fold, RV outflow tract, and RV apex. A semi-
automated border detection algorithm based on in vivo normal subjects 
and pathologic RV modeling is subsequently run (Figure 2-4), with the 
option of manual correction of the traced contours in the event of sub-
optimal border tracking[116, 117]. 
Figure 2-4: The results of a semi-automated RV endocardial border detection 
algorithm, with the border tracking through the cardiac cycle in the sagittal (three 
levels), 4-chamber and coronal views displayed to the operator. 
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A surface-rendered cast of the RV is then created, with accompanying 
RV EDV, ESV and EF automatically displayed (Figure 2-5)[105]. 
Segmental analysis of the inlet, apex and outlet portions of the RV can be 
performed with some software versions, and time curves of global and 
regional function during the cardiac cycle can also be generated. 
Figure 2-5: Surface-rendered cast of the RV following 3DE reconstruction with a 
time curve of global function during the cardiac cycle. 
 
The volumetric semi-automated border detection approach is significantly 
more accurate than disk summation, in part due to less geometric 
assumptions and the superior ability to visually delineate the boundaries 
of the RV inlet and outlet portions[106]. As such it is the recommended 
3DE post-processing technique for quantification of RV function[49]. 
 
2.2.3 Comparison of 3DE versus MRI in PH for RV volumetric 
quantification 
All three studies specifically designed to investigate 3DE against CMRI 
for assessing RV volumes in PH utilized multiple-beat gated 3DE, with 
variable results reported. Grapsa et al. found minimal mean differences 
for 3D RV metrics using 3DE in 60 consecutive patients with newly 
diagnosed PH and 20 healthy controls[118]. However, there were wide 
limits of agreement for these parameters between modalities, particularly 
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in the PH patient population (RVEDV -3.7mL [-61.1, 53.7], P<0.001; 
RVESV 0.0mL [+/-48.8], P<0.001; EF -1.3% [-15.5, 12.9], P=0.005). 
Contrastingly, Morikawa et al. reported small underestimations of indexed 
RV volumes by 3DE in 30 patients with PH and 15 healthy volunteers, but 
with narrower limits of agreement (RVEDV -9.0mL/m2 [-33, 15], P<0.001; 
RVESV -3.5mL/m2 [-13.1, 6.1], P<0.001; EF -3.1% [-8.5, 2.3], 
P<0.001)[114]. Finally, Li et al. also found a bias for underestimation of 
RV cavity volume measurements in a population of 23 patients with PH, 
but with clinically acceptable limits of agreement (RVEDV -9.7mL [-6.0, 
25.5], P<0.001; RVESV 3.4mL [-13.3, 20.1], P<0.001; EF 2.4% [-6.6, 
11.3], P<0.001)[119]. This most recent study also stated in the 
methodology that two different 3DE transducers were used for ECG-
gated recordings over 4 to 7 cardiac cycles, although one of the two 
transducers specified is actually capable of single-beat full-volume 
acquisition (4Z1C matrix-array transducer, Siemens Acuson SC2000). 
 
2.2.4 Test-retest reproducibility of 3DE for RV volumetric 
quantification 
The test-retest reproducibility of RV assessment by 3DE has been 
reported in five studies, all of which utilized multiple-beat gated 3DE 
(Table 2-1). 
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However, the methodology and statistical reporting of these studies 
varies widely. Despite acquiring repeated measures of RV size and 
function, the study of van der Zwaan et al. uses multiple paired t-tests to 
compare differences between serial acquisitions, which may 
underestimate potential differences between studies. Nevertheless, 
current American Society of Echocardiography (ASE) guidelines for RV 
assessment favour 3DE, partly due to its superior reproducibility than 
2DE metrics when properly performed in echocardiography laboratories 
with appropriate training and experience[49, 50, 110, 120]. 
 
2.2.5 Summary 
From the literature overview it is evident that 3DE is a feasible technique 
for RV functional quantification, with emerging recognition over traditional 
2DE methods. However; 
  Multiple-beat gated 3DE with disk summation reconstruction is 
limited by breath-holding throughout successive cardiac cycles, 
stitching artifacts during acquisition, and difficulties identifying inlet 
and outflow regions in the basal slices during post-processing. 
  There is an abundance of data demonstrating a tendency for 
underestimation of RV volumes using multiple-beat gated 3DE, 
particularly in dilated RV cavities. 
  There is a relative paucity of data comparing single-beat full-
volume 3DE against CMRI for RV volumetric quantification, with no 
studies of this iteration of 3DE technology in homogeneous 
populations of acquired RV disease. 
  There are no studies of test-retest reproducibility utilizing single-
beat full volume 3DE technology. Furthermore, the statistical 
methodology for evaluating the test-retest reproducibility of 3DE-
derived metrics could be optimized. 
 
I aim to demonstrate the feasibility of contemporary ultrasound transducer 
technology that allows single-beat full-volume acquisition of a 90 o X 90o 
3D RV dataset. This will be applied to homogeneous patient populations 
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of pressure- and volume-overload, namely PH and CHD respectively. By 
comparing single-beat 3DE against CMRI for RV quantification, I aim to 
perform the largest study of the accuracy of this novel 3DE technique and 
the first study of its test-retest reproducibility. I will also provide data to 
investigate the incremental benefit of single-beat 3DE over 2DE-derived 
metrics for the identification of RV dysfunction. 
 
2.3 Methods 
A prospective cross-sectional study was performed that enrolled 100 
participants in sinus rhythm with no contraindications to magnetic 
resonance imaging, all of whom underwent comprehensive 2DE, single-
beat 3DE of the RV, and CMRI within 2 hours of one another. 
 
2.3.1 Study Population 
The participants were divided into four subgroups: 
  A group of 49 consecutive patients with PH (diagnosed by right 
heart catheterization as a mean pulmonary artery pressure >25 
mmHg and a pulmonary capillary wedge pressure <15 mmHg 
[121]) who presented for diagnosis and/or follow-up of PH by 
clinical evaluation and/or right heart catheterization as a disease 
model of RV pressure-overload. The aetiologies of PH included 
idiopathic (n = 9), connective tissue disease-associated (n = 32), 
and chronic thromboembolic disease (n = 8). Exclusion criteria 
comprised clinically significant restrictive or obstructive lung 
disease identified by pulmonary function tests, arrhythmia, and 
known independent left-sided cardiac disease unrelated to PH. 
  A group of 20 consecutive patients undergoing 2DE for diagnosis 
and/or follow-up of CHD [122] were studied as a disease model of 
RV volume-overload. 
  A control group of 20 healthy volunteers affiliated with our 
institution who were age and sex matched to the PH group. 
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  A control group of 11 age- and sex-matched patients with 
metastatic neuroendocrine tumour who were screened as negative 
by echocardiography for carcinoid valvular heart disease. 
 
All control participants were eligible for study inclusion if they had no 
cardiac symptomatology, no medical histories of cardiac disease 
including hypertension, and were not taking any cardiac medications. 
Normal 2D transthoracic echocardiographic findings were also required to 
exclude any occult structural cardiac disease before study inclusion. 
 
The study complied with the Declaration of Helsinki. The local institutional 
research ethics committee (North West London REC 2) approved the 
study and informed written consent was obtained from all participants. 
 
2.3.2 2DE 
All patients underwent comprehensive 2D and Doppler transthoracic 
echocardiography in the left lateral decubitus position using the Acuson 
Siemens SC2000 cardiac ultrasound system (Siemens Healthcare, 
Erlangen, Germany), with a 4V1c transducer (frequency bandwidth, 1.25-
4.5 MHz). A standard study protocol was followed in conjunction with 
ASE guidelines for chamber quantification [50, 123] and the British 
Society of Echocardiography guidelines for PH assessment [124] as 
appropriate. RV function was assessed using TAPSE, RV FAC, and 
mean RV free wall peak systolic strain using syngo Vector Velocity 
Imaging (Siemens Medical Solutions USA, Inc., Mountain View, CA). A 
three-beat 2DE digital clip of an apical 4-chamber view optimized for RV 
visualization was acquired and exported to Velocity Vector Imaging, and 
10 to 15 endocardial points were plotted in end-systole from the lateral to 
the medial tricuspid annulus [125]. The adequacy of speckle-tracking was 
visually checked and manually adjusted as required. 
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2.3.3 3DE 
2.3.3.1 Image Acquisition 
Single-beat full-volume 3D echocardiographic RV data sets were 
acquired using the 4Z1c matrix-array transducer (frequency bandwidth, 
1.5–3.5 MHz; maximum depth, 30 cm; maximum field of view, 90 o X 90o). 
Probe position started from the apical 4-chamber view with the patient in 
the left lateral decubitus position. Both the patient and transducer 
positions were subsequently modified for optimal simultaneous 
visualization of the tricuspid valve, cardiac apex, infundibulum, and RV 
outflow tract (RVOT) as assessed by the real-time 2D 4-chamber, basal 
sagittal, and coronal views, and by inclusion of the RV chamber in the 
pyramidal data set (Figure 2-6). 
Figure 2-6: A pyramidal dataset focusing upon a dilated RV in 4-chamber, sagittal 
and coronal views. 
Part of the LV is excluded from the volume pyramid (bottom right). Note the 
high volume rate (38 volumes per second). 
 
In both my experience and that of previous 3DE RV studies, a more 
lateral apical window with posterior tilt of the probe tail was beneficial to 
visualize the infundibulum and RVOT in the coronal window[126]. Image 
depth and sector width were adjusted for maximal visualization of the RV 
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at the highest volume rate. At least three 3DE RV data sets were 
acquired during a breath-hold to ensure optimal image quality, which was 
subjectively graded on a five-point scale ranging from zero (very poor) to 
four (perfect) [127]. A score of two or less was attributed if ultrasound 
dropout was evident in greater than half of the RVOT border. 
 
2.3.3.2 Post-Processing 
Full-volume 3DE RV data sets were imported into the on-cart RV Analysis 
application. Manual adjustment of the RV data set was initially required 
to: (i) ensure the correct orientation of 4-chamber, sagittal, and coronal 
slices; (ii) maximize the RV cavity area and identify the most apical RV 
view on visual assessment of the 4-chamber window; and, (iii) allow the 
identification of cardiac landmarks. This process was performed in a 
stepwise approach by rotation and angulation of the 4-chamber window, 
with manipulation of this plane causing the simultaneous adjustment of 
the other two (sagittal and coronal) orthogonal planes (Figure 2-7). 
Figure 2-7: Optimization of the RV cavity area in the three orthogonal views, and 
identification of landmarks. 
(MV=mitral valve indicated by the blue asterix, TV=tricuspid valve indicated 
by the red asterix). Note the RVOT seen in the coronal view (indicated by 
the purple asterix). 
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Both atrioventricular valves followed by the left ventricular apex were 
identified as anatomic landmarks. When the apex of a dilated RV 
overrode that of the left ventricle, the most apical cardiac point was 
identified with the left ventricular apex marker. End-diastolic and end-
systolic frames were assigned by visual identification of the largest and 
smallest RV 4-chamber areas, respectively. 
 
Endocardial RV borders were traced at end-diastole and end-systole in 4-
chamber, sagittal (basal level), and coronal views. The software algorithm 
obliges the operator to intersect the endocardial border tracing in 
sequential views with crosshair reference markers that are positioned in 
response to endocardial border traces from a preceding view. Therefore, 
correction of a previous slice tracing was undertaken when a crosshair 
position suggested a prior tracing error. Trabeculae were included in the 
blood pool volume. To assist with RVOT delineation in the basal sagittal 
view, the insertion point of the RV myocardium at the interventricular 
septum was routinely included in the endocardial tracing.  
 
At the final stage, the algorithm presents the results of semi-automated 
contour tracking for the 4-chamber, coronal and basal, middle and apical 
short-axis views. Misalignment of endocardial contours prompted 
identification of the region of suboptimal tracking followed by manual 
correction of the original tracing. Automated volumetric reconstruction 
was accepted only once the semi-automated endocardial border tracking 
was visually satisfactory and represented meaningful RV shapes in all 
views (Figure 2-8), as optimization of this final reconstruction stage 
significantly affects the results generated [128]. 
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Figure 2-8: The results of semi-automated border tracking. 
Note how the purple guideline (indicated by the purple asterix) bisects the 
tricuspid valve and RVOT in the short-axis views. This corresponds to the 
coronal RV reconstruction (highlighted), with clearly delineated RV inflow 
and outflow portions. 
 
2.3.4 Test-Retest Reproducibility of 3DE 
Reproducibility was studied in 20 randomly selected subjects (14 with PH, 
one with CHD, and five healthy volunteers) for both the 3DE acquisition 
and post-processing stages by two independent sonographers (D.S.K. 
and A.E.G.), as previously described (Figure 2-9) [129]. The two 
sonographers had equal experience with 2DE but differing levels of 
experience with 3DE RV full-volume acquisition (10 and 3 months, 
respectively). Data sets for intraobserver test-retest reproducibility were 
post-processed separately at time intervals of over 2 weeks. 
 
Sonographer 1 (D.S.K.) obtained a 3DE RV data set, after which 
sonographer 2 (A.E.G.) independently obtained a 3DE RV data set. Then, 
sonographer 1 acquired a second separate 3DE RV data set. The 
sonographers, who were blinded to each other’s results, performed post-
processing of their own 3DE RV data sets.  
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Figure 2-9: Study protocol to investigate test-retest variability of 3DE assessment 
of the RV. 
Adapted from van der Zwaan et al. [129] 
 
2.3.5 CMRI 
2.3.5.1 Image Acquisition 
All cardiac magnetic resonance images were acquired using a 1.5-T 
magnetic resonance scanner (Avanto; Siemens Healthcare) using a 12-
element phased-array coil for signal reception and the body coil for signal 
transmission. A vector electrocardiographic system was used for cardiac 
gating. Ventricular volumes and great vessel flow were measured in all 
patients. Volumetric RV data were obtained using either retrospectively 
gated balanced steady-state free precession (n = 19) cine imaging of 
contiguous short-axis slices [130] or real-time radial k-t sensitivity 
encoding imaging (n = 81) of contiguous transaxial slices [63] depending 
on the pathology under investigation and the patient’s ability to hold his or 
her breath. Real-time radial k-t sensitivity imaging allows the collection of 
high spatiotemporal resolution real-time images during free-breathing, 
and is part of the standard clinical CMRI work flow in paediatric PH 
populations [80]. Blood flow data were acquired in the ascending aorta, in 
the right and left branch pulmonary arteries, and at the level of the 
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atrioventricular valves using a velocity-encoded prospectively triggered 
spiral phase-contrast magnetic resonance flow sequence [131]. This 
provided an internal check for the RV volumetric data. 
 
2.3.5.2 Post-Processing 
All image post-processing was performed using ‘‘in-house’’ plug-ins for 
the open-source OsiriX Digital Imaging and Communications in Medicine 
(DICOM) software [63, 132, 133]. Endocardial RV borders were traced 
manually at end-diastole and end-systole, the time points of which were 
identified by the largest and smallest RV cavity areas, respectively 
(Figure 2-10). The inclusion of RV trabeculae was the same as that 
performed by 3DE post-processing. 
Figure 2-10: A transaxial RV stack by CMRI with manual endocardial border 
tracing in end-diastole from a healthy volunteer using a radial k-t SENSE 
sequence. 
 
Ventricular stroke volume (SV) was calculated as: 
 
    A ÂÃÁÀA ÁAÀ        ÀÂÀÁA   ÁAÀ   
Equation 2-1: Stroke volume 
 
Ejection fraction (EF) was calculated as: 
 ÁÀA  ÁAÀ  
  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 ÁAÀ       
Equation 2-2: Ejection fraction 
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Phase-contrast magnetic resonance flow data were segmented using a 
semiautomatic vessel edge detection algorithm with manual operator 
correction[132]. The CMRI data sets for the patients who underwent 3DE 
test-retest reproducibility scans were also tested for interobserver (D.S.K. 
and M.A.Q.) and intraobserver post-processing reproducibility. 
 
2.3.6 Statistical Analysis 
Statistical analysis was performed using SPSS version 21.0 (IBM 
Corporation, Armonk, NY) and Prism 6.0b for Mac (GraphPad Software, 
Inc., La Jolla, CA). Normally distributed continuous data were expressed 
as mean ± SD. Systematic differences between measurements were 
evaluated with Student paired t-tests (two-tailed), with Pearson 
correlation coefficients used to assess the relationship between 3DE- and 
CMRI-derived RV volumes and EF. Differences between the four 
participant subgroups were analyzed using one-way analysis of variance, 
with the Tukey post hoc tests identifying which specific means differed. P 
values <0.05 were considered statistically significant. Image scoring data 
were non-parametrically distributed, represented by medians with 25th 
and 75th percentiles. Rank sum tests were used for comparisons of 
image scoring data, with the Mann-Whitney U test and the Kruskal-Wallis 
test used for comparisons of two and three independent groups, 
respectively. 
 
Intermodality, interobserver, and intraobserver agreement was studied 
using the Bland-Altman method [134], whereby the mean difference was 
presented as the bias and 95% limits of agreement around the bias 
expressed as the mean difference ± 1.96 SDs. Differences between test-
retest measurements were analyzed by one-way repeated measures 
analysis of variance, with the Bonferroni post hoc test identifying which 
specific means differed. The Greenhouse-Geisser correction was used if 
the assumption of sphericity had been violated. Test-retest variability was 
expressed using ICCs, relative differences, and COVs. The ICC was 
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quantified by the two-way random-effects model with absolute 
agreement. An ICC >0.85 was considered excellent. Relative differences 
were calculated by taking the absolute difference between two 
observations divided by the mean of the repeated observations and 
expressed as a percentage. COVs were calculated as the standard 
deviation of the difference between two acquisitions divided by their mean 
value and expressed as a percentage [135]. A COV <10% was 
considered excellent. 
 
ROC curves were derived for 2D and 3D echocardiographic parameters 
to identify CMRI-derived RV EFs of <50% in patients with PH and healthy 
volunteers [75]. Patients with carcinoid disease were excluded from this 
analysis to avoid the confounding effects of the primary pathology of 
valvular regurgitation on ventricular function. The area under the ROC 
curve for an echocardiographic parameter is presented together with the 
optimal cut-off threshold for detecting CMRI-derived RV EF <50%, 
defined as the value of the parameter that corresponded to the highest 
sum of sensitivity and specificity. The Delong method was used to 
compare the areas under the curve between ROC curves [136] (Analyse-
it Software, Ltd, Leeds, United Kingdom). 
 
2.4 Results 
2.4.1 Study Population Characteristics 
Of 100 individuals who were recruited, four had unobtainable RV 
echocardiographic windows. The clinical characteristics of the final cohort 
of 96 subjects are presented in Table 2-2. Patients with PH had 
significantly larger and impaired RVs than controls, whereas the RVs of 
patients with CHD were also significantly dilated but with preserved EFs. 
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Variable 
(% of total) 
PH CHD Healthy 
controls 
Carcinoid (no 
valvulopathy) 
P* 
N 46 (48) 19 (20) 20 (21) 11 (11)  
Age (years) 56 ± 13 63 ± 8 50 ± 12 59 ± 10 
Female 35 (76) 7 (37) 15 (75) 7 (64) 
Height (cm) 164 ± 9 171 ± 10 169 ± 8 168 ± 10 0.035 
Weight (kg) 69 ± 17 72 ± 18 72 ± 12 77 ± 20 0.54 
BSA (m2) 1.8 ± 0.2 1.8 ± 0.3 1.8 ± 0.2 1.9 ± 0.3 0.37 
Heart rate (bpm) 74 ± 14 67 ± 13 68 ± 9 69 ± 12 0.19 
RVEDV (mL/m2) 87 ± 26 100 ± 35 64 ± 14 52 ± 8 <0.0001 
RVESV (mL/m2) 52 ± 25 33 ± 15 22 ± 7 16 ± 5 <0.0001 
RVEF (%) 43 ± 14 68 ± 7 65 ± 7 71 ± 7 <0.0001 
3DE temporal 
resolution (volumes 
per second) 
34 ± 5 32 ± 7 40 ± 5 45 ± 6 <0.0001 
PH patients (% of total) 
Mean PASP at RHC (mmHg) 44 ± 16     
Pulmonary vasodilators    
Endothelin antagonist 21 (46)     
PDE5 antagonist 31 (67)     
Prostanoid infusion 2 (4)     
Oral prostanoid 1 (2)     
Prostaglandin receptor agonist  1 (2)     
CHD patients 
Affected valves TV = 19 (100), PV = 13 (68), MV =3 (16), AV = 3 (16) 
Data are expressed as mean ± SD. 
*One-way ANOVA between groups 
 
Table 2-2: Clinical characteristics of study populations 
  
CHAPTER 2 Three-Dimensional Echocardiography of the RV  
 
 74 
2.4.2 3DE Technical Data 
Patient 3DE datasets had a significantly lower mean volume rate 
compared with controls because of the greater 3D sector angles (Table 
2-2). However, the median image quality score was significantly higher 
among patients (3.00; interquartile range, 2.00–3.00) than controls (2.00 
interquartile range, 1.00–3.00) (P <0.001). The image quality among 
three successive, equally populated subgroups of patients significantly 
improved with increasing experience with 3DE (Figure 2-11; P =0.031). 
There was a trend, albeit not statistically significant, for greater 
differences in SV between modalities with worse subjective image scores 
(Figure 2-12; P <0.13 for percentage intermodality difference in SV for 
image score groups 1 and 2 combined versus groups 3 and 4 combined). 
Figure 2-11: Box and whisker plots of subjective image quality scores amongst 
three successive subgroups of patients (group 1 acquired in the earliest phase of 
the study, group 3 in the latest phase of the study). Image quality significantly 
improved with increasing experience with 3DE. 
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Figure 2-12: Box and whisker plots of differences in stroke volume between 
modalities (expressed as a percentage of the CMRI reference value) for image 
scoring groups 1 to 4. There is a trend, albeit not statistically significant, for 
intermodality difference to increase with reductions in subjective image score. 
Median percentage intermodality differences in stroke volume (with 25th to 75th 
percentiles) by image score group were as follows: group 1 = 22% (-1 to 26), 
group 2 = 11% (-2 to 23), group 3 = 9% (3 to 16), group 4 = 2% (-6 to 19). 
 
Volumetric Analysis by 3DE versus CMRI 
Correlation coefficients showed good to excellent correlations between 
modalities for RV metrics in patient groups, and moderate to good 
correlations for control subjects (Table 2-3). RV volumes and EF by 3DE 
showed differences with CMRI in both patient groups (Table 2-4), with a 
bias for underestimating stroke volume and EF but with overall 
acceptable limits of agreement (Figure 2-13). By contrast, 3DE 
underestimated EDV for control subjects, with a consequent negative 
bias for quantifying SV in this group (Figure 2-14). 
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Group Measurements Bias ± SD LOA r P* 
All subjects EDV (mL) -2.3 ± 13.7 -29.1:24.5 0.97 <0.0001 
ESV (mL) 5.2 ± 9.5 -13.4:23.9 0.98 <0.0001 
SV (mL) -7.5 ± 11.8 -30.6:15.7 0.94 <0.0001 
EF (%) -4.6 ± 6.9 -18.2:9.0 0.91 <0.0001 
PH EDV (mL) 4.0 ± 13.1 -21.6:29.7 0.97 <0.0001 
ESV (mL) 8.4 ± 10.6 -12. 3:29.1 0.98 <0.0001 
SV (mL) -4.3 ± 10.8 -25.5:17.0 0.82 <0.0001 
EF (%) -4.8 ± 8.3 -21.1:11.5 0.81 <0.0001 
CHD EDV (mL) -3.1 ± 10.1 -22.9:16.8 0.99 <0.0001 
ESV (mL) 5.4 ± 8.2 -10.6:21.4 0.96 <0.0001 
SV (mL) -8.6 ± 13.9 -35.9:18.6 0.95 <0.0001 
EF (%) -3.8 ± 4.1 -11.9:4.2 0.82 <0.0001 
Healthy 
controls 
EDV (mL) -11.9 ± 9.0 -29.5:5.8 0.94 <0.0001 
ESV (mL) -0.4 ± 6.7 -13.6:12.9 0.88 <0.0001 
SV (mL) -11.2 ± 10.1 -31.0:8.7 0.84 <0.0001 
EF (%) -3.9 ± 6.5 -16.6:8.8 0.51 0.021 
Carcinoid (no 
valvulopathy) 
EDV (mL) -10.1 ± 15.0 -39.6:19.4 0.84 0.001 
ESV (mL) 2.1 ± 5.5 -8.7:12.9 0.92 <0.0001 
SV (mL) -12.2 ± 12.3 -36.3:11.9 0.53 0.096 
EF (%) -6.2 ± 5.6 -17.1:4.7 0.69 0.019 
*Pearson’s correlation coefficient 
Table 2-3: Bias, limits of agreement and correlation between single-beat 3DE and 
CMRI for RV volumes and EFs 
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Group RV metrics 3DE CMRI P* 
PH EDV (mL) 158 ± 53 154 ± 52 0.043 
ESV (mL) 100 ± 44 92 ± 47 <0.0001 
SV (mL) 58 ± 18 63 ± 17 0.011 
EF (%) 39 ± 11 43 ± 14 0.00029 
CHD EDV (mL) 182 ± 69 185 ± 71 0.21 
ESV (mL) 67 ± 28 62 ± 3 0.01 
SV (mL) 115 ± 42 124 ± 45 0.014 
EF (%) 64 ± 5 68 ± 7 0.001 
Healthy controls EDV (mL) 105 ± 26 117 ± 27 <0.0001 
ESV (mL) 41 ± 12 41 ± 14 0.80 
SV (mL) 65 ± 16 76 ± 18 <0.0001 
EF (%) 61 ± 5 65 ± 7 0.014 
Carcinoid (no 
valvulopathy) 
EDV (mL) 88 ± 21 98 ± 27 0.05 
ESV (mL) 32 ± 13 30 ± 14 0.24 
SV (mL) 56 ± 10 68 ± 14 0.009 
EF (%) 64 ± 7 71 ± 7 0.004 
Data are expressed as mean ± SD. 
*Paired Student’s t-test 
 
Table 2-4: RV volumes and EFs by single-beat 3DE versus CMRI 
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Figure 2-13: Bland Altman analysis of bias (black solid line) and 95% limits of 
agreement (red dashed line) for 3DE versus CMRI quantification of RV EDV, ESV, 
SV and EF in patients with PH and carcinoid heart disease. 
 
Figure 2-14: Bland Altman analysis of bias (black solid line) and 95% limits of 
agreement (red dashed line) for 3DE versus CMRI quantification of RV EDV, ESV, 
SV and EF for subjects in the control populations. 
  
 
 
CHAPTER 2 Three-Dimensional Echocardiography of the RV  
 
 79 
2.4.3 RV Quantification by 3DE and 2DE versus CMRI 
3DE-derived RV EF was the most superior echocardiographic parameter 
for identifying CMRI-derived RV EF <50% (Figure 2-15; P =0.031), with a 
sensitivity of 94%. A FAC of 39% (sensitivity, 85%) was the best 
conventional 2D echocardiographic measure, superior to both peak 
systolic strain and TAPSE (P =0.0443). TAPSE was the weakest marker 
to predict CMRI-derived RV EF <50%, with a sensitivity of 56% at a cut-
off threshold of 19 mm. 
 
Figure 2-15: Receiver operating curves for 3DE, fractional area change (FAC), RV 
free wall peak systolic strain by speckle tracking echocardiography, and tricuspid 
annular plane systolic excursion (TAPSE) to identify RV dysfunction (defined as 
RVEF <50% by CMRI). 
 
2.4.4 Test-Retest Intraobserver and Interobserver Reproducibility 
Limits of agreement were acceptable for intra- and interobserver 3DE 
studies, with good to excellent ICCs (Table 2-5). However, there was a 
significant interobserver bias for underestimating RV EDV (P =0.001; 
Table 2-6) that resulted in underestimation of SV (P =0.002) and EF (P 
=0.033), with accompanying large interobserver COVs and relative 
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differences. Moreover, despite no significant differences between 
intraobserver EDV and ESV, the differences translated into statistically 
significant test-retest differences for SV (P =0.032) and EF (P =0.005). 
The interobserver and intraobserver reproducibility for RV volumes and 
EF by CMRI showed no significant bias and superior limits of agreement 
compared with 3DE. 
 
3DE Intraobserver 
RV metric EDV (mL) ESV (mL) SV (mL) EF (%) 
ICC 0.992 0.974 0.96 0.906 
CoV (%) 3.0 6.6 8.0 6.9 
RD (%) 4.3 9.4 11.3 9.8 
Bias -0.2 4.6 -4.7 -3.6 
LOA -16.2:15.8 -12.8:22.0 -19.0:9.7 -12.2:5.0 
SD 8.2 8.9 7.3 4.4 
CMRI Intraobserver 
RV metric EDV (mL) ESV (mL) SV (mL) EF (%) 
Bias -2.6 -2.4 -0.1 0.7 
LOA -15.4:10.2 -11.3:6.5 -11.8:11.6 -5.9:7.2 
SD 6.5 4.6 6.0 3.4 
3DE Interobserver 
RV metric EDV (mL) ESV (mL) SV (mL) EF (%) 
ICC 0.955 0.965 0.867 0.827 
CoV (%) 7.7 8.0 16.6 9.4 
RD (%) 10.3 11.4 23.5 13.3 
Bias -12.5 -2.0 -10.6 -4.0 
LOA -40.0:15.1 -24.0:20.1 -33.2:12.1 -16.2:8.3 
SD 14.1 11.3 11.6 6.3 
CMRI Interobserver 
RV metric EDV (mL) ESV (mL) SV (mL) EF (%) 
Bias -1.9 -2.80 1.1 0.9 
LOA -18.2:14.4 -13.1:7.5 -9.3:11.5 -4.1:5.8 
SD 8.3 5.2 5.3 2.5 
Table 2-5: Interobserver and intraobserver reproducibility for RV volumes and EF 
by 3DE and CMRI 
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 Sonographer 1 Sonographer 2 
RV 
metrics 
1st (S1.1) 2nd (S1.2) P* 1st 
vs. 2nd 
Acquisition P* vs. 
S1.1 
P* vs. 
S1.2 
EDV (mL) 145 ± 63 145 ± 62 NS 133 ± 59 0.003 0.003 
ESV (mL) 78 ± 44 83 ± 42 NS 76 ± 39 NS NS 
SV (mL) 67 ± 31 63 ± 29 0.032 57 ± 27 0.002 0.046 
EF (%) 48 ± 13 44 ± 12 0.005 44 ± 11 0.033 NS 
Data are expressed as mean ± SD. 
*One-way repeated measures ANOVA with Bonferroni post-hoc test. 
 
Table 2-6: Interobserver and intraobserver test-retest reproducibility for RV 
metrics by 3DE 
 
2.5 Discussion 
This study demonstrates the feasibility of single-beat full volume 3DE for 
RV quantification in, to my knowledge, the largest homogenous acquired 
RV pressure- and volume-overloaded patient populations. The main 
findings of this study were: 
(i) Single-beat 3DE is an agreeable technique compared with 
CMRI for RV volumetric quantification. 
(ii) There is a demonstrable learning curve for RV assessment 
using 3DE. 
(iii) There is a significant underestimation of RV cavity volumes by 
3DE in subjects with non-dilated RVs. 
(iv) Volumetric 3DE-derived parameters are of incremental benefit 
for identifying RV dysfunction compared with traditional 2DE 
measures. 
(v) There is significant intraobserver and interobserver test-retest 
variability in RV volumetric quantification using 3DE. 
 
2.5.1 RV Remodelling in PH and CHD 
Accurate quantitation of RV size and function is important in many 
congenital and acquired cardiac diseases, and is of particular relevance 
in the patient populations in this study. RV size and function are of 
greater prognostic significance in PH than the afterload to which the right 
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heart is exposed[21, 81], with RVEF being the key determinant of 
outcome regardless of changes in PVR afforded by pulmonary 
vasodilator therapy[137]. Similarly, right heart dilatation is independently 
associated with poor outcome in patients with advanced CHD[100]. 
However, the RV responds differently to pressure- and volume-overload 
conditions, with dilatation occurring in both but with relative preservation 
of function in elevated preload rather than afterload. What remains 
unclear is to what extent this preserved EF represents normality of 
function in the presence of severe tricuspid regurgitation, a valvular lesion 
common to all patients in this CHD cohort. 
 
2.5.2 Benefit of 3DE over 2DE for RV Assessment 
The incremental benefit of 3DE over 2DE has previously been shown in 
congenital heart disease[78], and single-beat 3DE showed similar added 
value over 2DE metrics in acquired RV pressure-overload. Whilst this is 
in part due to equivalent parameters being assessed by 3DE and CMRI, it 
is importantly also a reflection of the limitations of conventional 2DE 
measures. TAPSE had the poorest sensitivity for detecting impaired RV 
EF in PH, with a cut-off of 19mm having the highest combined sensitivity 
and specificity. This is higher than the recommended threshold of 16mm 
for detecting RV dysfunction[50], suggesting that TAPSE would have 
performed worse by current guidelines in this cohort. The rocking motion 
of the RV in pressure-overload can give rise to apparently normal TAPSE 
values[109], and TAPSE also does not account for the radial component 
of RV function that contributes significantly to RVEF[54]. By contrast FAC 
was the most superior 2DE marker for identifying RV dysfunction in PH, 
most likely a reflection of being the only 2DE marker that integrates both 
radial and longitudinal components of function. These findings are 
consistent with a previous study comparing 2DE markers of RV function 
in PH[77], and suggest that 3DE may have an important additive role in 
assessing RV function in this disease. 
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2.5.3 Advantages of 3DE over CMRI for RV Assessment 
RV quantification by echocardiography is advantageous through being 
more readily available and less expensive than CMRI. Since the first use 
of 3DE for RV volumetric quantification[127], improvements in matrix 
array transducer technology permit the simultaneous visualization of 
orthogonal 2D RV planes at the time of acquisition. The technique used in 
this study allows a pyramidal dataset of up to 90o by 90o to be acquired at 
higher temporal resolutions than previously reported for 3DE[118]. 
Acquisition of a full-volume in a single heartbeat avoids stitching artifact 
associated with acquiring slices over serial heartbeats, and also confers 
the advantage of shorter breath-hold durations. These reasons might 
explain the narrower limits of agreement for RV volumetric parameters 
between single-beat 3DE and CMRI compared with previous data from 
adult PH groups using the disk summation method[114, 118]. 
 
2.5.4 Disadvantages of 3DE for RV Assessment 
The disadvantages of echocardiography include constraints that afford 
inadequate transthoracic windows, including body habitus, hyperinflated 
lungs and chest deformities. Acquisition and post-processing was feasible 
in 96% of subjects, consistent with previous 3DE studies[113, 117]. 
However, patients with significant lung disease were excluded to ensure 
that PH was the predominant disease process in the RV pressure-
overload group, and this may in turn have biased the echogenicity of the 
study population. 
 
Whilst all post-processed 3DE datasets had a reconstructed RV polygon 
that tracked throughout the cardiac cycle, 45% of studies were judged by 
subjective image scoring to have some endocardial dropout of the outflow 
portion of the RV. This was reflected by a trend for increasing mean 
differences in stroke volumes between modalities with decreasing image 
quality, with mean differences of at least 11% when the RVOT was 
incompletely visualized. This is a consistent problem with 3DE that has 
been well documented previously due to the anterior position of the RV in 
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the thorax (Figure 2-16). Post-processing software extrapolates the 
endocardial borders during semi-automated border tracking[138], and 
hence whilst it is possible to analyze datasets with incomplete RVOT 
visualization, the accuracy of reconstructions will most likely deteriorate 
with progressive dropout in the outflow tract. 
 
Figure 2-16: Right ventricular outflow tract (RVOT) dropout by 3DE: (a) sternum or 
lung tissue commonly shadows the anterior RVOT; (b) due to the anterior 
retrosternal position and morphology of the RVOT, the anterior RVOT still might 
not be included in the 3DE pyramidal volume despite moving rib spaces in an 
attempt to avoid this shadowing. Adapted from Ostenfeld et al.[128]. 
 
2.5.5 RV Volumetric Quantification by 3DE in Health and Disease 
When comparing studies of RV quantification by 3DE, the homogeneity of 
the study population must be taken into account. The populations of 
acquired RV disease were favourable for the 3DE post-processing 
software algorithm, since it is set up for an adult-shaped RV rather than a 
subject with congenital heart disease[112]. This may be a reason why the 
limits of agreement were narrower than reported in patients with 
congenital heart disease[138]. No substantial bias was observed in either 
the PH or CHD groups, but subgroup analysis showed that end-diastolic 
volumes, and consequently stroke volumes, were underestimated in 
controls. This is despite the higher temporal resolution of images in this 
group, and is likely a result of low spatial resolution with single-beat 3DE. 
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Lower spatial resolution confers less ability to resolve myocardium and 
trabeculae, thus directing the operator to trace the endocardium further 
inside the RV cavity and hence underestimate volumes. This is supported 
by previous data showing greater variability and negative bias for 3DE to 
quantify RV volumes in non-dilated right hearts[111]. Conversely, RV 
endocardial delineation is known to be easier in the setting of RV 
hypertrophy or dilatation for both MRI and 3DE[111, 118], and is reflected 
by the higher image quality scores observed with the disease cohorts. 
 
2.5.6 Operator experience and Reproducibility of 3DE RV 
Assessment 
The progressive rise in 3DE image quality over the study duration reflects 
a significant learning curve with the technique also described in previous 
studies[78]. This is important clinically, as follow-up studies will vary 
depending upon operator experience for both acquisition and post-
processing. This finding also reaffirms the recommendation of the ASE 
that, whilst 3DE RV assessment is preferred on the grounds of accuracy 
and reproducibility, it should be properly performed in echocardiography 
laboratories that have satisfactory training and experience with the 
technique[49, 50, 105]. 
 
Few studies so far have addressed 3DE test-retest reproducibility for both 
the acquisition and post-processing stages[118, 129]. The interobserver 
test-retest study demonstrated a second operator bias for EDV 
underestimation, conferring lower SV and EF measurements. This was a 
systematic error likely reflecting relative operator inexperience with the 
technique. The susceptibility of 3DE to underestimate RV volumes has 
been well documented[104], and the data from this study suggest that 
operator experience is related to this underestimation. 
 
Furthermore, non-significant differences in intraobserver EDV and ESV 
nevertheless resulted in significant differences in SV and EF when the 
errors in the raw volumes are combined. Given that small changes in 
CHAPTER 2 Three-Dimensional Echocardiography of the RV  
 
 86 
endocardial border delineation are known to confer significant changes in 
3DE-derived volumetric parameters in the LV[139], this is also likely to be 
a problem with 3DE reconstruction of the RV too. This is clinically 
important since a change of as little as 10mL in stroke volume by CMRI is 
clinically significant in PH [140], but a change of this magnitude may be 
masked by 3DE reproducibility error and/or the degradation of accuracy 
found with poorer quality 3DE datasets. For example, the interobserver 
measurement of RV stroke volume by 3DE showed a significant bias with 
a standard deviation over double that of CMRI. The CMRI reproducibility 
data shows narrow limits of agreement with no major bias between 
observers, consistent with previous reproducibility studies of RV 
quantification by transaxial slices[67, 141] and sensitive enough for 
detecting small changes in RV indices on serial studies. 
 
2.6 Limitations 
This study is a single-centre study based upon acquisitions made by one 
sonographer with experience using single-beat 3DE for RV volumetric 
quantification. As demonstrated by the test-retest reproducibility data, 
results cannot be applied across operators with variable experience of 
3DE RV analysis. 
 
Patients with arrhythmia were excluded due to the extra variability 
introduced by irregular cardiac cycles when comparing modalities. Single-
beat acquisition is advantageous over traditional disk summation 
techniques that are limited by stitching artifact due to irregular R-R 
intervals, and this patient group requires further investigation with the 
technique. 
 
There was a bias to underestimate cavity size particularly in control 
subjects, but the study was not designed to compare the accuracy of the 
technique in patients with large versus small cavity sizes. This question 
should be addressed in a separate prospectively designed analysis of 
large versus small RVs. 
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The sensitivity and specificity values for 3DE and 2DE to identify MRI-
derived RVEF <50% were calculated by applying the ROC cut-off values 
to the same patients used to derive them as described previously[78], 
hence representing a "best case" scenario. A more appropriate method 
would be to identify cut-off values using ROC analysis in a derivation 
group, then prospectively evaluating the cut-off values in a separate test 
group in whom outcomes could be verified independently. Thus the 
diagnostic performances of the cut-off values found in this study need to 
be confirmed independently. 
 
Finally, the study was not designed to provide CMRI test-retest 
reproducibility similar to the 3DE study design for acquisition and post-
processing. However, CMRI does not have the same acquisition window 
restrictions inherent to transthoracic echocardiography, as contiguous 
transaxial RV slices of fixed thickness are acquired from the base of the 
right heart to the main pulmonary artery with the patient in the supine 
position. Nevertheless, this difference in technique methodology is a 
potential source of discrepancy, with the reference standard of CMRI 
building volumes from multiple slices compared with the full-volume 
datasets of 3DE[106]. Previous data overall suggest similar or slightly 
improved coefficients of variation for interstudy reproducibility of CMRI 
metrics of RV size and function to the 3DE-derived data in this study[64-
66]. These studies analyzed short-axis stacks of cines, unlike this study 
protocol of acquiring transaxial stacks that is reported to confer improved 
reproducibility for RV assessment[67, 68]. Furthermore, similar statistical 
scrutiny in a test-retest format on the same patients who underwent 3DE 
test-retest reproducibility assessment would be required for direct 
comparison of CMRI reproducibility. 
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2.7 Conclusions 
Single-beat full volume 3DE is a feasible technique for quantifying RV 
size and function in acquired right heart pressure- and volume-overload. 
The limits of agreement of 3DE are acceptable compared with CMRI, but 
may not be sensitive enough to detect small yet clinically significant 
responses to treatment demonstrated by this modality[140]. The test-
retest reproducibility of 3DE suggests a significant learning curve that 
needs to be considered, and thus results cannot necessarily be 
extrapolated to less experienced operators. Nevertheless, 3DE showed 
incremental benefit over conventional 2DE measures, suggesting an 
important role in assessing acquired RV pathology. Future work should 
focus upon improving spatial resolution to optimize RV endocardial 
delineation, and in particular for adequate visualization of the RVOT in 
non-dilated RVs. 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 3 Two-dimensional KBR of the Right Ventricle  
 
 89 
 
 
 
 
 
 
CHAPTER 3 Two-Dimensional 
Knowledge-Based 
Reconstruction of 
the Right Ventricle. 
  
CHAPTER 3 Two-dimensional KBR of the Right Ventricle  
 
 90 
3.1 Introduction 
Non-invasive imaging to quantify RV size and function should ideally yield 
three-dimensional data[26]. Despite advances in 3DE technology allowing 
acquisition of a full-volume RV data set in a single heartbeat, several 
disadvantages of RV volumetric quantification by 3DE persist: 
  The adequate visualization of all RV regions, in particular the RV 
outflow tract (RVOT), can be technically difficult by 3DE[138, 142] 
  There is an inherent operator learning curve associated with 3DE 
for RV assessment. Therefore, whilst the American Society of 
Echocardiography (ASE) favour the use of 3DE over 2DE for RV 
assessment, they stipulate that this applies to echocardiography 
laboratories with appropriate training and experience[49]. 
  Both spatial and temporal resolutions are more limited with 3DE 
compared with 2DE. The more limited spatial resolution of 3DE 
may partly account for underestimation of RV cavity volumes by 
this technique[104]. 
  The current commercially available 3DE RV post-processing 
algorithms do not account for the variability encountered of RV 
geometry in different disease states[112]. 
 
Some of the limitations of 3DE are not encountered with 2DE. Individual 
2DE planes can interrogate specific RV regions, such as the inlet, apex 
and outlet portions. 2DE is also a more routine clinical imaging modality 
than 3DE, with spatial and temporal resolutions that are higher than those 
of 3D ultrasound. However, 2DE alone is insufficient to fully characterize 
a complex geometric 3D shape such as that of the RV. The transthoracic 
windows used for 2DE RV acquisition will also vary with respect to probe 
position, partly accounting for the inferior reproducibility of 2DE-acquired 
metrics compared with 3DE. 
 
A hybrid approach affording the technical advantages of 2DE combined 
with the ability to reconstruct a 3D RV polygon would be most 
advantageous. Two-dimensional knowledge-based reconstruction (2D 
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KBR) is a novel technique that utilizes 2DE acquisition combined with 
additional technology for both the image acquisition and post-processing 
stages for volumetric RV quantitation. The KBR component utilizes a 
reference library of RV shapes from specific RV diseases to contribute to 
the final reconstruction of a 3D RV polygon. 
 
3.1.1 Aims 
The aims of this study were to: 
  Provide further validation data for 2D KBR RV quantification in PH 
through comparison against CMRI. 
  Evaluate the test-retest reproducibility for both the acquisition and 
post-processing components of this novel technique for volumetric 
quantification of RV function. 
  Investigate the comparable test-retest reproducibility of a 
conventional 2DE metric, namely RV FAC, from the same four-
chamber data sets utilized in the KBR reconstructions. 
 
3.1.2 Personal Contribution 
To fulfill the above aims I have: 
  Obtained ethical approval from the local institutional research 
ethics committee (North West London REC 2) and research and 
development (R&D) approval from the R&D departments at The 
Royal Free Hospital and Great Ormond Street Hospital NHS 
Trusts. 
  Enrolled 28 participants in sinus rhythm with no contraindications 
to magnetic resonance imaging. 
  Performed and post-processed comprehensive 2DE and KBR 
studies of the right ventricle for all participants. 
  Repeated the acquisition and post-processing stages for both FAC 
and KBR of RV functional parameters for all 28 participants. 
  Post-processed the CMRI studies for all participants to quantify the 
reference standard metrics of RV function.  
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The results from this work have been published by D. Knight, J. 
Schwaiger, S. Krupickova, J. Davar, V. Muthurangu and J. Coghlan, in 
the Journal of the American Society of Echocardiography, 2015, 28(8), 
entitled; “Accuracy and Test-Retest Reproducibility of Two-Dimensional 
Knowledge-Based Volumetric Reconstruction of the Right Ventricle in 
Pulmonary Hypertension” [143] (see Appendix 2). 
 
3.2 Literature Overview 
In this section, literature on the following areas will be discussed: 
  Heterogeneity of RV shape in response to disease 
  Development of the 2D KBR technique 
  Volumetric assessment of RV function using KBR 
  KBR versus 3DE post-processing algorithms 
 
This overview highlights relevant papers that were found using the 
PubMed search engine. The search terms used included (a combination 
of): 
  Knowledge-based reconstruction (KBR) 
  Right ventricle 
  Echocardiography 
  Piecewise smooth subdivision surface (PSSS) reconstruction 
  Cardiac MRI 
When a relevant paper was found, the referenced papers were followed 
up and any subsequent papers that have cited this paper were also 
followed up. 
 
3.2.1 Heterogeneity of RV shape in response to disease 
There is significant regional heterogeneity in both global and regional RV 
shapes in congenital and acquired right heart disease. The anatomy of 
the RVOT is particularly variable in different congenital heart disease 
groups[144]. The contribution from the RV outflow tract is known to be an 
important determinant of the overall accuracy of RV volumetric 
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assessment[145]. Moreover, the contribution of the RVOT to overall 
ejection has prognostic implications in tetralogy of Fallot[146]. This has in 
turn prompted investigation of modified 2DE parameters in order to 
account for this regional variation of RV function[147]. 
 
In acquired RV disease, several studies have shown different patterns of 
RV segmental dysfunction. McConnell’s sign describes regional wall 
motion abnormalities sparing the right ventricular apex being particularly 
suggestive of acute pulmonary embolism[148]. The pattern of regional 
wall motion abnormalities encountered in RV myocardial infarction will be 
dependent upon the culprit coronary artery[14]. Approximately four out of 
five of patients with arrhythmogenic right ventricular dysplasia have 
reduced RV function accounted for by regional wall motion abnormalities 
that vary in location[149]. Even within the disease spectrum of PH, there 
are known differences in RV shape that are encountered amongst 
different aetiological subtypes, such as idiopathic PH versus connective 
tissue disease-associated PH[150]. 
 
Therefore there is evidence to suggest that, whilst 3D assessment of the 
RV should be the preferred form of chamber quantitation, this should also 
take into account the spectrum of RV shapes and geometries 
encountered across different diseases. 
 
3.2.2 Development of the 2D KBR technique 
The 2D KBR technique investigated in this study utilizes novel technology 
for both the raw 2DE data acquisition and the post-processing RV 
polygon reconstruction stages. 
 
3.2.2.1 Probe tracking 
Data acquisition for 2D KBR relies upon using magnetic fields to track the 
spatial location and orientation of the 2DE probe, and consequently 
localization of the 2DE image planes in 3D space[151-154]. A magnetic 
localizer is attached to the probe, in this study mounted on a plastic 
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sheath moulded to the shape of the 2DE probe. This localizer detects 
orthogonal magnetic fields generated by a magnetic field transmitter, 
located either underneath or hung above the examination couch (Figure 
3-1). The spatial location and orientation of the 2DE probe to which the 
receiver is attached, and thus the 2DE image plane itself, can be 
detected and located within the volume of orthogonal magnetic fields 
generated by the transmitter. 
Figure 3-1: Schematic of the 2DKBR set-up. 
 
The performance of the magnetic tracking system is optimized through 
calibration of the device on the specific 2DE ultrasound machine to which 
it is connected[153]. Whilst the localizer can operate in a range of up to 
91 centimetres from the magnetic field transmitter, the optimal range for 
precision is within 25 to 60 centimetres[155]. The distance from the probe 
localizer to the magnetic field transmitter is indicated to the operator on 
the screen whilst acquisition takes place, and indicates to the user when 
the probe localizer is outside the optimal distance range. The localization 
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device has an accuracy of 0.74mm for locating a point target in vitro, and 
a resolution for measuring distances between point targets of -0.12 ± 
0.76mm[156]. Objects that would interfere with the magnetic field must be 
kept away from the field transmitter and receiver by a pre-determined 
distance. In a previous iteration of the system, a non-ferromagnetic bed 
was required to prevent interference with the field transmitter that was 
placed below the bed[157]. The iteration of the system utilized in this 
study comprised the magnetic field generator hung over the patient using 
a mechanical arm. A cushioned wedge was placed on the 
echocardiography couch to ensure that the metallic couch apparatus did 
not interfere with the magnetic field. 
 
Acquiring data by tracking the 2DE probe allows the sonographer to 
obtain images from any available 2DE window that permits visualization 
of any part of the RV. This is a specific advantage compared with 3DE, 
allowing unrestricted probe positioning and movement. This is especially 
important with respect to the potential for RVOT visualization by 2DE 
versus 3DE echocardiography windows (Figure 2-16). 
 
3.2.2.2 Piecewise smooth subdivision surface (PSSS) 
reconstruction method 
The PSSS reconstruction method[158] fits, subdivides and smoothens a 
volumetric mesh to the 2D RV endocardial borders that were identified 
and defined by the operator. These endocardial borders are delineated 
prior to the PSSS reconstruction either traditionally by manual tracing or, 
more simply, by using points plotted by the operator combined with 
knowledge-based reconstruction (KBR, see section 1.2.2.3). The PSSS 
method accepts raw data input from any combination of 2DE image 
planes. Therefore the visualization and localization of RV structures can 
be defined from the 2DE windows that most optimally display them, 
independently of the echocardiography probe orientation or position. 
PSSS is the only reconstruction method that has been shown to 
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reproduce the 3D shapes of the LV and RV chambers with anatomical 
accuracy[156, 159-161]. 
 
Reconstruction of the 3D endocardial surface by the PSSS method 
consists of a two-step reconstruction algorithm[156, 159, 162-164]. The 
first step comprises translating, rotating and scaling a triangulated control 
mesh to fit it to the traced or plotted data representing the RV 
endocardium. The raw traced or plotted data includes anatomic 
landmarks labeled by the operator. This allows parts of the fitted control 
mesh to be marked as sharp edges and vertices, corresponding to, for 
example, valvular annuli or the angle between the RV septum and free 
wall. This also allows knowledge of regions of complex shape such as the 
outflow tract to be integrated into the fitting of the control mesh to the 
endocardial borders (Figure 3-2). 
Figure 3-2: Stage 1 of PSSS: Abstract control meshes for both RV (left) and LV 
(right) used by the PSSS reconstruction technique. These meshes incorporate 
knowledge about the location and shape of certain ventricular structures.  
Reproduced with permission from Hubka et al.[159]. 
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The second step involves repeatedly refining the control mesh through 
subdividing the mesh twice. This entails automated repositioning of the 
mesh vertices to minimize the residual distances between the raw 
endocardial border data and the subdivided mesh, whilst also satisfying 
predetermined smoothness parameters for the 3D reconstruction (Figure 
3-3). 
Figure 3-3: Stage 2 of PSSS: The smooth surfaces of the LV (mesh) and RV 
(surface) having undergone the second stage of PSSS, entailing subdivision of 
the previously applied control mesh. 
Reproduced with permission from Sheehan et al. [164]. 
 
3.2.2.3 Knowledge-based reconstruction (KBR) 
In KBR, knowledge of the expected shape of the RV and of the range of 
shapes that it can adopt in disease processes is utilized to streamline the 
post-processing workflow for volumetric analysis. Sparse user input 
consists of points plotted at anatomical landmarks by the operator, which 
are used to identify RV endocardium. This is instead of the more 
laborious approach of conventional manual endocardial border tracing. 
The KBR algorithm then integrates the knowledge of the RV shape to fill 
in the gaps between the points to create a border. The accuracy of PSSS 
using plotted endocardial landmarks combined with KBR has been 
validated against PSSS using conventional manual endocardial border 
tracing[164]. 
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As already discussed, RV remodeling in response to haemodynamic 
overload results in a diverse range of cavity shapes. The KBR algorithm 
integrates a priori knowledge of the shape of the RV in specified disease 
processes in the reconstruction of 3D RV volumes. This knowledge 
consists of reference to databases or catalogues of fully traced MRI-
derived RV volumes of specified disease aetiologies, with a wide 
spectrum of RV volumes and shapes. In this case of this study, the KBR 
database was accessed via a secure Internet connection (Figure 3-1). 
The databases include normal right ventricles, repaired tetralogy of Fallot, 
pulmonary hypertension and post-atrial switch transposition of the great 
arteries. Furthermore, RV KBR assessment in patients with adult 
congenital heart disease with RV-to-pulmonary artery (PA) conduits was 
more recently performed using a specific database of fully traced CMR-
derived RV volumes of patients with RV-PA conduits[165]. The number of 
fully traced RV volumes that make up each KBR reference catalogue 
database is not specified by the system vendor (Ventripoint, Inc., Seattle, 
WA). However, the reconstructed RV volumes of 110 patients with 
tetralogy of Fallot comprised the KBR database in one validation 
study[164]. 
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3.2.3 Validation of volumetric assessment of RV function using 
KBR versus CMRI 
Six studies have compared 2D KBR for volumetric RV assessment 
against CMRI in a total of 158 subjects (Table 3-1)[157, 165-169]. 
 
Investigator (year) N Patient characteristics 
Dragelescu et al. (2011) 30 Repaired tetralogy of Fallot 
Dragelescu et al. (2012) 40 Repaired tetralogy of Fallot 
Kutty et al. (2012) 15 Repaired d-transposition of great arteries 
Bhave et al. (2013) 27 Pulmonary hypertension 
Neukamm et al. (2014) 29 Repaired tetralogy of Fallot and PVR 
Wheeler et al. (2015) 17 Congenital heart disease (tetralogy of 
Fallot, pulmonary atresia with ventricular 
septal defect, or truncus arteriosus) with 
RV to PA conduit 
Table 3-1: Studies of RV quantification by 2D KBR versus CMRI 
 
There is a small tendency for RV cavity volumetric underestimation, but 
less so than previously reported with 3DE and with clinically acceptable 
limits of agreement (Figure 3-4). 
 
The reproducibility of 2D KBR RV echocardiography has not been studied 
in a test-retest format. Only interobserver and intraobserver post-
processing reproducibility analyses of the same data sets acquired by a 
single observer have been described to date. Overall, good metrics of 
post-processing reproducibility were reported in all studies. 
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Figure 3-4: Forest plots of results from previous studies of RV quantification by 
2D KBR versus CMRI. 
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3.2.4 Direct comparison of KBR versus 3DE RV post-processing 
algorithms 
The differential response of RV shape and remodeling by disease state 
has been suggested as a limitation of the accuracy of conventional 3DE 
RV reconstruction post-processing algorithms, which are based upon 
normal RV cavity shapes[112]. Therefore KBR offers a novel volumetric 
reconstruction post-processing technique to compare with the current 
clinical standard of the volumetric semi-automated border detection 
approach[49]. Currently, there are limited data to provide such a 
comparison. 
 
Laser et al. studied 3DE-acquired RV data sets post-processed with KBR 
against CMRI[170]. The authors note that this could provide a potential 
advantage for RV echocardiography in patients with arrhythmia and 
consequent R-R interval variability. However, the study itself was 
performed utilizing a multiple-beat gated 3DE system acquired over 4 
sub-volumes in 60 subjects in sinus rhythm (40 patients with RV disease 
and 20 healthy volunteers), negating this theoretical advantage. 
Nevertheless, analysis of 3DE-acquired RV datasets using KBR post-
processing was both feasible and accurate compared to CMRI. 
 
A further criticism of the study is that the comparative accuracies of the 
KBR and conventional 3DE post-processing algorithms with the same 
3DE datasets were not examined against CMRI. The only study 
comparing the accuracy and reproducibility of both 2D KBR and 3DE 
versus CMRI is by Dragelescu et al.[167]. The 2D KBR technique had 
higher feasibility than 3DE, was more accurate than the conventional 
Beutel method against CMRI, and had better post-processing 
reproducibility than 3DE. 
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3.2.5 Summary 
From the literature overview, it is clear that a more disease-specific 
approach needs to be considered for 3D RV echocardiography 
assessment. 2D KBR is recognized as a feasible and accurate novel 
technique for RV functional quantification. Furthermore, 2D KBR takes 
into account the heterogeneity of geometric alterations encountered in 
congenital and acquired RV pathology. However; 
  There are a limited number of studies comparing RV assessment 
by 2D KBR versus CMRI. 
  There is only one small study comparing 2D KBR to CMRI in an 
adult acquired RV disease population (PH). 
  There are no studies of reproducibility in a test-retest format for 2D 
KBR RV quantification for both the acquisition and post-processing 
components of the technique. 
 
I aim to perform the first test-retest study of 2D KBR for RV volumetric 
quantification in an adult population of acquired RV pressure overload. 
This will be compared against the reproducibility of 2DE-acquired RV 
FAC using the same 2DE raw data from which the KBR volumetric 
reconstruction is performed. I will also provide further validation data for 
the technique against CMRI in PH. 
 
3.3 Methods 
A prospective cross-sectional study was performed that enrolled 28 
patients in sinus rhythm with no contraindications to magnetic resonance 
imaging, all of whom underwent comprehensive 2D transthoracic 
echocardiography and CMRI on the same day (median scan interval, 116 
min; interquartile range, 104–150 minutes). 
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3.3.1 Study Population 
All participants had presented for diagnosis and/or follow-up of PH 
(diagnosed by right heart catheterization as a mean pulmonary artery 
pressure >25mmHg and a pulmonary capillary wedge pressure 
<15mmHg[121]). The aetiologies of PH were idiopathic (n = 5), 
connective tissue disease associated (n = 14), chronic thromboembolic 
disease (n = 8) and portopulmonary (n = 1). Exclusion criteria were 
arrhythmia and known independent left-sided cardiac disease unrelated 
to PH. 
 
The study complied with the Declaration of Helsinki. The local institutional 
research ethics committee (North West London REC 2) approved the 
study and informed written consent was obtained from all participants 
 
3.3.2 Two-dimensional echocardiography and KBR 
3.3.2.1 Image acquisition 
All patients underwent comprehensive 2D and Doppler transthoracic 
echocardiography in the left lateral decubitus position using the Philips 
iE33 echocardiographic system (Philips Medical Systems, Andover, MA) 
with the S5-1 transducer (frequency bandwidth, 1–5 MHz). A standard 
clinical protocol for all examinations was followed in conjunction with 
American Society of Echocardiography guidelines for chamber 
quantification [50, 123]. 
 
A magnetic localizer was attached to the S5-1 transducer by a moulded 
plastic sheath. The magnetic localizer was connected to a dedicated 
console, from which a mechanical arm with an attached magnetic field 
generator hung over the patient (Figure 3-5; VentriPoint Diagnostics Ltd., 
Seattle, WA). The localizer mounted on the ultrasound transducer were 
calibrated to detect orthogonal magnetic fields from the generator 
hanging over the patient. A cushioned wedge was placed on the 
echocardiography couch to ensure that the metallic couch apparatus did 
not interfere with the magnetic field, and patients were instructed to 
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remain entirely stationary in the left lateral decubitus position for the 
duration of a study acquisition. The ultrasound depth required to visualize 
all relevant structures was determined before commencing the study and 
remained fixed throughout. 
Figure 3-5: 2DKBR apparatus. 
A localizing transducer (a) attached by a moulded plastic sheath to a 
conventional 2DE probe (b) detects orthogonal magnetic f ields emitted by 
the generator (c) attached to the mechanical arm that hangs over the 
patient. Here in the 2DKBR calibration module the die on the screen (d) 
represents the 2DE probe, which moves synchronously with any movement 
of the 2DE probe. Note the cushioned wedge in the background that is 
placed on the echocardiography couch to ensure that the metall ic 
apparatus underneath couch does not interfere with detection of the 
magnetic f ields. 
 
Seven 2D transthoracic echocardiographic views were obtained in all 
subjects: parasternal long axis, parasternal short axis at the papillary 
muscle and apical levels, parasternal RV inflow, parasternal RV outflow 
including pulmonary valve hinge points and infundibulum, apical four 
chamber, and an off-axis RV apical view. The 2D KBR acquisition from 
each view consists of a 2-second period (usually containing two or three 
heartbeats) acquired during end-expiratory breath-holds. The 
electrocardiograph was connected to the echocardiographic system via 
the dedicated 2D KBR console, and the console images were reproduced 
from the echocardiographic system’s video output and digitized at 30 
frames/second. Image quality was subjectively graded on a 5-point scale 
from 0 (very poor) to 4 (perfect) [127]. 
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3.3.2.2 Post-processing: RV FAC 
End-diastolic and end-systolic frames were assigned by visual 
identification of the largest and smallest RV four-chamber cavity areas, 
respectively, on the 2D KBR console. These frames were exported to the 
open-source OsiriX DICOM software for the measurement of RV FAC by 
tracing the RV endocardium in both frames as described in 1.2.1.2. 
 
3.3.2.3 Post-processing: KBR 
The largest and smallest RV cavity areas were visually identified as end-
diastole and end-systole, respectively, on the 2D KBR console in the four-
chamber view. The software subsequently assigned the same time 
interval between these frames to all other views. Due to the peristaltic 
contraction pattern of the RV and the abnormal interventricular septal 
dynamics in PH, identifying the smallest RV cavity area can be subject to 
variation when inspecting different 2D views[24]. The smallest RV cavity 
size determined from the four-chamber view, however, has been shown 
to be a convenient, consistent and accurate method to identify RV end-
systole for determining RV volumes[171]. 
 
On the 2D KBR console, a series of anatomic RV landmarks were 
identified on the 2D echocardiography images (Figure 3-6, Table 3-2) in 
the end-diastolic frames and subsequently in the end-systolic frames. A 
minimum of 26 points was plotted for each of the end-diastolic and end-
systolic data sets. RV endocardial points were placed at the junction 
between trabeculations and myocardium. The plotted anatomic 
landmarks with their respective 3D spatial coordinates were then 
submitted via the Internet to a secure remote server for remote 
processing by a proprietary 2D KBR algorithm. The algorithm interpolates 
between the plotted points by referencing against a catalogue of RV 
shapes generated by CMRI from patients with known diagnoses of PH. 
 
End-diastolic and end-systolic 3D models of the right ventricle were 
reviewed in a systematic fashion. Intersections between the borders of 
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the 3D model and the original 2D scan plane were inspected to ensure 
concordance between 2D images and 3D reconstructions (Figure 3-6), 
and marked points were checked for alignment with the surface of the 3D 
model. Where significant deviations between the reconstructed model 
and either the plotted points and/or 2D echocardiographic endocardial 
borders existed, points were re-plotted and the algorithm was rerun. 
Where significant border versus 2D image misalignment suggested a shift 
in patient position or an inadequate breath-hold, all points from that 2D 
view were removed, and the erroneous 2D echocardiographic view was 
excluded from the 2D KBR reconstruction. A maximum of one view of the 
seven required in the data acquisition protocol could be excluded for any 
given study because of a change in patient position or an inadequate 
breath-hold. If this problem was encountered in more than one of the 
seven required views, the entire study was excluded from the final 
analysis. 
 
The final check entailed inspection of the nested view of end-diastolic and 
end-systolic models to verify alignment of the tricuspid and pulmonary 
annular planes (Figure 3-6). The final 2D KBR polygon was assessed for 
precision by subjectively scoring on a 5-point scale depending on the 
proximity of intersections of the plotted landmarks with the reconstructed 
polygon: 4 (all points intersect), 3 (three or fewer points significantly 
deviate from polygon), 2 (five or fewer points significantly deviate from 
polygon), 1 (seven or fewer points significantly deviate from polygon), and 
0 (poor agreement). 
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Figure 3-6: Post-processed 2DKBR data from a participant with PH. 
All required 2DE scan planes are displayed: (a) parasternal long-axis 
(PLAX), (b) PLAX RV inflow, (c) PLAX RV outflow including infundibulum 
and pulmonary valve hinge points, (d) parasternal short -axis (PSAX) at mid-
cavity (papil lary muscle) level, (e) PSAX apical level, (f) 4-chamber RV, (g) 
off-axis RV apical view (note how the RV apex rides over the LV apex). The 
different coloured cross-hairs represent user-defined plots for different RV 
structures; for example, red crosses are plotted along the RV endocardium, 
turquoise crosses along the RV side of the interventricular septum, a yellow 
cross at the RV apex, orange crosses at the pulmonary valve annulus, and 
purple crosses at the tricuspid valve annulus. The yellow border tracings 
are superimposed projections of the 2DKBR RV reconstruction onto the 
original 2DE scan data, also showing how the polygon extends beyond the 
original 2DE image sector. Landmarks can be checked and repositioned by 
the user if required, and the 2DKBR algorithm is re-run. A final check is the 
nested view (h) of end-diastolic and end-systolic polygons to ensure 
alignment of tr icuspid and pulmonary valve orif ices. 
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3.3.2.4 FAC and 2DKBR test-retest reproducibility 
All subjects underwent serial 2DE acquisition and post-processing by two 
independent sonographers (D.S.K. and J.S.) as described previously (see 
section 2.3.4)[129]. The two sonographers had similar experience of 2D 
transthoracic echocardiography (over 4 years each), and received the 
same vendor training for the 2DKBR system. Sonographer 1 (D.S.K.) 
obtained a 2DKBR data set, following which sonographer 2 (J.S.) 
independently obtained a 2DKBR data set. Following this, sonographer 1 
acquired a second 2DKBR dataset. The sonographers, who were blinded 
to each other’s results and the results from cardiac MRI, performed post-
processing of their own datasets for FAC and 2DKBR. Datasets analyzed 
for intraobserver test-retest reproducibility were post-processed 
separately at time intervals of more than two weeks. 
 
3.3.3 Cardiac MRI 
3.3.3.1 Image acquisition 
All CMRI images were acquired using a 1.5 Tesla MR scanner (Avanto, 
Siemens, Erlangen, Germany) using a 12-element phased array coil for 
signal reception and the body coil for signal transmission. A vector 
electrocardiogram system was used for cardiac gating. In all patients, 
ventricular volumes and great vessel flow were measured as previously 
described[142]. Volumetric RV data was obtained using real-time radial k-
t SENSE imaging of contiguous transaxial slices[63, 80]. 
 
3.3.3.2 Post-processing 
All image post-processing was performed using ‘in-house’ plug-ins for the 
open source OsiriX DICOM software[63, 132, 133]. Endocardial RV 
borders were traced manually at end-diastole and end-systole, the time 
points of which were identified by the largest and smallest RV cavity 
areas respectively (Figure 2-10). The inclusion of RV trabeculations was 
the same as that performed by echocardiography post-processing. RV 
volumetric parameters were calculated as described in section 2.3.5.2. 
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3.3.4 Statistics 
Statistical analysis was performed using SPSS 22.0 (IBM Corporation, 
Armonk, New York, USA) and Prism 6.0b for Mac (GraphPad Software, 
Inc., La Jolla, California, USA). All continuous data were normally 
distributed and expressed as mean ± standard deviation (SD). Systematic 
differences between measurements were evaluated with Student’s paired 
t-test (two-tailed). P-values < 0.05 were considered statistically 
significant. Intermodality agreement was studied using the Bland-Altman 
method, whereby the mean difference was presented as the bias and 
95% limits of agreement around the bias expressed as the mean 
difference ± 1.96 SD[134]. 
 
Differences between test-retest measurements were analyzed by one-
way repeated measures ANOVA, with the Bonferroni post-hoc test 
identifying which specific means differed. The Greenhouse-Geisser 
correction was used if the assumption of sphericity had been violated. 
Test-retest variability was expressed using intraclass correlation 
coefficients (ICC), relative differences (RD) and coefficients of variation 
(COV). The ICC was quantified by the two way random effects model with 
absolute agreement. An ICC > 0.85 was considered excellent. RDs were 
calculated by taking the absolute difference between two observations 
divided by the mean of the repeated observations and expressed as a 
percent. COVs were calculated as the standard deviation of the 
difference between two acquisitions divided by their mean value, and 
expressed as a percentage[135]. A COV   10% was considered 
excellent. 
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3.4 Results 
3.4.1 Study Population Characteristics 
The clinical characteristics of the 28 participants are presented in Table 
3-3, all of whom had adequate 2DE windows for the specified protocol. 
 
Variable Number (%) 
Number of patients 28 
Age (years) 54 ± 13 
Female 20 (71) 
Height (cm) 165 ± 11 
Weight (kg) 71 ± 18 
Body surface area (m2) 1.8 ± 0.3 
Heart rate (bpm) 79 ± 13 
Mean PASP at RHC (mmHg) 47 ± 12 
  
Pulmonary vasodilators (% of total) 
Endothelin antagonist 11 (39) 
PDE5 antagonist 18 (64) 
Oral prostanoid 1 (4) 
Inhaled prostanoid 1 (4) 
  
CMRI RV parameters  
RVEDV (mL/m2) 98 ± 26 
RVESV (mL/m2) 59 ± 23 
RVEF (%) 41 ± 11 
Data are expressed as mean ± SD 
Table 3-3: Patient characteristics 
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3.4.2 2DKBR Technical Data 
Participant heart rates recorded on the 2DE loop acquired first were 
similar to those recorded on the 2DE loop acquired last (P = 0.90). Image 
acquisition for one data set took of the order of approximately 5 minutes 
per patient, with 2DKBR post-processing and analysis taking no longer 
than about 15 minutes. Good mean subjective scores were observed for 
2DE image acquisition (2.9 ± 0.9) and 2DKBR reconstruction (3.2 ± 0.7), 
with moderate correlation between the two scores (r = 0.54, P = 0.003). 
 
3.4.3 RV quantification by 2DKBR versus CMRI 
RV volumes and EF for all participants measured by 2DKBR showed no 
significant differences with CMRI (Table 3-4), with no significant bias and 
clinically acceptable limits of agreement (Figure 3-7). 
 
Measurement 2DKBR CMRI P* 
RVEDV (mL) 179 ± 66 176 ± 61 0.16 
RVESV (mL) 107 ± 47 106 ± 47 0.63 
RVSV (mL) 73 ± 27 70 ± 26 0.26 
RVEF (%) 42 ± 10 41 ± 11 0.66 
Data are expressed as mean ± SD 
*Paired Student’s t-test 
n = 27 (1 patient excluded due to movement artifact during 2DKBR study) 
Table 3-4: RV volumes and ejection fractions by 2DKBR versus CMRI 
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Figure 3-7: Bland Altman analysis of bias (black solid line) and 95% limits of 
agreement (red dashed line) for 2DKBR versus CMRI quantification of RV EDV, 
ESV, SV and EF. n = 27 (1 patient excluded due to movement artifact during 
2DKBR study). 
 
3.4.4 Test-retest intraobserver and interobserver reproducibility. 
One patient moved in the first dataset acquisition, one patient moved in 
the third dataset acquisition, and two patients moved in both the second 
and third dataset acquisitions. The 2DKBR datasets for these four 
individuals were therefore excluded from the final test-retest 
reproducibility analysis due to significant movement artifact. 
 
Good reproducibility metrics and acceptable limits of agreement were 
observed for the 24 intra- and interobserver 2DKBR test-retest studies 
(Table 3-5, Figure 3-8). 
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 Intraobserver Interobserver 
2DKBR variable ICC COV (%) RD (%) ICC COV (%) RD (%) 
RVEDV (mL) 0.985 3.0 4.2 0.986 3.9 5.5 
RVESV (mL) 0.987 4.3 6.1 0.960 7.7 10.9 
RVSV (mL) 0.953 8.3 11.7 0.856 11.7 16.5 
RVEF (%) 0.919 6.4 9.0 0.758 10.5 14.8 
       
2DE variable ICC COV (%) RD (%) ICC COV (%) RD (%) 
RVEDA (cm2) 0.885 9.0 12.7 0.394 25.0 35.4 
RVESA (cm2) 0.931 9.3 13.2 0.440 31.0 43.9 
RV FAC (%) 0.784 18.1 25.6 0.619 20.8 29.4 
Table 3-5: Test-retest reproducibility results for 2DKBR and 2DE RV metrics.  
 
Figure 3-8: Bland Altman analysis of bias (black solid line) and 95% limits of 
agreement (red dashed line) for interobserver 2DKBR test-retest reproducibility of 
RV EDV, ESV, SV and EF. n = 25 (3 patients excluded due to movement artifact 
during 2DKBR study). 
S1 = sonographer 1, S2 = sonographer 2. 
  
CHAPTER 3 Two-dimensional KBR of the Right Ventricle  
 
 115 
There were no significant differences for RV volumes or EF between 
serial 2DKBR studies, but significant intra- and interobserver test-retest 
variability was demonstrated for serial RV areas and FAC (Table 3-6). 
 
2DKBR variable** S1.1 S2 S1.2 P* 
RVEDV (mL) 184 ± 68 185 ± 65 180 ± 66 0.17 
RVESV (mL) 110 ± 49 111 ± 45 111 ± 48 0.80 
RVSV (mL) 74 ± 27 74 ± 30 69 ± 27 0.15 
RVEF (%) 41 ± 10 41 ± 11 40 ± 10 0.39 
     
2DE variable*** S1.1 S2 S1.2 P* 
RVEDA (cm2) 23 ± 6 32 ± 7 23 ± 7 <0.001 
RVESA (cm2) 15 ± 6 22 ± 6 16 ± 6 <0.001 
RV FAC (%) 36 ± 15 31 ± 10 34 ± 14 0.05 
S1 = Sonographer 1 (1.1 = first acquisition, 1.2 = repeat acquisition) 
S2 = Sonographer 2 
Data are expressed as mean ± SD 
*One-way repeated measures ANOVA 
**n = 24 (4 patients excluded due to movement artifact) 
***n = 27 (1 patient had an unanalyzable 4 chamber image that precluded 
FAC but not 2DKBR) 
Table 3-6: Interobserver and intraobserver test-retest reproducibility of RV 
volumes and EF by 2DKBR, and RV areas and FAC by 2DE 
 
3.5 Discussion 
The main findings of this study were: 
(i) 2DKBR is a feasible and accurate technique for RV 
quantification in PH. 
(ii) This study provides the first test-retest reproducibility data for 
2DKBR volumetric RV assessment and 2DE RV assessment 
by FAC. 
(iii) The 2DKBR technique demonstrated good test-retest 
reproducibility, with no significant differences between serial 
interobserver and intraobserver test-retest studies. 
(iv) Conventional RV assessment by 2DE-derived FAC has 
significant intraobserver and interobserver test-retest variability. 
CHAPTER 3 Two-dimensional KBR of the Right Ventricle  
 
 116 
 
3.5.1 Validation of the 2DKBR technique for RV Assessment 
2DKBR is an emerging technique that has been validated in congenital 
heart disease populations[157, 167, 168] and more recently in a small 
population of PH patients[166]. The limits of agreement in this study are 
clinically acceptable compared with the gold standard of cardiac MRI, 
slightly more favourable than those obtained previously in idiopathic 
PH[166], and similar to previous work in children following surgical repair 
of tetralogy of Fallot[167]. 
 
A potential explanation for these differences might be due to the 
quantification of RV volumes by CMRI using a transaxial stack of RV 
slices rather than the short-axis stack approach. This has the advantage 
of avoiding partial voluming of the basal RV slices that is of particular 
relevance in PH due to the relative preservation of longitudinal over radial 
function[54]. A transaxial slice orientation facilitates the identification of 
the inflow and outflow components of the RV, and ultimately confers 
better reproducibility for RV volumetric quantification by CMRI[67, 68, 
141]. The 2DKBR hardware used in this study also differs from that in 
previous studies in terms of the position of the magnetic field generator 
either above or underneath the patient bed. The equipment comprised a 
magnetic field generator suspended directly above the patient’s chest. 
However, the magnetic field generator location above or below the 
echocardiography couch should not theoretically affect the spatial 
detection of the 2DE probe localizer. 
 
3.5.2 Test-retest reproducibility of 2DKBR RV Assessment 
To my knowledge, this is the first study designed to assess the test-retest 
reproducibility of 2DKBR. Importantly, the 2DKBR technique showed no 
significant differences for interobserver or intraobserver test-retest 
reproducibility, whereas FAC had significant test-retest variability. The 
only previous study of test-retest reproducibility of 2DE RV area metrics 
had a comparable intraobserver test-retest coefficient of variation for RV 
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FAC of 16.5%[52]. The reproducibility of FAC post-processing alone (not 
including variability in image acquisition) has also been shown to have 
significant interobserver bias and wide limits of agreement in children 
following surgical repair of tetralogy of Fallot compared with 2DKBR[167]. 
The test-retest reproducibility of 2DKBR RV volumetric quantification is 
also improved compared to that previously demonstrated by 3DE in either 
congenital heart disease[129] or acquired PH[142]. 
 
The superior reproducibility of 2DKBR compared with conventional 2DE 
and that previously reported for 3DE may be accounted for by several 
reasons. Firstly, FAC and 3DE require good endocardial delineation to 
trace the RV border, whereas 2DKBR requires the user to define single 
points along the endocardium rather than the border in its entirety. 
Secondly, in contrast to 2D FAC, the 3D spatial localization of the 2DE 
probe compensates for the acquisition variability in transthoracic windows 
between operators[156]. Finally, post-processing reproducibility is also 
likely to be enhanced by the KBR process. The software allows 
simultaneous display of the raw 2DE data intersecting with the 
reconstructed endocardial borders and 3D polygon. The user then has 
the option of readjusting or adding plotted points when the intersections 
between reconstructed borders and the borders visualized on the raw 
2DE images are not in agreement. The current study protocol mandated 
a review of the reconstructed RV polygon endocardial borders relative to 
the original 2DE images, with editing, adjustment and/or addition of 
plotted points if required. Thus the KBR process itself confers an element 
of reproducibility to the technique. 
 
3.5.3 Utility of 2DE with KBR versus 3DE 
Compared to 3DE, the use of 2DE technology for data acquisition also 
has methodological advantages. Fundamentally, spatial and temporal 
resolutions of 2DE are higher than those of 3DE. Underestimation of RV 
volumes is a known limitation of 3DE due to the inferior spatial resolution 
conferring blurred endocardial borders and thus a visually smaller RV 
CHAPTER 3 Two-dimensional KBR of the Right Ventricle  
 
 118 
cavity[104]. In particular, the contribution from the RVOT is known to be 
an important determinant of the overall accuracy of RV volumes[145]. 
However, accurate visualization of this region can be technically difficult 
by 3DE (Figure 2-16)[108, 126, 138]. The 2DKBR acquisition protocol 
includes dedicated imaging of the RVOT by 2DE, affording higher spatial 
resolution when imaging this region that may contribute to more accurate 
volumetric quantification (Figure 3-9). 
 
There are further technical advantages of the requirement for image 
acquisition from multiple acoustic windows by 2DE. Each region of the 
RV can be visualized from acoustic windows with optimal border 
definition. Axial resolution is superior to lateral resolution with ultrasound 
imaging[155]. Therefore structures can be preferentially identified in 
views in which their appearance is affected more by the axial resolution of 
the ultrasound system. Image acquisition from multiple acoustic windows 
also allows perpendicular rather than oblique cuts through the RV wall, 
thereby reducing errors in identifying endocardial borders because of 
beam width[153]. 
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Figure 3-9: Demonstration of the interaction between the reconstructed 2DKBR 
polygon with a 4-chamber view 2DE scan plane. 
The reconstructed polygon can be rotated in any direction (here through 90o 
from top to bottom, indicated by the curved arrow). Any original 2DE 
acquisit ion can be displayed (here, the 4-chamber view) and viewed in 
relation to the polygon by clicking on one of the dots. In this way the 
reconstructed polygon can be inspected to ensure accurate alignment with 
the original 2DE data. From this view it is also readily appreciable how 
much of the RV, predominantly the outflow portion, is neglected in a 
standard 4-chamber view used to derive FAC. 
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The utility of applying a knowledge-based approach to reconstruction of 
the RV polygon is reflected by the known differences in RV shapes that 
are encountered not only in congenital and acquired disease, but also 
between different subtypes of PH[150]. Algorithms for RV reconstruction 
by conventional 3DE are typically based upon generic healthy adult RV 
shapes rather than taking into account differences in congenital 
populations, or subtle changes in volume- and pressure-overload 
states[112]. Furthermore, the subjective image scoring suggests that the 
requirement for the identification of plotted landmarks only for PSSS with 
KBR rather than manually tracing the whole endocardial border still 
permits adequate reconstruction despite cases of poor quality 
transthoracic 2DE windows. 
 
However, subtle changes in RV function may nevertheless be masked by 
the margins of error demonstrated in the study. CMRI data demonstrates 
that a change in RV stroke volume in PH of as little as 10mL can be 
regarded as clinically significant[140], and therefore 2DKBR may not be 
able to differentiate minor variations in RV volumes from the variance in 
reproducibility. CMRI does not have the same acquisition window 
restrictions and variability inherent to transthoracic echocardiography, 
with datasets consisting of contiguous fixed thickness RV slices acquired 
from the base of the right heart to the main pulmonary artery with the 
patient in the supine position. A further consideration with respect to the 
use of 2DKBR in the serial evaluation of patients is that a change in RV 
volume might confer a change in cavity shape, which could also have 
implications for the application of the KBR algorithm to follow-up studies.  
 
The disadvantage of obtaining data from several 2DE planes is that they 
are acquired over separate cardiac cycles. Image acquisition over several 
cardiac cycles with potential beat-to-beat variability is also a limitation 
shared by traditional disk summation 3DE and by CMRI, but not with 
single-beat full-volume 3DE. However, no significant differences were 
found in heart rates between the start and end of the studies. Acquiring 
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several 2DE planes also requires reproducible breath-holding and a 
stable patient position throughout the study. Repeated breath-holding is 
also conventionally associated with CMRI, but we used a real-time high 
spatiotemporal resolution sequence as per our institution protocol for PH 
imaging that allows free breathing and the rapid acquisition of ventricular 
volumes[63]. Once image acquisition for a 2DKBR study has 
commenced, the operator is unable to manoeuvre the patient to optimize 
TTE windows. Therefore an optimal patient position for parasternal and 
apical views has to be decided upon prior to commencing 2DKBR data 
acquisition. These optimal breath-hold and positional constraints may 
confer difficulty when applied to acutely unwell individuals, and hence 
2DKBR is more likely to be practically applicable in the stable outpatient 
setting. It should also be remembered that whilst global volumetric indices 
of RV function are highly prognostic, they do not account for the 
heterogeneity in RV regional function in different disease states as shown 
by 2DE and 3DE deformation imaging[172, 173]. Finally, 2DKBR includes 
the RV trabeculations together with the blood volume, which may in turn 
impact upon the accuracy of volumetric indices. However, this is also a 
limitation shared with 3DE techniques, and has been shown by CMRI to 
improve reproducibility metrics compared with excluding trabeculations 
from the RV cavity volume[59]. 
 
3.6 Limitations 
This study represents a single-centre experience with a small participant 
sample size. However, we have supported the validation data for 2DKBR 
obtained by previous single-centre studies using similar sample 
sizes[157, 166, 167], and a total of 84 2DE studies were performed in this 
study for test-retest reproducibility purposes. The increase in excluded 
studies with successive repeated scans was more due to the serial 2DE 
scan acquisition protocol for test-retest reproducibility, rather than the 
2DKBR technique itself. Only one out of twenty-eight patients moved in 
the first 2DE dataset image acquisition. Therefore this limitation is unlikely 
to be so prevalent for individual clinical scans, and the study analysis 
CHAPTER 3 Two-dimensional KBR of the Right Ventricle  
 
 122 
times would allow for reacquisition of a second dataset within a 
scheduled clinical echocardiogram. 
 
Patients with arrhythmia were specifically excluded from this study, but 
patients with atrial fibrillation (AF), for example, would require a different 
approach to 2DKBR post-processing. In AF, the end-diastolic frame for 
each view would have to be manually selected by visually determining the 
largest RV cavity size. This could theoretically affect the border alignment 
of the reconstructed polygon, as different cardiac cycles in separate 
views will inherently have different end-diastolic volumes due to the 
variability of irregular R-R intervals. Several reconstructions could be 
performed on the same dataset by selecting different cardiac cycles for 
each reconstruction, with the resulting 2DKBR RV metrics averaged over 
the number of cardiac cycles analyzed. However, the accuracy and 
reproducibility of this approach using 2DKBR in AF requires further 
investigation. 
 
Finally, CMRI reproducibility data was not acquired in a test-retest format 
that allowed comparison of the acquisition and post-processing variability 
of this technique. However, as detailed above, the acquisition stage of 
CMRI consists of a set acquisition of cross-sectional, fixed thickness, 
contiguous cranio-caudal slices that include the entirety of the heart with 
the patient supine. Therefore CMRI fundamentally has less potential for 
acquisition variability compared with 2DE, which has imaging windows 
obtained from different rib spaces acquired in non-uniform patient 
positions. 
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3.7 Conclusions 
Novel 2DKBR is a feasible and clinically reproducible technique for RV 
volumetric quantification in PH, with superior test-retest reproducibility 
compared with 2DE FAC for quantifying RV function. It offers the benefits 
of employing operator experience with conventional 2DE for image 
acquisition, and utilizes algorithmic reconstruction that takes into account 
the heterogeneity in shape of the RV cavity in different disease states. 
The applicability of 2DKBR to serial follow-up studies for assessing the 
response to treatment should be the focus for further work in advancing 
this novel echocardiography technique. 
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4.1 Introduction 
Pulmonary hypertension (PH) is characterized by increased pulmonary 
artery pressure and right ventricular (RV) failure. CMRI is the reference 
standard method of assessing RV function and is now routinely used in 
PH. Several studies have shown that CMRI-derived RV volumes and 
ejection fraction (EF) are prognostic in this condition[80, 81]. 
 
It has also been shown that left ventricular ejection fraction (LVEF) is 
reduced in late stage PH[45]. However, the majority of PH patients have 
normal LVEF, and LV function is not prognostic[81]. Nevertheless, it is 
likely that these patients do have abnormal LV mechanics due to 
ventricular interdependence[44, 174-177]. This could result in additional 
functional deficits, as is the case in patients with RV failure due to 
congenital heart disease[178]. Consequently, assessment of LV 
myocardial mechanics may be clinically useful in this patient population. 
 
The most comprehensive way of evaluating LV mechanics is to assess 
the regional and geometric components of LV motion. There are several 
CMRI methods that can be used to assess these metrics. In this study, I 
used tissue phase mapping (TPM) to assess radial, longitudinal and 
tangential myocardial velocities in patients with PH[179-182]. As this type 
of evaluation has not been performed in this population before, it is of 
uncertain clinical value. Therefore, my general aim was to explore the 
utility of TPM measures of LV myocardial mechanics in patients with PH.  
 
4.1.1 Aims 
The specific aims of this feasibility study were: 
  To assess global and regional LV myocardial mechanics in healthy 
volunteers and in patients with PH with preserved LVEF. 
  To determine the relationship between LV myocardial velocities 
and exercise capacity. 
  To test the ability of LV myocardial velocities to predict clinical 
worsening. 
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4.1.2 Personal Contribution 
To fulfill the above aims for this study I have: 
  Obtained ethical approval from the local institutional research 
ethics committee (North West London REC 2) and research and 
development (R&D) approval from the R&D departments at The 
Royal Free Hospital and Great Ormond Street Hospital NHS 
Trusts. 
  Enrolled 60 participants (40 patients with PH and 20 age- and sex-
matched healthy volunteers) in sinus rhythm with no 
contraindications to magnetic resonance imaging. 
  Performed and post-processed comprehensive CMRI studies for 
all participants. 
 
This has contributed to the writing of two papers: 
  The results of the development and validation of the novel TPM 
sequence have been published by J. Steeden, D. Knight, S. Bali, 
D. Atkinson, A. Taylor and V. Muthurangu, in Magnetic Resonance 
in Medicine, 2014, 71(1), entitled; “Self-navigated tissue phase 
mapping using a golden-angle spiral acquisition-proof of concept in 
patients with pulmonary hypertension” [108] (see Appendix 3).  
  The results of the application of the novel TPM sequence have 
been submitted with revisions for consideration of publication by D. 
Knight, J. Steeden, S. Moledina, A. Jones, J.G. Coghlan and V. 
Muthurangu, entitled; “Left ventricular diastolic dysfunction in 
pulmonary hypertension predicts functional capacity and clinical 
worsening: a tissue phase mapping study” (see Appendix 4). 
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4.2 Literature Overview 
In this section, the different CMRI techniques to assess regional and 
geometric components of myocardial motion will be summarized, 
specifically: 
  Tissue tagging. 
  Displacement encoding with stimulated echoes (DENSE). 
  Strain encoding (SENC). 
  Tissue phase mapping (TPM). 
 
This overview highlights relevant papers that were found using PubMed. 
The search terms used included (a combination of): 
  Magnetic resonance imaging. 
  Tissue/phase velocity mapping. 
  Myocardial mechanics. 
  Pulmonary hypertension. 
When a relevant paper was found, the referenced papers were followed 
up and any subsequent papers that have cited this paper were also 
followed up. 
 
4.2.1 Tissue Tagging 
Tissue tagging is the most clinically utilized CMRI technique for assessing 
regional myocardial motion, originally described in 1998[183]. Tissue 
tagging sequences consist of a preparation phase where lines or a grid of 
magnetic saturation, termed tags, are imposed on the myocardium at one 
time point. This time point is usually immediately after the R wave on the 
scanner vector cardiogram (VCG). This is followed by an imaging phase 
that shows the deformation of the tags through the cardiac cycle (Figure 
4-1). Since magnetization is an intrinsic property of the underlying 
myocardium, the tagged lines, which form part of the tissue, follow 
myocardial motion. In this way tissue deformation is demonstrated 
visually from the time of application of the tagging pulses. This permits an 
immediate qualitative visual assessment of myocardial deformation 
without the need for post-processing. 
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Figure 4-1: Tissue tagging in a healthy volunteer from preparation pulse (left 
pane) through systole (middle pane) and into diastole (right pane), by which 
point the tag lines are fading. 
 
Tissue tagging can also be analyzed quantitatively with the deformation 
outputs of strain, strain rate and torsion. The most reproducible and 
accurate tagging-derived parameters are circumferential strain and strain 
rate[184]. The typical spatial and temporal resolutions of a Spatial 
Modulation of Magnetization (SPAMM) preparation tagging sequence are 
1.6x1.6mm and 32ms respectively acquired during a breathhold over 14 
cardiac cycles[185]. Accelerated imaging techniques have also been 
applied to reduce acquisition times to 5 cardiac cycles[186].  
 
Tissue tagging has demonstrable clinical application for assessing 
regional myocardial function in many conditions, including coronary artery 
disease[187, 188], myocardial infarction[189-191], LV hypertrophy[192], 
ventricular dyssynchrony analysis[193, 194], and dilated[194-196] and 
hypertrophic heart muscle disease[197-199]. It has also been used in the 
multi-centre MESA trial to investigate risk factor analysis of left ventricular 
function[200]. 
 
There are several disadvantages of the tissue tagging technique. The 
tags fade over time, which generally limits their use to the first two-thirds 
of the cardiac cycle. Additionally, the tag takes time to apply, resulting in 
a gap in image acquisition (normally at the beginning of each R-wave). 
Deformation measurement by tagging utilizes a single 2D image plane, 
thus ignoring through-plane motion. For truly complete cardiac motion 
analysis by tagging, a fully 3D tagged dataset has been described but this 
requires multiple breathholds over an acquisition time of between 30 to 
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40 minutes[201]. The spatial resolution of tagging is limited by the tag 
spacing, thus precluding applicability to investigate myocardial motion of 
the thin RV wall. Finally, the quantitative analysis of tissue tagging is 
complex, involving time-consuming post-processing. 
 
4.2.2 Displacement Encoding with Stimulated Echoes (DENSE) 
DENSE encodes tissue displacement pixel by pixel, in-plane[202] or 
through-plane[203], directly into the phase of a magnetic resonance 
image (Figure 4-2). 
Figure 4-2: In vivo systolic displacement measured by DENSE. (a) A displacement 
map showing through-plane motion. (b) A displacement map showing in-plane 
motion. (c) Magnitude reconstruction of the DENSE raw data. 
Reproduced with permission from Epstein et al. [203].  
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DENSE is neither widely available nor a standard clinical CMRI 
sequence, and has predominantly been applied in the research setting 
with limited clinical application to date. However, potential clinical utility 
has been demonstrated in patients with myocardial infarction[204], non-
ischaemic cardiomyopathy[205], and constrictive pericarditis in the post-
pericardectomy setting[206]. 
 
The post-processing of DENSE is relatively simple and quick. Strain 
curves can be created from both 2D[207, 208] and 3D[209, 210] tissue 
tracking post-processing techniques. However, the DENSE sequence 
itself has intrinsically low signal-to-noise ratio (SNR) and, like tagging, the 
encoding does not last for the entire cardiac cycle due to T1 recovery. 
The original description of DENSE implemented a cardiac and respiratory 
gated unsegmented acquisition, with a spatial resolution of 1x1.9mm 
acquired over 4.3 minutes[202]. Since this original implementation, echo 
combination techniques such as fast cine-DENSE[211] have been 
performed to reduce acquisition times and increase SNR with good levels 
of precision for measuring deformation[205]. 
 
4.2.3 Strain Encoded (SENC) Imaging 
Of the techniques described here, SENC is the most recent CMRI 
sequence used to investigate myocardial motion[212] (Figure 4-3). 
Figure 4-3: Longitudinal strain measured by SENC. 
Reproduced with permission from Osman et al. [212]  
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As is the case with DENSE, SENC is also neither widely available nor a 
standard clinical CMRI sequence. SENC measures through-plane strain; 
longitudinal strain is hence measured from a short-axis image plane, and 
circumferential strain from a long-axis image plane. Radial strain cannot 
be measured by SENC. The strain is directly related to pixel intensity, and 
therefore post-processing is relatively simple using this technique. 
However, as with tagging and DENSE imaging, the whole cardiac cycle 
cannot be analyzed. Furthermore, like DENSE imaging, SENC has a 
relatively low SNR. 
 
SENC has been applied to patients with myocardial infarction[213, 214], 
coronary artery disease[215-217] and heart failure[218]. It also has 
application for RV myocardial motion analysis in healthy volunteers[219] 
and in patients with PH[220]. 
 
4.2.4 Tissue Phase Mapping (TPM) 
Phase velocity mapping in one direction is widely available as a standard 
clinical sequence on most clinical CMRI scanners. It is a commonly used, 
well established sequence that is considered the gold standard method 
for measuring blood flow velocity[221]. A bipolar gradient is used for 
velocity encoding directly into the phase of the signal pixel by pixel. The 
application of phase velocity mapping to measure myocardial velocities 
first occurred over 30 years ago[222]. In order to analyze three-
dimensional myocardial motion, velocity can be sequentially encoded in 
three orthogonal directions in a pre-selected 2D short-axis slice position. 
This permits the simultaneous collection of x, y and z velocities (relative 
to the image plane), which can then be converted to radial, 
circumferential and longitudinal (through-plane) velocities respectively 
(Figure 4-4). 
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Figure 4-4: A TPM data set from a healthy volunteer. Clockwise from top left: 
magnitude data, and phase data in Z (through-plane), X and Y directions. 
 
Unlike the three aforementioned CMRI techniques, allows the 
simultaneous measurement of multi-directional velocity-encoded data 
throughout the entire cardiac cycle with high spatiotemporal resolution 
[181, 182]. The main disadvantage of TPM is susceptibly to motion 
artifacts and phase distortion. This complicates the calculation of 
deformation parameters from the raw TPM data, as the errors can be 
propagated; strain can be determined by integrating velocities with 
respect to time[223], and strain rate by calculating the spatial derivatives 
of the velocities at each pixel[224]. Nevertheless, TPM has been widely 
used for the assessment of LV mechanics in health[180, 181, 225-227] 
and disease, including myocardial infarction[228, 229], coronary artery 
disease[230, 231], cardiac failure and ventricular dyssynchrony[232], and 
dilated[179] and hypertrophic[233] heart muscle disease. 
 
Similar data could be acquired using either tissue Doppler imaging (TDI) 
or speckle tracking echocardiography (STE). Of particular interest is STE, 
which allows measurement of radial, longitudinal and circumferential 
myocardial deformation. This technique has also been shown to have 
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utility in PH for the investigation of LV myocardial mechanics[177]. 
However, unlike TPM, the simultaneous acquisition of through plane 
motion to obtain longitudinal velocities from a short-axis plane is not 
possible on echocardiography. Images from both a short-axis plane and 
also multiple apical planes would have to be acquired in order to provide 
radial, longitudinal and circumferential motion data from all LV walls. 
Furthermore, CMRI is the most accurate method for assessing 
biventricular function, and accordingly has become increasingly used in 
PH. Therefore it is desirable to also have a CMRI method for the 
comprehensive assessment of myocardial mechanics. 
 
4.2.5 Summary 
From the literature review it can be concluded that: 
  TPM is technically advantageous over echocardiography or other 
CMRI methods for the assessment of myocardial motion. In 
particular, multi-directional velocity-encoded data can be 
simultaneously acquired throughout the entire cardiac cycle. 
  There has been a limited application of CMRI to the investigation 
of myocardial mechanics in PH despite evidence of LV dysfunction 
in advanced disease. 
 
I aim to apply a novel TPM sequence by CMRI to investigate LV 
myocardial mechanics in PH for the first time. In particular, I will 
investigate patients from a population with ostensibly normal LV function 
by conventional clinical markers, namely LVEF. I also aim to assess the 
relationship between TPM metrics of LV function and functional capacity, 
and the ability of these metrics to predict clinical worsening against 
conventional global measures of cardiac function.  
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4.3 Methods 
A prospective cross-sectional study was performed that enrolled 60 
participants in sinus rhythm with no contraindications to magnetic 
resonance imaging. 
 
4.3.1 Study Population 
The study population consisted of 40 consecutive patients with PH and 
20 healthy volunteers. 
 
Inclusion criteria for patients were: 
  PH diagnosed by right heart catheterization (RHC): mean 
pulmonary artery pressure (mPAP) >25mmHg and pulmonary 
capillary wedge pressure (PCWP) <15mmHg[121], or 
  Presentation for routine out-patient clinical evaluation with known 
PH, and/or RHC for diagnosis or follow-up of PH. 
 
Exclusion criteria for patients were: 
  Left-sided cardiac disease unrelated to PH (including ischaemic 
heart disease, LV dysfunction or hypertrophy, and left-sided valve 
disease). 
  Clinically significant restrictive or obstructive lung disease 
identified by pulmonary function tests. 
  Arrhythmia. 
  Contraindications to CMRI. 
 
Exclusion criteria for healthy volunteers were: 
  Past medical history of cardiovascular disease (including 
hypertension). 
  History of cardiac medications. 
  Arrhythmia. 
  Contraindications to CMRI.  
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All patients underwent the CMRI study between 3rd October 2012 and 
24th November 2013. All participants were imaged using a 1.5T MR 
scanner (Magnetom Avanto, Siemens Healthcare, Erlangen, Germany). 
All patients underwent a 6-minute walk distance test (6-MWD). Twenty-
nine patients (73%) underwent clinically-indicated right heart 
catheterization within 40 days of CMRI (median 8 days, IQR 12 days). 
 
The study complied with the Declaration of Helsinki. The local institutional 
research ethics committee (North West London REC 2) approved the 
study and informed written consent was obtained from all participants. 
 
4.3.2 Conventional CMRI Protocol and Image Post-Processing 
Biventricular volumetric data were obtained as described previously, 
using a radial k-t SENSE real-time sequence[63], with contiguous 
transaxial and short-axis ventricular stacks acquired for RV and LV 
analyses respectively. Through-plane flow data were acquired in the 
ascending aorta, right and left branch pulmonary arteries, and for mitral 
valve inflow, using a velocity-encoded, prospectively-triggered spiral 
PCMR sequence[131]. 
 
All images were processed using in-house plug-ins for the open source 
OsiriX DICOM software platform (OsiriX Foundation, Geneva, 
Switzerland)[133]. Endocardial borders were traced manually at end-
diastole and end-systole of both ventricles to assess biventricular 
function. This allowed evaluation of end diastolic volume (EDV) and end 
systolic volume (ESV), and calculation of stroke volume (SV) and ejection 
fraction (EF)[63]. Aortic and pulmonary artery flow were measured from 
the PCMR data, which were segmented using a semi-automatic vessel 
edge detection algorithm with manual operator correction[132]. 
Transmitral E and A wave peaks were measured from the mitral valve 
inflow PCMR data, allowing calculation of E/A ratio. Septal curvature was 
assessed using the mid-ventricular short axis cine images, as described 
previously[83].  
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4.3.3 Tissue Phase Mapping Protocol and Image Post-Processing 
Myocardial velocities were acquired using a respiratory self-navigated, 
cardiac gated, velocity encoded golden-angle spiral sequence[182]. To 
summarize, a two-sided flow-encoding scheme (with positive and 
negative bipolar pulses applied for each velocity-encoding direction) was 
used to enable high temporal-resolution imaging (rather than 
conventional one-sided flow-encoding where four flow-encoded readouts 
are required). Data were continuously acquired, with each consecutive 
flow-encoding couplet rotated by the golden-angle. Consecutive spiral 
pairs (10 in each window) are combined to produce low temporal 
resolution (315ms) real-time images. These real-time data are used to 
create an image based respiratory navigator, used to select 30% of the 
expiratory spiral interleaves for the final retrospectively cardiac-gated 
reconstruction. Sequence parameters: TE/TR 3.85/14.9ms, FOV 450mm, 
Matrix: 384x384, uniformly distributed spiral interleaves required to fill k-
space: 30 (for each of the three phase-encoded directions), slice 
thickness: 7mm, VENC: 30cm/s, Flip angle: 25o, pixel bandwidth: 
930Hz/pixel. This achieved a temporal resolution of 27.14ms, with a 
spatial resolution 1.17x1.17mm, giving approximately 40 cardiac phases. 
The nominal scan time, assuming a heart rate of 60bpm and 100% 
respiratory efficiency, would be 1 minute 30 seconds, resulting in a scan 
time of approximately 4 to 5 minutes per subject depending upon heart 
rate. TPM data were acquired in mid-ventricular short-axis, which was 
chosen by reference to a 4-chamber cine at end-systole. 
 
This sequence does not include any black blood pulses (as 
conventionally used in TPM) as this would have disrupted the continuous 
acquisition of data necessary for calculation of the respiratory navigator 
and retrospective cardiac gating. No off-resonance correction was 
performed as this would have increased the scan time or reduced the 
temporal resolution of the scan. Some minor image blurring was 
observed around fat tissue, but this did not severely affect the velocity 
measurements as the fat was generally spatially separated from the 
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myocardium. Background phase offsets were minimized in the TPM data 
by optimizing the flow gradients and correcting for Maxwell terms. This 
resulted in no observable background phase offsets in the data. 
 
All images were processed using an in-house plug-in for OsiriX[133]. For 
each dataset, endocardial and epicardial ventricular borders were 
manually segmented on the magnitude images to create a ventricular 
region of interest (ROI). The ventricular ROI was further split into four 
segments: septal, anterior, lateral and inferior. Bulk motion correction was 
performed[234], before transformation of the in-plane velocities to an 
internal polar coordinate system positioned at the centre-of-mass of the 
LV. This allowed motion to be described in terms of radial (Vrad), 
tangential (Vtang) and longitudinal (Vlong) velocities[227]. For each 
direction, global velocities were calculated by averaging the velocity in a 
given direction (radial, longitudinal and tangential) within the ventricular 
ROI in each frame. Regional velocities were calculated by averaging the 
velocities in each segment. Peak systolic (S wave) and early diastolic (E 
wave) values were quantified from the longitudinal, radial and tangential 
velocity-time curves. The tangential S (S1 and S2) and E (E1 and E2) 
wave peaks were biphasic. Vector field plots and colour-coded position-
time maps were generated for each myocardial velocity component to 
allow easy visualization of the results.  
 
4.3.4 Statistics 
STATA 13 was used for statistical analyses. Data were examined for 
normality using the Shapiro-Wilk test. Descriptive statistics are expressed 
as mean±standard deviation (SD) when normally distributed and median 
(inter-quartile range, IQR) when non-normally distributed. Proportions are 
expressed as percentages. Independent samples t-tests with Welch’s 
correction for unequal variances were used to compare parametric data 
in PH patients and controls (n=11). The Mann-Whitney-U test was used 
for non-parametric data (n=9). Fisher’s exact test was used to compare 
proportions data (n=3). For subgroup analysis, PH patients were divided 
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into 3 groups: PH associated with connective tissue disease (CTD), PH 
not associated with CTD, and chronic thromboembolic PH (CTEPH). The 
Kruskal-Wallis test was used to test for equality of abnormal global 
myocardial velocities (n=5) between the different sub-groups of PH. The 
group of tests comparing controls to patients was considered a single 
family of statistical inferences and the familywise error rate was controlled 
using Bonferroni correction. Specifically, 28 statistical comparator tests 
were adjusted for resulting in a corrected critical p-value of <0.0018. 
 
Random-effects generalized least squares models were used to compare 
myocardial velocities in the four myocardial segments. Interaction terms 
for the myocardial segment and presence of disease were included in the 
models. This analysis was only performed if the global velocities were 
abnormal (Erad, Elong, S2tang, E1tang, and E2tang). In addition, this analysis 
was used to assess the timing of the Erad peak, which on visual inspection 
appeared to vary between segments. Bonferroni correction was required 
to control the familywise error rate in this group of 6 generalized least 
squares models, and the adjusted critical p-value was 0.0083.  
 
To assess the relationships between abnormal myocardial velocities and 
haemodynamic parameters a 2-stage procedure was employed. Firstly, 
simple univariate analysis was performed using Pearson’s correlation 
coefficient. This allowed selection of the conventional CMRI biventricular 
parameters and afterload metrics with the strongest correlation to the 
abnormal myocardial velocities. To identify independent predictors of 
myocardial velocity these variables were entered into random-effects 
generalized least squares models. Variables in this model with a p-value 
of <0.05 were considered statistically significant.  
 
A similar 2-stage analysis was performed to assess the relationship 
between 6-MWD and CMRI data. From the univariate analysis, the 
strongest correlating E and S wave peaks and conventional CMRI metrics 
were identified. These were then entered into a multiple linear regression 
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model to determine covariates that were independently associated with 6-
MWD. Variables in this model with a p-value of <0.05 were considered 
statistically significant. 
 
All patients were followed up until death, transplantation, progression to 
intravenous epoprostenol, or the end of the study (February 25th, 2015). 
The decision to list a patient for transplantation or commence intravenous 
vasodilator therapy was based upon clinical assessment of deterioration 
in functional class and/or RHC-derived haemodynamic data. CMRI data 
were not used in these management decisions and the physicians 
involved in the patients’ care were blinded to the CMRI results. Univariate 
Cox proportional hazards analysis was used to assess the predictive 
ability of all CMRI variables in the 34 patients without proximal CTEPH 
and not treated with intravenous epoprostenol. The primary outcome was 
freedom from death, transplantation or progression to intravenous 
therapy. The E and S waves and conventional CMRI metrics with the 
greatest hazard ratios were entered into a multivariable Cox proportional 
hazards analysis to determine which covariates were independent 
predictors of clinical worsening. A p-value of <0.05 was taken as 
statistically significant. 
 
4.4 Results 
4.4.1 Study Population Characteristics 
There was no difference in the age distributions of PH patients and 
controls (50 years (IQR 45-59) versus 47 years (IQR 42-54) respectively, 
p=0.30).  Thirty-out-of-forty patients were female versus 16 out of 20 
controls (p=0.76). Patient characteristics and underlying diagnoses are 
detailed in Table 4-1. The largest sub-group had PH associated with CTD 
(20/40), the next largest sub-group (12/40) had PH not associated with 
CTD (10/12 had idiopathic PAH), followed by patients with CTEPH (8/40). 
All patients were normotensive at the time of study (median systolic BP 
110mmHg, IQR: 105-120mmHg; mean diastolic BP 72±11mmHg). Thirty-
two patients were receiving PH therapy at the time of CMRI study.  
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 Number (%) 
Aetiology[86]  
1. PAH 11 (28) 
- 1.1 Idiopathic 10 
- 1.2 Heritable 1 
  
1.4 Associated with (APAH): 21 (53) 
- 1.4.1 CTD 20 
   - Limited cutaneous systemic sclerosis 13 
   - Diffuse cutaneous systemic sclerosis 2 
   - Systemic lupus erythematosus 3 
   - Sjögren’s syndrome 1 
   - Mixed CTD 1 
- 1.4.3 Portal Hypertension 1 
  
4 CTEPH 8 (20) 
- Proximal (operable) 5 
- Distal (inoperable) 3 
  
Right Heart Catheterization (RHC) data (n=29)  
Time interval between CMRI and RHC 8 (IQR 12) 
Mean pulmonary artery pressure (mPAP, mmHg) 46±13 
Pulmonary vascular resistance (PVR, dyns/cm5) 523 (IQR 286-450) 
  
World Health Organization class (%)  
I 1 (2.5) 
II 14 (35) 
III 22 (55) 
IV 3 (7.5) 
  
6-minute walking distance (6-MWD, metres) 372 (IQR 286-450) 
  
Vasodilator therapy   
Phosphodiesterase type 5 inhibitor 28 (70) 
Endothelin receptor antagonist 22 (55) 
Intravenous prostacyclin 1 (3) 
  
Treatment regimens  
Treatment naive 8 (20) 
Oral monotherapy 14 (35) 
Dual combination oral therapy 16 (40) 
Triple combination therapy 1 (3) 
  
Additional PH therapies  
Oral prostacyclin 1 (3) 
Inhaled prostacyclin 1 (3) 
Tyrosine-kinase inhibitor 2 (5) 
Table 4-1: Patient characteristics. 
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Conventional CMRI metrics from normal subjects and PH patients are 
shown in Table 4-2. In PH, the RV was dilated with reduced RVEF and 
the LV was compressed with reduced SV. In addition, septal curvature 
was lower (or reversed in 65% of patients). Nevertheless, LVEF and E/A 
ratio were not significantly different between patients and controls.  
 
 Normal PH patient p-value 
RVEDV 130 (104-156) 158 (128-204) 0.0056 
RVESV 38 (31-63) 103 (70-133) <0.00001* 
RVSV 87 (74-99) 62 (48-75) 0.0006* 
RVEF 65±8 40±12 <0.00001* 
LVEDV 134 (108-139) 88 (74-109) 0.0001* 
LVESV 42±16 32±13 0.012 
LVSV 85±19 62±18 <0.00001* 
LVEF 67±8 66±9 0.61 
LV cardiac output 5.6 (4.8-6.4) 4.6 (3.8-5.5) 0.0094 
Septal curvature 1.09±0.10 -0.20±0.58 <0.00001* 
E/A ratio 1.56 (1.23-2.88) 1.33 (1.11-2.36) 0.31 
Values are mean±SD, or median (interquartile range). 
*indicates statistical significance (p<0.0018 following Bonferroni 
correction). 
Table 4-2: CMRI characteristics of control subjects versus PH patients 
 
Median 6-MWD in PH patients was 372m (IQR: 286-450m). Twenty-nine 
PH patients underwent clinically-indicated right heart catheterization 
within 40 days of CMRI (median 8 days, IQR 12 days). Median pulmonary 
vascular resistance (PVR) was 523 dyns/cm5 (IQR 402-717 dyns/cm5) 
and average mPAP was 46±13mmHg. All patients had a 
PCWP<15mmHg. 
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4.4.2 Myocardial Velocities in Normal Subjects and PH Patients 
Myocardial velocities were acquired successfully in all subjects. Figure 
4-5 shows representative LV velocity vectors in a normal subject and a 
patient with PH. 
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Global myocardial peak velocities in normal subjects and PH patients are 
summarized in Table 4-3. 
 
Global LV velocity Normal PH patient p-value 
Srad 2.4±0.4 2.3±0.5 0.14 
Erad 3.1±0.5 2.3±1.0 0.001* 
Slong 3.3±1.0 3.3±1.1 0.98 
Elong 4.2 (3.4,5.5) 2.6 (1.7,3.3) <0.00001* 
S1tang -1.8±0.7 -1.4±0.8 0.064 
S2tang 1.3±0.6 0.50±0.69 0.0001* 
E1tang -0.4±0.6 1.4±0.5 <0.00001* 
E2tang 0.9 (0.7,1.3) -0.8 (-1.1,-0.3) <0.00001* 
Values are mean±SD, or median (interquartile range). 
*indicates statistical significance (p<0.0018 following Bonferroni 
correction). 
Table 4-3: Peak global myocardial velocities in controls versus patients with PH. 
 
Patients with PH had reduced LV peak Erad, Elong and S2tang velocities, 
with reversal and significant change in both Etang peaks. This can be 
appreciated in Figure 4-6, which shows representative global radial, 
longitudinal, and tangential velocity curves from a normal subject and a 
PH patient. Reversal of both Etang waves was highly discriminatory for the 
presence of PH. All patients had a reversed E1tang compared to 4/20 
normal subjects (p<0.0001), while 32/40 patients had a reversed E2tang 
compared to 2/20 normal subjects (p<0.0001). The magnitude of all 
abnormal global myocardial velocity peaks did not differ between 
aetiological groups (p>0.59). 
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4.4.3 Regional Variations in Normal Subjects and PH Patients 
In patients, there was a trend towards Erad velocity peaking in the anterior 
segment first (approximately 80ms, p=0.026) as seen in Figure 4-7. 
However, there was no significant regional difference in the magnitude of 
the Erad peaks (p>0.07). Figure 4-8a shows radial LV myocardial 
velocities as a function of position and time in a normal subject and a 
patient with PH.  
 
Longitudinal velocity maps are shown in Figure 4-8b. In normal subjects, 
Elong peak velocity was similar in the inferior wall and septum (p=0.88) but 
higher in the anterior (p=0.008) and lateral walls (p<0.001). However, in 
patients, this regional variation was less distinct (Figure 4-7) with only a 
trend towards higher Elong peak in the lateral segment (p=0.012). 
 
Figure 4-8c shows tangential velocity maps in a normal subject and 
patient. There were no regional variations in tangential velocity peaks in 
controls or patients. 
Figure 4-7: Graphs demonstrating segmental variation in health (dotted line) and 
PH (--- line) in (a) Erad time to peak, (b) Elong magnitude. 
(a) There is a trend for an earlier Erad t ime to peak for the anterior segment 
in PH. There is no regional heterogeneity in Erad t ime to peak in health. 
(b) The anterior and lateral walls had higher Elong peak velocities than the 
inferior wall and septum in health. Regional variation in the magnitude of 
Elong velocit ies is less distinct in PH, with only the lateral segment having a 
tendency, albeit not statistically significant, for higher Elong velocit ies. 
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4.4.4 Haemodynamic Correlates with Myocardial Velocities 
Univariate haemodynamic correlates with abnormal global myocardial 
velocities are shown in Table 4-4. 
 
 Erad Elong S2tang E1tang E2tang 
 r p r p r p r p r p 
SC 0.40 0.01 0.33 0.041 -0.041 0.80 -0.24 0.13 0.13 0.43 
mPAP -0.60 0.0005 -0.41 0.027 0.17 0.38 0.17 0.38 -0.19 0.32 
PVR -0.47 0.011 -0.27 0.16 0.046 0.82 0.14 0.49 -0.16 0.43 
RVEDV -0.26 0.11 -0.41 0.0087 0.0024 0.99 0.24 0.14 0.071 0.66 
RVESV -0.45 0.004 -0.51 0.0007 0.030 0.86 0.35 0.023 0.062 0.71 
RVSV 0.33 0.038 0.1006 0.54 -0.074 0.65 -0.17 0.29 0.040 0.81 
LVEDV 0.34 0.035 0.13 0.43 0.083 0.61 -0.18 0.27 0.20 0.22 
LVESV 0.061 0.71 -0.035 0.83 0.24 0.13 -0.093 0.57 0.29 0.067 
LVSV 0.45 0.0032 0.22 0.18 -0.063 0.70 -0.20 0.23 0.077 0.64 
E/A ratio 0.43 0.0077 0.38 0.019 -0.016 0.93 0.031 0.85 -0.0035 0.98 
Table 4-4: Correlations between abnormal global LV myocardial velocities in PH 
and haemodynamics. 
 
Univariate haemodynamic correlates with abnormal global myocardial 
velocities are shown in Table 4. Both peak Erad and Elong strongly 
correlated with mPAP, RVESV and E/A ratio. In addition, peak Erad also 
correlated with LVSV. The first global Etang peak only correlated with 
RVESV (r=0.35, p=0.023). The second Etang and Stang peaks did not 
correlate with any of the tested metrics (p>0.1). In a generalized least 
squares model that included mPAP, RVESV, LVSV and E/A, only RVESV 
was independently predictive of either longitudinal or radial E wave 
velocities ( =-0.43, p=0.001).  
 
4.4.5 Functional Correlates with Myocardial Velocities  
All correlates with 6-MWD are shown in Table 4-5. The strongest E wave 
myocardial velocity correlate with 6-MWD was the global Erad peak 
(r=0.58, p=0.0001). The strongest S wave myocardial velocity was the 
lateral Srad peak (r=0.48, p=0.0018). The conventional RV metric with the 
strongest correlation to 6-MWD was RVEF (r=0.54, p=0.0003) and the 
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strongest conventional LV metric was LVSV (r=0.39, p=0.013). In 
addition, there was a significant correlation between 6-MWD and E/A 
ratio (r=0.39, p=0.013). When these metrics were inputted into a multiple 
linear regression analysis, only global Erad ( =0.41, p=0.017) and lateral 
Srad ( =0.33, p=0.028) were independent predictors of 6-MWD. 
 
  6-MWD, r p-value 
RVEDV -0.22 0.17 
RVESV -0.41 0.0079 
RVSV 0.35 0.027 
RVEF 0.54 0.0003* 
LVEDV 0.22 0.16 
LVESV -0.075 0.65 
LVSV 0.39 0.013* 
LVEF 0.37 0.021 
LVCO 0.17 0.29 
SC 0.18 0.26 
E/A ratio 0.4 0.013* 
LV global Srad 0.36 0.024 
LV anterior Srad 0.29 0.067 
LV septal Srad 0.28 0.078 
LV inferior Srad 0.072 0.66 
LV lateral Srad 0.48 0.0018* 
LV global Erad 0.58 0.0001* 
LV anterior Erad -0.024 0.88 
LV septal Erad 0.55 0.0002 
LV inferior Erad 0.24 0.13 
LV lateral Erad 0.54 0.0003 
LV global Slong 0.19 0.24 
LV anterior Slong 0.2 0.22 
LV septal Slong 0.18 0.27 
LV inferior Slong 0.19 0.24 
LV lateral Slong 0.012 0.94 
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 (continued) 6-MWD, r p-value 
LV global Elong 0.53 0.0004 
LV anterior Elong 0.39 0.014 
LV septal Elong 0.5 0.0011 
LV inferior Elong 0.49 0.0015 
LV lateral Elong 0.35 0.028 
LV global S1tang 0.35 0.025 
LV anterior S1tang 0.3 0.057 
LV septal S1tang 0.46 0.0025 
LV inferior S1tang 0.39 0.014 
LV lateral S1tang 0.3 0.065 
LV global E1tang -0.15 0.36 
LV anterior E1tang -0.081 0.62 
LV septal E1tang 0.077 0.64 
LV inferior E1tang -0.13 0.41 
LV lateral E1tang -0.071 0.66 
LV global S2tang 0.14 0.39 
LV anterior S2tang 0.065 0.69 
LV septal S2tang 0.072 0.66 
LV inferior S2tang 0.11 0.49 
LV lateral S2tang 0.12 0.47 
LV global E2tang -0.075 0.65 
LV anterior E2tang 0.056 0.73 
LV septal E2tang -0.12 0.47 
LV inferior E2tang -0.21 0.2 
LV lateral E2tang -0.19 0.25 
Table 4-5: Correlates of conventional and novel CMRI metrics with 6-MWD in 
pulmonary hypertension. 
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4.4.6 Relationship between Myocardial Velocity and Clinical 
Worsening 
All five patients who had operable proximal CTEPH underwent 
subsequent thromboendarterectomy, and one PAH patient was already 
receiving intravenous vasodilator therapy at the time of CMRI study. 
Clinical worsening was studied in the remaining 34 patients. Over a 
median follow-up period of 20 months (IQR 7.9 months), 8 patients were 
started on intravenous therapy and 1 died. 
 
Metrics that predicted clinical worsening on univariate cox regression 
analysis are shown in Table 4-6. The strongest predictive E wave 
myocardial velocity was global Elong peak (6.3x increase in hazard per SD 
reduction in the magnitude of the peak velocity). The strongest 
conventional RV metric was RVEF (2.4x increase in hazard per SD 
reduction in RVEF). In addition, septal curvature was also predictive of 
clinical worsening (3.6x increase in hazard per SD distortion of septum 
towards the LV). Conventional LV metrics and E/A ratio did not predict 
clinical worsening. When global Elong peak, RVEF and SC were inputted 
into a multivariable cox regression model, only global Elong was an 
independent predictor of clinical worsening (p=0.009). 
 
  HR (95% CI) p-value 
Age 0.76 (0.41-1.42) 0.39 
LVEF 0.78 (0.39-1.55) 0.47 
LVEDV 0.82 (0.39-1.72) 0.6 
LVESV 1.03 (0.55-1.95) 0.92 
LVSV 0.69 (0.31-1.55) 0.37 
LVCO 1.08 (0.58-2.01) 0.81 
RVEF 0.42 (0.19-0.93) 0.032* 
RVEDV 2.18 (1.05-4.51) 0.037 
RVESV 2.16 (1.08-4.30) 0.029 
RVSV 0.99 (0.48-2.04) 0.98 
SC 0.28 (0.11-0.75) 0.011* 
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(continued) HR (95% CI) p-value 
HR 1.72 (0.89-3.34) 0.11 
E/A ratio 0.94 (0.46-1.94) 0.88 
LV global Srad 0.46 (0.19-1.12) 0.087 
LV anterior Srad 0.71 (0.33-1.53) 0.38 
LV septal Srad 0.72 (0.36-1.48) 0.37 
LV inferior Srad 0.74 (0.34-1.61) 0.45 
LV lateral Srad 0.68 (0.34-1.33) 0.26 
LV global Slong 1.00 (0.54-1.85) 1 
LV anterior Slong 1.36 (0.75-2.45) 0.32 
LV septal Slong 1.60 (0.82-3.13) 0.17 
LV inferior Slong 0.69 (0.33-1.47) 0.34 
LV lateral Slong 0.57 (0.24-1.32) 0.19 
LV global S1tang 0.68 (0.34-1.36) 0.27 
LV anterior S1tang 0.79 (0.41-1.52) 0.48 
LV septal S1tang 0.63 (0.31-1.29) 0.21 
LV inferior S1tang 0.72 (0.37-1.44) 0.36 
LV lateral S1tang 0.57 (0.27-1.20) 0.14 
LV global S2tang 1.27 (0.72-2.25) 0.41 
LV anterior S2tang 1.17 (0.66-2.10) 0.59 
LV septal S2tang 1.52 (0.88-2.61) 0.13 
LV inferior S2tang 1.36 (0.73-2.54) 0.34 
LV lateral S2tang 1.12 (0.61-2.05) 0.72 
LV global Erad 0.29 (0.13-0.69) 0.005 
LV anterior Erad 0.95 (0.46-1.96) 0.88 
LV septal Erad 0.74 (0.32-1.72) 0.48 
LV inferior Erad 0.67 (0.33-1.35) 0.26 
LV lateral Erad 0.56 (0.29-1.09) 0.089 
LV global Elong 0.16 (0.047-0.58) 0.005* 
LV anterior Elong 0.50 (0.22-1.13) 0.098 
LV septal Elong 0.33 (0.15-0.72) 0.005 
LV inferior Elong 0.37 (0.12-1.20) 0.098 
LV lateral Elong 0.23 (0.065-0.82) 0.023 
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(continued) HR (95% CI) p-value 
LV global E1tang 0.66 (0.34-1.28) 0.22 
LV anterior E1tang 0.93 (0.47-1.86) 0.85 
LV septal E1tang 0.99 (0.47-2.07) 0.97 
LV inferior E1tang 0.62 (0.30-1.28) 0.2 
LV lateral E1tang 0.50 (0.23-1.11) 0.087 
LV global E2tang 1.11 (0.58-2.13) 0.74 
LV anterior E2tang 1.53 (0.71-3.31) 0.28 
LV septal E2tang 1.02 (0.52-1.98) 0.96 
LV inferior E2tang 0.89 (0.46-1.70) 0.72 
LV lateral E2tang 1.27 (0.73-2.20) 0.4 
Table 4-6: Univariate Cox regression analysis of conventional and novel CMRI 
metrics to predict disease progression in PH. 
 
4.5 Discussion 
This is the first study to use CMRI tissue phase mapping to assess LV 
myocardial velocities in patients with PH. The main findings of this study 
were: 
i) Patients with PH had reduced global Erad and Elong velocities, 
and reversal of both Etang waves. 
ii) Peak global Erad velocity was an independent predictor of 6-
MWD. 
iii) Peak global Elong peak velocity was an independent predictor of 
clinical worsening. 
 
These results demonstrate that LV myocardial mechanics are negatively 
affected by RV pressure overload and may contribute to symptoms and 
clinical worsening. 
 
4.5.1 LV Myocardial Velocities in PH 
In keeping with previous studies, these results indicate that PH is 
primarily associated with early diastolic LV dysfunction[175, 177, 235]. 
Specifically, peak E wave velocities were lower in patients compared to 
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age and sex matched controls. Importantly, LVSV was not an 
independent predictor of E wave velocities. Thus, it is unlikely that 
reduced pulmonary venous return is the main reason for this finding. 
Interestingly, the only independent predictor of reduced E wave velocity 
was increased RVESV. This suggests a link between RV dilation and LV 
diastolic dysfunction, which I believe is mediated through external 
constraint of the LV. It is easily understood that LV filling can be reduced 
by abnormal septal dynamics[178]. However, it is also possible that the 
pericardium also plays an important part. As the RV dilates, the whole of 
the pericardium becomes stretched and less compliant[16, 236]. This 
could constrain the inferior and lateral LV walls and additionally reduce 
LV filling. This idea is backed up by animal studies of acute RV dilation, 
where removal of the pericardium normalizes LV filling[237, 238]. The fact 
that the anterior segment is not constrained by the pericardium or septum 
may explain the trend towards its earlier Erad peak, further corroborating 
this hypothesis. The exact mechanism underlying the reversal of the Etang 
peaks is not clear from the results. A possible explanation might be the 
significant geometric alterations seen in patients with PH, but this 
requires further study. 
 
It should be noted that these diastolic abnormalities could be the result of 
LV remodeling and intrinsic myocardial stiffening. This is particularly 
pertinent in the study patient population due to the high prevalence of 
CTD, which is known to cause diastolic dysfunction[239]. However, E 
wave velocities were similar across aetiological subgroups, suggesting 
that the results were not due to CTD-specific LV remodeling. It is possible 
that PH itself could cause changes in LV structure such as myocardial 
fibrosis or fibre reorientation[240]. Techniques such as T1 Mapping and 
myocardial diffusion tensor imaging may be better placed to determine if 
these factors are also important[241]. 
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4.5.2 Functional Correlates with Myocardial Velocities 
This study has shown that lower radial and longitudinal E wave velocities 
are associated with reduced 6-MWD. This is in keeping with E wave 
velocities being a marker for diastolic dysfunction, which is known to limit 
augmentation of stroke volume during exercise. In keeping with the 
pivotal role of stroke volume, it is unsurprising that resting LVSV also 
correlated with 6-MWD. However, global Erad was an independent 
predictor of 6-MWD in a model adjusted for resting LVSV. This suggests 
that resting Erad may be a better predictor of exercise stroke volume 
augmentation than resting LVSV. In addition, the lateral Srad peak was 
also predictive of 6-MWD. This is interesting because the population Srad 
peaks were similar in patients and controls. Nevertheless, patients did 
have greater variance in Srad, which may explain the exercise findings. 
The increased peak systolic velocity seen in some patients is probably an 
attempt to maintain cardiac output in the face of worsening disease. 
Conversely, the reduced peak velocity found in other patients is possibly 
due to intrinsic LV systolic dysfunction or abnormal septal interactions.  
 
This study has also found that E wave velocities, in particular global Elong, 
predicted clinical worsening. This is probably because patients with 
impaired diastolic function have less cardiac reserve and are therefore 
more symptomatic. This increases the likelihood of up-titration of therapy 
or death. The reasons why longitudinal rather than radial E wave is a 
better predictor of progression are not obvious from the data. One 
possibility is that longitudinal velocities might integrate more measures of 
cardiac dysfunction than simply reduced LV filling. Importantly, E/A ratio 
was similar in patients and controls and did not independently predict 6-
MWD or clinical worsening. This demonstrates the benefits of TPM over 
conventional measures of diastolic dysfunction. 
 
In keeping with previous studies, RVEF did correlate with 6-MWD and 
predicted clinical worsening[80]. However, RVEF was not an independent 
predictor of exercise capacity in a model including global Erad, nor was it 
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an independent predictor of clinical worsening in a model adjusted for 
global Elong. These results suggest that reduced LV diastolic function may 
be more important than RV function itself. This is consistent with studies 
in patients with other forms of RV pressure overload. For instance, in 
congenital heart disease it has been shown that improved exercise 
capacity after relief of RV outflow obstruction is primarily due to better LV 
filling[178]. 
 
4.5.3 Using TPM to assess RV function in PH 
An important limitation of this study is that RV TPM metrics were not 
assessed. RV deformation parameters by STE are prognostic in 
PAH[242]. Therefore, given that RV dysfunction is a hallmark of PH, a 
comprehensive assessment of biventricular myocardial mechanics would 
be advantageous. CMRI would be particularly well placed to provide this 
information over echocardiography given that it is not limited by imaging 
planes afforded by intercostal rib spaces. By contrast, a specific limitation 
of STE is that it tends to only provide reproducible deformation 
assessment of the RV free wall from a single acoustic window, namely 
the apical 4-chamber view. 
 
Although RV data are not reported in this study, it has been shown that it 
is possible to assess RV TPM metrics using this technique[182]. The 
sequence used in the current study was originally designed and validated 
in order to measure clinically relevant myocardial velocities in both the LV 
and the RV (Appendix 3)[182]. Specifically, an image-based respiratory 
navigator calculated from the TPM data itself was constructed. This 
enabled the long acquisition times required for the collection of velocity-
encoded data in three directions during free breathing. In particular, this 
was of sufficiently high spatiotemporal resolution to enable TPM 
assessment of the thin RV free wall. Furthermore, the sequence proof of 
concept study demonstrated the feasibility of TPM data acquisition from 
20 healthy volunteers and also 10 patients with PH. 
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However, a limitation of short axis TPM is that it is not possible to correct 
for longitudinal bulk motion. In the LV this is not a significant problem as 
longitudinal bulk motion is limited. However, in severe PH the RV displays 
a rocking motion that results in errors in longitudinal velocity 
assessment[55]. During the course of data acquisition in the current study 
it became clear that the rocking motion of the RV in PH presented a 
significant limitation to the application of this sequence in this setting. As 
a result, the meaningfulness of the RV TPM data became uncertain. In all 
likelihood these problems of TPM used to assess RV motion in PH were 
not previously encountered during the sequence validation study for two 
reasons; firstly due to the low number of patients with PH, and secondly 
because the healthy volunteers in that study were neither age- nor sex-
matched with the patient cohort. 
 
4.6 Limitations 
This feasibility study represents a single centre experience of applying 
TPM to a small cohort of patients. Furthermore, the low mortality in this 
population required a more broadly defined composite outcome measure 
that included transplant and intravenous therapy. These ‘softer’ outcome 
measures are more susceptible to bias, although CMRI was not used to 
make clinical management decisions in this study. 
 
Another important limitation of this study was the heterogeneity of the 
population and in particular the high number of patients with CTD, 
possibly limiting the applicability of the results to the majority of PH 
patients. Therefore, this can only be considered a feasibility study 
demonstrating that TPM data may be of clinical interest in this group of 
patients. Nevertheless, the positive findings do warrant further work in 
this area. Furthermore, no differences in haemodynamics were found 
between the sub-groups, suggesting that the data is valid across a ‘real 
world’ patient population. 
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Other limitations include the fact that catheter haemodynamic data was 
not available in all patients, but septal curvature nevertheless correlated 
strongly with the recent cardiac catheter data. In order to ensure a 
streamlined acquisition protocol, sequences for tissue characterization 
were not acquired. Myocardial involvement in connective tissue disease, 
for example, has been demonstrated by CMRI[241, 243]. However, the 
magnitude and waveform characteristics of myocardial motion were 
consistent irrespective of disease aetiology or treatment. The study 
exclusion criteria also required the absence of post-capillary PH and 
known left-sided heart disease. In future studies, it will be vital that these 
deficiencies are addressed.   
 
4.7 Conclusions 
Novel TPM by CMRI is feasible in PH, permitting accurate quantification 
of global and regional myocardial velocities. TPM metrics of LV diastolic 
dysfunction in PH reliably discriminate between health and disease, and 
are also strongly predictive of functional capacity. TPM may also be 
incrementally beneficial in identifying clinical worsening in PH compared 
with conventional CMRI metrics of RV function. These feasibility data 
support the application of the technique to a larger group of patients over 
a longer follow-up period. This would allow full determination of the 
prognostic capacity of LV TPM metrics in PH. Future work should also be 
directed at assessing the response of these novel biomarkers to 
vasodilator therapy. 
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5.1 Summary 
The present work has focused on the application of novel 
echocardiography and CMRI techniques to provide a more 
comprehensive assessment of cardiac function in acquired disease of the 
right heart. 
 
Chapter 2 presented a comparison of single-beat full-volume 3DE for RV 
volumetric quantification against CMRI in large homogeneous patient 
populations of RV pressure- and volume-overload. The technique was 
feasible, with clinically acceptable limits of agreement compared with the 
clinical reference standard. However, limitations of this contemporary 
3DE method include the operator learning curve associated with using 
the technique, reduced accuracy when applied to non-dilated RV cavities, 
and its test-retest reproducibility. 
 
Previous literature also suggests that commercially available 3DE post-
processing algorithms may be too generic to apply to the clinical 
spectrum of RV diseases and their respective heterogeneous chamber 
shapes. In order to overcome this limitation and to take advantage of the 
clinical familiarity and higher spatiotemporal resolution of 2DE, chapter 3 
presented a validation study of novel 2D KBR for RV volumetric 
quantification against CMRI in a patient population with PH. 2D KBR was 
feasible, accurate and had good test-retest reproducibility in patients with 
acquired RV pressure-overload. Moreover, the reproducibility metrics 
were significantly better than those for conventional RV FAC, which was 
obtained from the same 4-chamber loops that also constituted the 2D 
KBR datasets. 
 
These two echocardiography techniques represented novel non-invasive 
methods to quantify RV size and global systolic function. Chapter 4 
presented the application of a novel CMRI tissue phase mapping (TPM) 
sequence to provide a more comprehensive understanding of 
biventricular myocardial mechanics in PH. TPM metrics of LV diastolic 
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function were significantly abnormal in PH, with reversal of LV tangential 
E waves observed in all patients and being highly discriminative for the 
presence of PH. More importantly, abnormal LV E wave velocities were 
the only independent predictors of functional capacity and clinical 
worsening in a model that included conventional metrics of biventricular 
function. This is most likely to be a manifestation of ventricular 
interdependence due to RV distention in PH, and may a 
pathophysiological step towards the previously reported finding of LV 
atrophic remodeling in advanced disease. 
 
5.2 Future Work 
Future developments related to these novel imaging techniques are 
described in turn. 
 
5.2.1 Three-Dimensional Echocardiography of the RV 
Further work aimed at improving 3DE RV assessment can be divided into 
acquisition and post-processing components. 
 
5.2.1.1 3DE RV acquisition 
Contrast-enhancement could have a role for 3DE RV assessment given 
the reported difficulties in differentiating trabeculations from endocardium, 
and there is significant scope for further work in this area. Contrast-
enhancement has previously been reported to be beneficial for the 
accuracy and reproducibility of 3DE assessment of the LV, particularly in 
patients with suboptimal transthoracic echocardiography windows[244-
246]. Agitated colloid is known to be an effective, safe and inexpensive 
agent for right heart chamber opacification[247]. My anecdotal experience 
using this method was of visually improved endocardial delineation 
(Figure 5-1), consistent with reports of improved RV endocardial 
visualization with contrast when using 2DE[248]. However, this was at the 
expense of the ability of the semi-automated border-tracking algorithm to 
identify and track the endocardium. Given that this compromised the 
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working of the vendor-specific post-processing software, this approach 
precluded any analysis of contrast-enhanced 3DE RV datasets and thus 
had to be abandoned. 
Figure 5-1: A 3DE RV data set from a patient with severe carcinoid heart disease 
following administration of intravenous agitated colloid. 
Endocardial borders in the 4-chamber (top left), coronal (middle) and 
sagittal (bottom) windows have been delineated for i l lustrative purposes. 
 
There are to date few studies of contrast-enhanced 3DE RV assessment. 
The feasibility of RV contrast-enhancement has been shown in vitro and 
in vivo in a small 3DE study using agitated saline contrast[249]. Datasets 
in this study were manually post-processed using the summation of disks, 
bypassing any potential interference with automated border-tracking post-
processing algorithms. Van der Zwaan et al. also published their 
experience of contrast-enhanced 3DE of the RV in abstract form[250]. 
Intravenous echocardiography contrast was reported to visually improve 
RV endocardial contour definition, but generated smaller RV volumes. 
One possible reason for this result might be that dense contrast-
enhancement of the cavity could interfere with the generally accepted 
advice to trace ‘on the white side’ of the RV endocardium when post-
processing 3DE data sets.  
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5.2.1.2 3DE RV post-processing 
A new iteration of the commercially available 3DE RV post-processing 
software has recently been reported[251]. This has been prompted by the 
known difficulty in obtaining RV coronal views and RVOT visualization of 
consistently satisfactory quality. This novel approach for 3DE RV 
volumetric analysis utilized a method without post-processing coronal 
views, instead using multiple short-axis views extracted from RV-focused 
3DE datasets acquired as described in Chapter 2. The new post-
processing technique was of clinically acceptable accuracy versus CMRI, 
and had reasonable reproducibility metrics. Importantly, the novel post-
processing method showed improved accuracy for RV volumetric 
quantification compared with the standard post-processing algorithm in a 
subset of 30 patients with 3DE datasets of suboptimal quality. 
 
Ongoing developments in the post-processing of RV 3DE datasets should 
also not be limited to global metrics. Given the evolving improvements in 
ultrasound transducer technology and the spatiotemporal resolution of 
single-beat full-volume 3DE, the quantitative analysis of RV shape and 
curvature parameters from transthoracic 3DE datasets can now be 
studied[252]. By quantitatively analyzing RV regional curvature from 3DE-
derived dynamic endocardial surfaces, the curvature of the RV inflow 
portion was shown to be a more robust predictor of mortality in PH 
compared with conventional 3DE metrics including RV volumes and EF. 
The application of this methodology, both by this custom 3DE method 
and also by KBR, merits further development and application to the 
spectrum of congenital and acquired heart diseases affecting the right 
heart. 
 
5.2.2 Two-Dimensional Knowledge-Based Reconstruction of the RV 
Contrast-enhancement for improved RV endocardial visualization on 2DE 
would immediately lend itself to the 2D KBR as described in Chapter 3, 
as cavity opacification might assist the operator in plotting the endocardial 
points[247, 248]. This would also not interfere with the KBR post-
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processing algorithm, as the KBR reconstruction process is independent 
of the raw 2DE image data when reconstructing a 3D RV volume. 
 
A side-by side comparison of 3DE versus 2D KBR in a small sample size 
favoured 2D KBR for accuracy[167]. However, the relative contributions 
of 2DE (for acquisition) and KBR (for post-processing) to the accuracy of 
the technique remain undefined. The ability to acquire a full-volume 3DE 
RV dataset in a single cardiac cycle has been demonstrated in Chapter 2, 
and the feasibility of applying KBR to 3DE-derived RV datasets has also 
previously been demonstrated[170]. Using a 3DE dataset with KBR post-
processing would make the technique theoretically quicker for image 
acquisition and less prone to error introduced by patient movement or 
breathing. Furthermore, the extra specialist equipment used to spatially 
localize the position of the 2DE ultrasound probe would not be required 
with a single-beat full-volume 3DE acquisition. However, the higher 
spatiotemporal resolution of 2DE and familiarity with this modality may 
instead be advantageous. Further study should be undertaken to define 
the optimal ultrasound mode to acquire RV datasets for KBR post-
processing. 
 
Given the accuracy of the technique, the clinical utility and sensitivity of 
2D KBR to detect changes in RV size and function in response to 
treatment should be studied in large patient populations. Changes in RV 
volumes and function following treatment were detected at follow-up 
echocardiography study using 2D KBR in a small group of patients with 
PH, published by our group in abstract form[253]. Just over half of a 
group of 22 patients with PH had a demonstrable reduction in indexed RV 
EDV of more than 10% during a mean follow-up period of 6 months. 
Furthermore, all of those patients also showed reductions in NT-proBNP 
levels by at least two-thirds, or NT-proBNP levels were already normal or 
near normal at baseline. The ability to track changes in RV size and/or 
function in response to treatment by a 2DE technique would be of great 
clinical value in PH, certainly in terms of technique availability and cost 
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compared with CMRI. This is especially important in terms of global 
health resources given that the prevalence of pulmonary vascular disease 
is far higher in developing countries than in the developed world[254]. 
 
5.2.3 Tissue Phase Mapping for Myocardial Mechanics 
TPM is a promising technique for the comprehensive assessment of 
myocardial mechanics. In the small cohort of PH patients that were 
studied, TPM metrics of LV diastolic function were highly discriminative 
between health and disease, and were the only independent predictors of 
functional capacity and clinical worsening in a model that included 
conventional metrics of biventricular function. The low mortality in this 
small population, however, required a more broadly defined composite 
outcome measure that included transplant and intravenous therapy. 
Therefore, this can only be considered a feasibility study demonstrating 
that TPM data may be of clinical interest in this group of patients. 
Nevertheless, the positive findings do warrant further work in this area 
and support the application of the technique to a larger group of patients 
over a longer follow-up period. This would allow full determination of the 
prognostic capacity of LV TPM metrics in PH. Future work in the PH 
setting should also be directed at assessing the response of these novel 
biomarkers to vasodilator therapy. 
 
Increasing the speed of data acquisition would be helpful to apply the 
technique to larger study populations. Recently, it has been shown that it 
is possible to acquire TPM data in a breath hold using a spiral SENSE 
acquisition.[255] This opens up the possibility of the rapid acquisition of 
myocardial velocity data, which would make this technique more clinically 
feasible. The sequence used in this study has since been adapted in-
house allowing the acquisition of high spatiotemporal resolution LV TPM 
data in a single breath hold. This is currently being validated and applied 
in ongoing work to assess LV function in, amongst other studies, 
paediatric patients with chronic kidney disease. 
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Further work should also be directed at addressing the limitations of 
applying the technique to RV assessment in patients with PH. As 
discussed, we have demonstrated the feasibility of the novel TPM 
sequence to assess RV function[182]. However, the inability to correct for 
longitudinal bulk motion is a particular limitation of short axis TPM when 
applied to the rocking motion of the RV in severe PH[55]. A simple 
approach would be to perform TPM in the 4-chamber view for 
simultaneous assessment of in-plane longitudinal and radial motion of the 
RV. This analysis could be extended to study RV deformation. 
Parameters that could be assessed include strain, by integrating 
velocities with respect to time[223]; and strain rate, by calculating the 
spatial derivatives of the velocities at each pixel[224]. 
 
A further step in the application of TPM could involve the use of 4D phase 
contrast techniques. Acquisitions of 4D TPM data sets have previously 
been carried out, allowing velocities to be extracted from any point in the 
myocardium without the need for prior slice positioning[256, 257]. 
However, this is at the expense of lengthy scan times of up to 30 to 40 
minutes. A pilot breath hold 4D phase contrast sequence of 
approximately 20 seconds duration has been developed in-house within 
our group for future validation (Figure 5-2). However, the inferior 
spatiotemporal resolution of a 3D phase contrast technique would not be 
suitable for analysis of the thin RV myocardium, and would likely be 
restricted to LV functional analysis. 
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Figure 5-2: A 4D TPM breath hold data set from a healthy volunteer. 
The raw phase contrast data shows a short-axis view (top right) and the 
corresponding 4-chamber view (middle right). The bottom images 
demonstrate reconstruction of the post-processed data for LV velocities in 
x, y and z. 
Courtesy of Dr Vivek Muthurangu 
 
5.3 Conclusion 
This thesis has investigated the feasibility of novel echocardiography and 
CMRI techniques to investigate cardiac function in patients with acquired 
right heart disease. These techniques not only have demonstrable 
feasibility in a clinical setting, but they also provide incremental benefit 
over conventional clinical non-invasive metrics used to monitor patients 
with PH. I am optimistic that future work using these novel techniques 
and the continued application of advances in imaging technology to non-
invasive diagnostic cardiology could be of benefit to the clinical 
management of these patients. 
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Background: The right ventricle is a complex structure that is challenging to quantify by two-dimensional (2D)
echocardiography. Unlike disk summation three-dimensional (3D) echocardiography (3DE), single-beat 3DE
can acquire large volumes at high volume rates in one cardiac cycle, avoiding stitching artifacts or long
breath-holds. The aim of this study was to assess the accuracy and test-retest reproducibility of single-
beat 3DE for quantifying right ventricular (RV) volumes in adult populations of acquired RV pressure or volume
overload, namely, pulmonary hypertension (PH) and carcinoid heart disease, respectively. Three-dimensional
and 2D echocardiographic indices were also compared for identifying RV dysfunction in PH.
Methods: A prospective cross-sectional study was performed in 100 individuals who underwent 2D echocardi-
ography, 3DE, and cardiac magnetic resonance imaging: 49 patients with PH, 20 with carcinoid heart disease,
11with metastatic carcinoid tumorswithout cardiac involvement, and 20 healthy volunteers. Two operators per-
formed test-retest acquisition and postprocessing for inter- and intraobserver reproducibility in 20 subjects.
Results:: RV single-beat 3DE was attainable in 96% of cases, with mean volume rates of 32 to 45 volumes/sec.
Bland-Altman analysis of all subjects (presented asmean bias6 95% limits of agreement) revealed good agree-
ment for end-diastolic volume (!2.36 27.4mL) and end-systolic volume (5.26 19.0 mL) measured by 3DE and
cardiac magnetic resonance imaging, with a tendency to underestimate stroke volume (!7.5 6 23.6 mL) and
ejection fraction (!4.66 13.8%) by 3DE. Subgroup analysis demonstrated a greater bias for volumetric under-
estimation, particularly in healthy volunteers (end-diastolic volume, !11.9 6 18.0 mL; stroke volume,
!11.2 6 20.2 mL). Receiver operating characteristic curve analysis showed that 3DE-derived ejection fraction
was significantly superior to 2D echocardiographic parameters for identifying RV dysfunction in PH (sensitivity,
94%; specificity, 88%; area under the curve, 0.95; P = .031). There was significant interobserver test-retest bias
for RV volume underestimation (end-diastolic volume, !12.5 6 28.1 mL; stroke volume, !10.6 6 23.2 mL).
Conclusions: Single-beat 3DE is feasible and clinically applicable for volumetric quantification in acquired RV
pressure or volume overload. It has improved limits of agreement compared with previous disk summation 3D
echocardiographic studies and has incremental value over standard 2D echocardiographicmeasures for iden-
tifying RV dysfunction. Despite the ability to obtain and postprocess a full-volume 3D echocardiographic RV
data set, the quality of the raw data did influence the accuracy of the data obtained. The technique performs
better with dilated rather than nondilated RV cavities, with a learning curve that might affect the test-retest
reproducibility for serial RV studies. (J Am Soc Echocardiogr 2015;28:363-74.)
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Quantification of right ventricular
(RV) size and function is prog-
nostic in congenital and acquired
heart disease.1-4 The most
convenient imaging modality for
assessing the right ventricle is
two-dimensional (2D) echocardi-
ography (2DE). However, this
is limited by the crescentic RV
chamber shape and complex ge-
ometry, with inflow and outflow
portions in different planes.5,6
Thus, cardiac magnetic resonance
imaging (CMRI) has become the
gold-standard imaging modality
for RV quantification.7
Unfortunately,CMRI is expensive,
time consuming, and of limited
availability compared with echo-
cardiography.
One possibility to overcome
the limitations of 2DE is three-
dimensional (3D) echocardiog-
raphy (3DE), compared against
CMRI in a range of congenital
and acquired diseases for RV
volumetric quantification.8
Three-dimensional echocar-
diography traditionally uses the
disk summation method to
reconstruct the right ventricle af-
ter sequential slice acquisition
over consecutive electrocardio-
graphically gated heartbeats.9 This technique, however, is limited by
breath holding throughout successive cardiac cycles, stitching artifacts
during acquisition, and difficulties identifying inlet and outflow re-
gions in the basal slices during postprocessing.10
More recently, ultrasound transducer technology allows the real-
time acquisition of a 90" # 90" data set in a single cardiac cycle.11
We therefore compared RV volumetric quantification by single-beat
full-volume 3DE against CMRI in homogenous patient populations
of acquired RV pressure and volume overload, namely, pulmonary
hypertension (PH) and carcinoid heart disease, respectively. We also
sought to determine the potential incremental value of 3DE versus
2DE in PH and to evaluate the test-retest reproducibility of 3DE for
both the acquisition and postprocessing components.
METHODS
Study Population
We performed a prospective cross-sectional study that enrolled 100
participants in sinus rhythm with no contraindications to magnetic
resonance imaging, all of whom underwent comprehensive 2DE,
single-beat 3DE of the right ventricle, and CMRI within 2 hours of
one another. The participants were divided into four subgroups:
$ A group of 49 consecutive patients with PH (diagnosed by right heart cath-
eterization as a mean pulmonary artery pressure >25 mmHg and a pulmo-
nary capillary wedge pressure <15 mm Hg12) who presented for diagnosis
and/or follow-up of PH by clinical evaluation and/or right heart catheteriza-
tion as a disease model of RV pressure overload. The etiologies of PH
included idiopathic (n = 9), connective tissue disease associated (n = 32),
and chronic thromboembolic disease (n = 8). Exclusion criteria comprised
clinically significant restrictive or obstructive lung disease identified by pul-
monary function tests, arrhythmia, and known independent left-sided
cardiac disease unrelated to PH.
$ A group of 20 consecutive patients undergoing 2DE for diagnosis and/or
follow-up of carcinoid heart disease13 were studied as a disease model of
RV volume overload.
$ A control group of 20 healthy volunteers affiliated with our institution who
were age and sex matched to the PH group.
$ A control group of 11 age- and sex-matched patients with metastatic neuro-
endocrine tumor whowere screened as negative for carcinoid valvular heart
disease.
All control participants were eligible for study inclusion if they had
no cardiac symptomatology, had no medical histories of cardiac
disease including hypertension, and were not taking any cardiac med-
ications. Normal 2D transthoracic echocardiographic findings were
also required to exclude any occult structural cardiac disease before
study inclusion.
The institutional research ethics committee approved the study,
and informedwritten consent was obtained from all patients and con-
trol subjects.
2DE
All patients underwent comprehensive 2D andDoppler transthoracic
echocardiography in the left lateral decubitus position using the
Acuson Siemens SC2000 cardiac ultrasound system (Siemens
Healthcare, Erlangen, Germany), with a 4V1c transducer (frequency
bandwidth, 1.25–4.5 MHz). A standard study protocol was followed
in conjunction with American Society of Echocardiography guide-
lines for chamber quantification14,15 and the British Society of
Echocardiography guidelines for PH assessment16 as appropriate.
RV function was assessed using M-mode tricuspid annular plane sys-
tolic excursion (TAPSE); RV fractional area change, calculated as
[(end-diastolic area) ! (end-systolic area)/end-diastolic area] # 100;
and mean RV free wall peak systolic strain using syngo Vector
Velocity Imaging (Siemens Medical Solutions USA, Inc, Mountain
View, CA). A three-beat 2D echocardiographic digital clip of an apical
four-chamber view optimized for RV visualization was acquired and
exported to Velocity Vector Imaging, and 10 to 15 endocardial points
were plotted in end-systole from the lateral to the medial tricuspid
annulus.17 The adequacy of speckle-tracking was visually checked
and manually adjusted as required.
3DE
Image Acquisition. Single-beat full-volume 3D echocardiographic
RV data sets were acquired using the 4Z1c matrix-array transducer
(frequency bandwidth, 1.5–3.5 MHz; maximum depth, 30 cm;
maximum field of view, 90" # 90"). Probe position started from
the apical four-chamber view with the patient in the left lateral decu-
bitus position. Both the patient and transducer positions were subse-
quently modified for optimal simultaneous visualization of the
tricuspid valve, cardiac apex, infundibulum, and RV outflow tract
(RVOT) as assessed by the real-time 2D four-chamber, basal sagittal,
and coronal views, and by inclusion of the RV chamber in the pyrami-
dal data set. In our experience, a more lateral apical windowwith pos-
terior tilt of the probe tail was beneficial to visualize the infundibulum
and RVOT in the coronal window. Image depth and sector width
were adjusted for maximal visualization of the right ventricle at the
Abbreviations
CMRI = Cardiac magnetic
resonance imaging
COV = Coefficient of variation
EDV = End-diastolic volume
EF = Ejection fraction
ESV = End-systolic volume
ICC = Intraclass correlation
coefficient
PH = Pulmonary hypertension
ROC = Receiver operating
characteristic
RV = Right ventricular
RVOT = Right ventricular
outflow tract
SV = Stroke volume
TAPSE = Tricuspid annular
plane systolic excursion
3D = Three-dimensional
3DE = Three-dimensional
echocardiography
2D = Two-dimensional
2DE = Two-dimensional
echocardiography
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highest volume rate. At least three 3D echocardiographic RV data sets
were acquired during a breath-hold to ensure optimal image quality,
which was subjectively graded on a five-point scale ranging from zero
(very poor) to four (perfect).18 A score of two or less was attributed if
ultrasound dropout was evident in greater than half of the RVOT
border.
Postprocessing. Full-volume 3D echocardiographic RV data sets
were imported into the on-cart RV Analysis application. Manual
adjustment of the RV data set was initially required to ensure the
correct orientation of four-chamber, sagittal, and coronal slices; maxi-
mize the RV cavity area and identify themost apical RV view on visual
assessment of the four-chamber window; and allow the identification
of cardiac landmarks. This process was performed in a stepwise
approach by rotation and angulation of the four-chamber window,
with manipulation of this plane causing the simultaneous adjustment
of the other two (sagittal and coronal) orthogonal planes (Figure 1A).
Both atrioventricular valves followed by the left ventricular apex were
identified as anatomic landmarks. When the apex of a dilated right
ventricle overrode that of the left ventricle, the most apical cardiac
Figure 1 Example of the stepwise process of RV reconstruction by 3DE. (A) The cavity area is optimized in the three orthogonal views,
and landmarks are identified (mitral valve indicated by the blue asterisk, tricuspid valve indicated by the red asterisk). Note the RVOT
seen in the coronal view (indicated by the purple asterisk). (B)Having traced endocardial borders in three orthogonal views, the semi-
automated border tracking results are displayed for inspection. Note how the purple guideline (indicated by the purple asterisk) bi-
sects the tricuspid valve and RVOT in the short-axis views. This corresponds to the coronal RV reconstruction (highlighted), with
clearly delineated RV inflow and outflow portions. A4C, Apical four-chamber.
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point was identified with the left ventricular apex marker. End-
diastolic and end-systolic frames were assigned by visual identification
of the largest and smallest RV four-chamber areas, respectively.
Endocardial RV borders were traced at end-diastole and
end-systole in four-chamber, basal sagittal, and coronal views. The
software algorithm obliges the operator to intersect the endocardial
border tracing in sequential views with crosshair reference markers
that are positioned in response to endocardial border traces from a
preceding view. Therefore, correction of a previous slice tracing was
undertaken when a crosshair position suggested a prior tracing error.
Trabeculae were included in the blood pool volume. To assist with
RVOT delineation in the basal sagittal view, the insertion point of
the RV myocardium at the interventricular septum was routinely
included in the endocardial tracing.
At the final stage, the algorithm presents the results of semiauto-
mated contour tracking for the four-chamber, coronal and basal,
middle and apical short-axis views. Misalignment of endocardial con-
tours prompted identification of the region of suboptimal tracking
followed by manual correction of the original tracing. Automated
volumetric reconstruction was accepted only once the semiauto-
mated endocardial border tracking was visually satisfactory and repre-
sented meaningful RV shapes in all views (Figure 1B), as optimization
of this final reconstruction stage significantly affects the results gener-
ated.19 The algorithm from which the final RV volume is generated
has been previously described.20,21
Test-Retest Reproducibility of 3DE. Reproducibility was stud-
ied in 20 randomly selected subjects (14 with PH, one with carcinoid
heart disease, and five healthy volunteers) for both the 3D echocar-
diographic acquisition and postprocessing stages by two independent
sonographers (D.S.K. and A.E.G.), as described previously.22 The two
sonographers had equal experience with 2DE but differing levels of
experience with 3D echocardiographic RV full-volume acquisition
(10 and 3 months, respectively). Sonographer 1 (D.S.K.) obtained a
3D echocardiographic RV data set, after which sonographer 2
(A.E.G.) independently obtained a 3D echocardiographic RV data
set. Then, sonographer 1 acquired a second separate 3D echocardio-
graphic RV data set. The sonographers, who were blinded to each
other’s results, performed postprocessing of their own 3D echocar-
diographic RV data sets. Data sets for intraobserver test-retest repro-
ducibility were postprocessed separately at time intervals of >2
weeks.
Cardiac MRI
Image Acquisition. All cardiac magnetic resonance images were
acquired using a 1.5-T magnetic resonance scanner (Avanto;
Siemens Healthcare) using a 12-element phased-array coil for signal
reception and the body coil for signal transmission. A vector electro-
cardiographic systemwas used for cardiac gating. Ventricular volumes
and great vessel flow were measured in all patients. Volumetric RV
data were obtained using either retrospectively gated balanced
steady-state free precession (n = 19) cine imaging of contiguous
short-axis slices23 or real-time radial k-t sensitivity encoding imaging
(n = 81) of contiguous transaxial slices24 depending on the pathology
under investigation and the patient’s ability to hold his or her breath.
Real-time radial k-t sensitivity imaging allows the collection of high
spatiotemporal resolution real-time images during free breathing
and is part of the standard clinical CMRI work flow at our institution
in the pediatric PH population.25 Transaxial RV slices were preferred
for the PH cohort and their respective control population because of
the relative preservation of longitudinal versus radial RV function that
is manifest in this condition.26 Blood flow data were acquired in the
ascending aorta, in the right and left branch pulmonary arteries, and
at the level of the atrioventricular valves using a velocity-encoded pro-
spectively triggered spiral phase-contrast magnetic resonance flow
sequence.27 This provided an internal check for the RV volumetric
data.
Postprocessing. All image postprocessing was performed using
‘‘in-house’’ plug-ins for the open-source OsiriX Digital Imaging and
Communications in Medicine software.24,28,29 Endocardial RV
borders were traced manually at end-diastole and end-systole, the
time points of which were identified by the largest and smallest RV
cavity areas, respectively. The inclusion of RV trabeculae was the
same as that performed by 3D echocardiographic postprocessing.
Ventricular stroke volume (SV) was the difference between end-
diastolic volume (EDV) and end-systolic volume (ESV), and ejection
fraction (EF) was calculated as (SV/EDV)# 100. Phase-contrast mag-
netic resonance flow data were segmented using a semiautomatic
vessel edge detection algorithm with manual operator correction.28
The CMRI data sets for the patients who underwent 3D echocardio-
graphic test-retest reproducibility scans were also tested for interob-
server (D.S.K. and M.A.Q.) and intraobserver postprocessing
reproducibility.
Statistical Analysis
Statistical analysis was performed using SPSS version 21.0 (IBM
Corporation, Armonk, NY) and Prism 6.0b for Mac (GraphPad
Software, Inc, La Jolla, CA). Normally distributed continuous data
were expressed as mean6 SD. Systematic differences between mea-
surements were evaluated with Student paired t tests (two tailed),
with Pearson correlation coefficients used to assess the relationship
between 3DE- and CMRI-derived RV volumes and EF. Differences
between the four participant subgroups were analyzed using one-
way analysis of variance, with the Tukey post hoc tests identifying
which specific means differed. P values < .05 were considered statis-
tically significant. Image scoring data were nonparametrically distrib-
uted, represented by medians with 25th and 75th percentiles. Rank
sum tests were used for comparisons of image scoring data, with
theMann-WhitneyU test and the Kruskal-Wallis test used for compar-
isons of two and three independent groups, respectively.
Intermodality, interobserver, and intraobserver agreement was
studied using the Bland-Altman method,30 whereby the mean differ-
ence was presented as the bias and 95% limits of agreement around
the bias expressed as themean difference6 1.96 SDs. Differences be-
tween test-retest measurements were analyzed by one-way repeated
measures analysis of variance, with the Bonferroni post hoc test iden-
tifying which specific means differed. The Greenhouse-Geisser
correction was used if the assumption of sphericity had been violated.
Test-retest variability was expressed using intraclass correlation coeffi-
cients (ICC), relative differences, and coefficients of variation (COVs).
The ICC was quantified by the two-way random-effects model with
absolute agreement. An ICC > 0.85 was considered excellent.
Relative differences were calculated by taking the absolute difference
between two observations divided by the mean of the repeated ob-
servations and expressed as a percentage. COVs were calculated as
the standard deviation of the difference between two acquisitions
divided by their mean value and expressed as a percentage.31 A
COV # 10% was considered excellent.
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Receiver operating characteristic (ROC) curves were derived for
2D and 3D echocardiographic parameters to identify CMRI-
derived RV EFs of <50% in patients with PH and healthy volun-
teers.32 Patients with carcinoid disease were excluded from this
analysis to avoid the confounding effects of severe valvular regurgita-
tion on ventricular function. The area under the ROC curve for an
echocardiographic parameter is presented together with the optimal
cutoff threshold for detecting CMRI-derived RV EF < 50%, defined
as the value of the parameter that corresponded to the highest sum
of sensitivity and specificity. The Delong method was used to
compare the areas under the curve between ROC curves33
(Analyse-it Software, Ltd, Leeds, United Kingdom).
RESULTS
Population Characteristics and 3DE Technical Data
Of 100 individuals who were recruited, four had unobtainable RV
echocardiographic windows. The clinical characteristics and 3D echo-
cardiographic technical data of the final cohort of 96 subjects are
presented in Table 1. Patients with PH had significantly larger and
impaired right ventricles than controls, whereas the right ventricles
of patients with carcinoid heart disease were also significantly dilated
but with preserved EFs. The dilated right ventricles of the patient
groups resulted in a significantly lower mean volume rate compared
with controls because of the greater 3D sector angles (P < .001), but
the median image quality score was significantly higher among
patients (3.00; interquartile range, 2.00–3.00) than controls (2.00 in-
terquartile range, 1.00–3.00) (P < .001). The image quality among
three successive, equally populated subgroups of patients significantly
improved with increasing experience with 3DE (Figure 2; P = .031).
There was a trend, albeit not statistically significant, for greater differ-
ences in SV between modalities with worse subjective image scores
(Figure 3; P< .13 for percentage intermodality difference in SV for im-
age score groups 1 and 2 combined vs groups 3 and 4 combined).
Volumetric Analysis by 3DE versus CMRI
Correlation coefficients showed good to excellent correlations be-
tween modalities for RV metrics in patient groups and moderate to
good correlations for control subjects (Table 2). RV volumes and
EFs by 3DE showed differences with CMRI in both patient groups,
with a bias for underestimating SVand EF but with overall acceptable
limits of agreement (Figure 4). By contrast, 3DE underestimated EDV
for control subjects (Table 3), with a consequent negative bias for
quantifying SV in this group (Figure 5).
RV Quantification by 3DE and 2DE versus CMRI
Three-dimensional echocardiographic EF was the most superior
echocardiographic parameter for identifying CMRI-derived RV EF
Table 1 Clinical characteristics of study populations
Variable
PH
(n = 46)
Carcinoid heart
disease (n = 19)
Healthy
volunteers
(n = 20)
Carcinoid (no
valvulopathy) (n = 11) P*
Age (y) 56 6 13 63 6 8 50 6 12 59 6 10
Women 35 (76%) 7 (37%) 15 (75%) 7 (64%)
Height (cm) 164 6 9 171 6 10 169 6 8 168 6 10 .035
Weight (kg) 69 6 17 72 6 18 72 6 12 77 6 20 .54
Body surface area (m2) 1.8 6 0.2 1.8 6 0.3 1.8 6 0.2 1.9 6 0.3 .37
Heart rate (beats/min) 74 6 14 67 6 13 68 6 9 69 6 12 .19
Mean PASP on RHC (mm Hg) 44 6 16
Pulmonary vasodilators
Endothelin antagonist 21 (46%)
PDE-5 antagonist 31 (67%)
Prostanoid infusion 2 (4%)
Oral prostanoid 1 (2%)
Prostaglandin receptor agonist 1 (2%)
Carcinoid heart disease: affected valves TV = 19 (100%), PV = 13 (68%), MV = 3 (16%), AV = 3 (16%)
EDV (mL/m2) 87 6 26 100 6 35 64 6 14 52 6 8 <.0001
ESV (mL/m2) 52 6 25 33 6 15 22 6 7 16 6 5 <.0001
EF (%) 43 6 14 68 6 7 65 6 7 71 6 7 <.0001
3D echocardiographic temporal
resolution (volumes/sec)
34 6 5 32 6 7 40 6 5 45 6 6 <.0001
AV, Aortic valve; ESV, end-systolic volume;MV, mitral valve; PASP, pulmonary artery systolic pressure; PDE-5, phosphodiesterase-5; PV, pulmo-
nary valve; RHC, right heart catheterization; TV, tricuspid valve.
Data are expressed as mean 6 SD or as number (percentage).
*One-way analysis between groups.
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< 50% (Figure 6; P = .031), with sensitivity of 94%. A fractional area
change of 39% (sensitivity, 85%) was the best conventional 2D echo-
cardiographic measure, superior to both peak systolic strain and
TAPSE (P = .0443). TAPSE was the weakest marker to predict
CMRI-derived RV EF < 50%, with sensitivity of 56% at a cutoff
threshold of 19 mm.
Test-Retest Intraobserver and Interobserver
Reproducibility
Limits of agreement were acceptable for intra- and interobserver 3D
echocardiographic studies, with good to excellent ICCs (Table 4).
However, there was a significant interobserver bias for underestimat-
ing RV EDV (P= .001; Table 5) that resulted in underestimation of SV
(P = .002) and EF (P = .033), with accompanying large interobserver
COVs and relative differences. Moreover, despite no significant
differences between intraobserver EDV and ESV, the differences
translated into statistically significant test-retest differences for SV
(P = .032) and EF (P = .005). The interobserver and intraobserver
reproducibility for RV volumes and EF by CMRI showed no signifi-
cant bias and superior limits of agreement compared with 3DE.
DISCUSSION
This study demonstrates the feasibility of single-beat full-volume 3DE
for RV quantification in, to our knowledge, the largest homogenous
acquired RV pressure- and volume-overloaded patient populations.
Single-beat 3DE is an agreeable technique compared with CMRI,
albeit with significant differences especially in subjects with nondi-
lated right ventricles. Furthermore, 3D echocardiographic parameters
are of incremental benefit for RV functional quantification compared
with traditional 2DE measures.
Accurate quantitation of RV size and function is important in many
congenital and acquired cardiac diseases and is of particular relevance
in our study populations. RV size and function are of greater prog-
nostic significance in PH than the afterload to which the right heart
is exposed,34,35 with RV EF being the key determinant of outcome
regardless of changes in pulmonary vascular resistance afforded by
pulmonary vasodilator therapy.36 Similarly, right heart dilatation is
independently associated with poor outcomes in patients with
advanced carcinoid heart disease.37 However, the right ventricle re-
sponds differently to pressure- and volume-overload conditions,
with dilatation occurring in both but with relative preservation of
Figure 3 Box-and-whisker plots of differences in stroke volume
betweenmodalities (expressedasapercentageof theCMRI refer-
ence value) for image scoring groups 1 to 4. There was a trend,
albeit not statistically significant, for the intermodality difference
to increasewith reductions in subjective image score.Median per-
centage intermodality differences in stroke volumeby image score
group were as follows: group 1, 22% (interquartile range [IQR],
!1% to 26%); group 2, 11% (IQR, !2% to 23%); group 3, 9%
(IQR, 3% to 16%); group 4, 2% (IQR, !6% to 19%).
Table 2 RV volumes and EFs by single-beat full-volume 3DE
versus CMRI
Group Measurement 3DE CMRI P*
PH EDV (mL) 158 6 53 154 6 52 .043
ESV (mL) 100 6 44 92 6 47 <.0001
SV (mL) 58 6 18 63 6 17 .011
EF (%) 39 6 11 43 6 14 .00029
Carcinoid heart
disease
EDV (mL) 182 6 69 185 6 71 .21
ESV (mL) 67 6 28 62 6 3 .01
SV (mL) 115 6 42 124 6 45 .014
EF (%) 64 6 5 68 6 7 .001
Healthy
volunteers
EDV (mL) 105 6 26 117 6 27 <.0001
ESV (mL) 41 6 12 41 6 14 .80
SV (mL) 65 6 16 76 6 18 <.0001
EF (%) 61 6 5 65 6 7 .014
Carcinoid (no
valvulopathy)
EDV (mL) 88 6 21 98 6 27 .05
ESV (mL) 32 6 13 30 6 14 .24
SV (mL) 56 6 10 68 6 14 .009
EF (%) 64 6 7 71 6 7 .004
ESV, End-systolic volume.
Data are expressed as mean 6 SD.
*Paired Student t tests.
Figure 2 Box-and-whisker plots of subjective image quality
scores among three successive subgroups of patients (group
1 acquired in the earliest phase of the study, group 3 in the latest
phase of the study). Image quality significantly improved with
increasing experience with 3DE (P = .031).
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function in elevated preload rather than afterload. What remains un-
clear is to what extent this preserved EF represents normality of func-
tion in the presence of severe tricuspid regurgitation, a valvular lesion
common to all patients in our carcinoid heart disease cohort.
The incremental benefit of 3DE over 2DE has previously been
shown in congenital heart disease,38 and single-beat 3DE showed
similar added value over 2DE metrics in acquired RV pressure over-
load. Although this is due in part to equivalent parameters being as-
sessed by 3DE and CMRI, it is, importantly, also a reflection of the
limitations of conventional 2D echocardiographic measures. TAPSE
had the poorest sensitivity for detecting lowRVEF in PH, with a cutoff
of 19 mm having the highest combined sensitivity and specificity. This
is higher than the recommended threshold of 16mm for detecting RV
dysfunction,14 suggesting that TAPSE would have performed worse
Figure 4 Bland-Altman analysis of bias (black solid line) and 95% limits of agreement (red dashed line) for 3DE versus CMRI quan-
tification of RV EDV, ESV, SV, and EF in patients with PH and carcinoid heart disease.
Table 3 Bias, limits of agreement, and correlation between single-beat full-volume 3DE and CMRI for RV volumes and EFs
Group Measurements Bias 6 SD Limits of agreement r P*
All subjects EDV (mL) !2.3 6 13.7 !29.1 to 24.5 0.97 <.0001
ESV (mL) 5.2 6 9.5 !13.4 to 23.9 0.98 <.0001
SV (mL) !7.5 6 11.8 !30.6 to 15.7 0.94 <.0001
EF (%) !4.6 6 6.9 !18.2 to 9.0 0.91 <.0001
PH EDV (mL) 4.0 6 13.1 !21.6 to 29.7 0.97 <.0001
ESV (mL) 8.4 6 10.6 !12. 3 to 29.1 0.98 <.0001
SV (mL) !4.3 6 10.8 !25.5 to 17.0 0.82 <.0001
EF (%) !4.8 6 8.3 !21.1 to 11.5 0.81 <.0001
Carcinoid heart disease EDV (mL) !3.1 6 10.1 !22.9 to 16.8 0.99 <.0001
ESV (mL) 5.4 6 8.2 !10.6 to 21.4 0.96 <.0001
SV (mL) !8.6 6 13.9 !35.9 to 18.6 0.95 <.0001
EF (%) !3.8 6 4.1 !11.9 to 4.2 0.82 <.0001
Healthy volunteers EDV (mL) !11.9 6 9.0 !29.5 to 5.8 0.94 <.0001
ESV (mL) !0.4 6 6.7 !13.6 to 12.9 0.88 <.0001
SV (mL) !11.2 6 10.1 !31.0 to 8.7 0.84 <.0001
EF (%) !3.9 6 6.5 !16.6 to 8.8 0.51 .021
Carcinoid (no
valvulopathy)
EDV (mL) !10.1 6 15.0 !39.6 to 19.4 0.84 .001
ESV (mL) 2.1 6 5.5 !8.7 to 12.9 0.92 <.0001
SV (mL) !12.2 6 12.3 !36.3 to 11.9 0.53 .096
EF (%) !6.2 6 5.6 !17.1 to 4.7 0.69 .019
ESV, End-systolic volume.
*Pearson correlation coefficient.
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by current guidelines in our cohort. The rocking motion of the right
ventricle in pressure overload can give rise to apparently normal
TAPSE values,39 and TAPSE also does not account for the radial
component of RV function that contributes significantly to RV EF.26
By contrast, fractional area change was the most superior 2D echocar-
diographic marker for identifying RV dysfunction in PH, most likely a
reflection of being the only 2D echocardiographic marker that ac-
counts for radial function. These findings are consistent with previous
studies comparing 2D echocardiographic markers of RV function in
PH40 and suggest that 3DE may have an important additive role in
assessing RV function.
RV quantification by echocardiography is advantageous through
being more readily available and less expensive than CMRI. Since
the first use of 3DE for RV volumetric quantification,18 improvements
in matrix-array transducer technology permit the simultaneous visual-
ization of orthogonal 2D RV planes at the time of acquisition. The
technique used in this study allows a pyramidal data set of up to
90" # 90" to be acquired at higher temporal resolutions than previ-
ously reported for 3DE.41 Acquisition of a full volume in a single
heartbeat avoids stitching artifacts associated with acquiring slices
over serial heartbeats and also confers the advantage of shorter
breath-hold durations. These reasons might explain the narrower
limits of agreement for RV volumetric parameters between single-
beat 3DE and CMRI compared with previous data from adult PH
groups using the disk summation method.41,42
The disadvantages of echocardiography include constraints that
afford inadequate transthoracic windows, including body habitus,
hyperinflated lungs, and chest deformities. Acquisition and postpro-
cessing was feasible in 96% of subjects, consistent with previously re-
ported studies using the technique.43,44 However, patients with
significant lung disease were excluded to ensure that PH was the
predominant disease process in the RV pressure-overload group,
and this may in turn have biased the echogenicity of the study popu-
lation. Although all postprocessed 3D echocardiographic data sets
had a reconstructed RV polygon that tracked throughout the cardiac
cycle, 45% of studies were judged by subjective image scoring to have
some endocardial dropout of the outflow portion of the right
ventricle. This was reflected by a trend toward increasing differences
Figure 5 Bland-Altman analysis of bias (black solid line) and 95% limits of agreement (red dashed line) for 3DE versus CMRI quan-
tification of RV EDV, ESV, SV, and EF for subjects in the control populations.
Figure 6 ROC curves for 3DE, fractional area change (FAC), RV
free wall peak systolic strain by speckle-tracking echocardiog-
raphy, and TAPSE to identify RV dysfunction (defined as RV
EF < 50% on CMRI).
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in SVs between modalities with decreasing image quality, with a me-
dian difference of $11% when the RVOT was incompletely visual-
ized. This is a consistent problem with 3DE that has been well
documented previously and is due to the anterior position of the right
ventricle in the thorax. Postprocessing software extrapolates the
endocardial borders during semiautomated border tracking,45 and
hence although it is possible to analyze data sets with incomplete
RVOT visualization, the accuracy of reconstructions will most likely
deteriorate with progressive dropout in the outflow tract.
When comparing studies of RV quantification by 3DE, the homo-
geneity of the study population must be taken into account. Our pop-
ulations of acquired RV disease were favorable for the 3D
echocardiographic postprocessing software algorithm, because it is
set up for an adult-shaped right ventricle rather than a congenital
heart.46 This may be a reason why our limits of agreement were nar-
rower than reported in congenital heart disease.45 No substantial bias
was observed in either the PH or carcinoid heart disease group, but
subgroup analysis showed that EDVs, and consequently SVs, were
underestimated in controls. This is despite the higher temporal reso-
lution of images in this group and is likely a result of low spatial reso-
lution with single-beat 3DE. Lower spatial resolution confers less
ability to resolve myocardium and trabeculae, thus directing the oper-
ator to trace the endocardium further inside the RV cavity and hence
underestimate volumes. This is supported by previous data showing
greater variability and negative bias for 3DE to quantify RV volumes
in nondilated right hearts.47 Conversely, RVendocardial delineation is
Table 4 Interobserver and intraobserver reproducibility for RV volumes and EF by 3DE and CMRI
Variable EDV (mL) ESV (mL) SV (mL) EF (%)
3DE intraobserver
ICC 0.992 0.974 0.96 0.906
COV (%) 3.0 6.6 8.0 6.9
RD (%) 4.3 9.4 11.3 9.8
Bias !0.2 4.6 !4.7 !3.6
LOA !16.2 to 15.8 !12.8 to 22.0 !19.0 to 9.7 !12.2 to 5.0
SD 8.2 8.9 7.3 4.4
CMRI intraobserver
Bias !2.6 !2.4 !0.1 0.7
LOA !15.4 to 10.2 !11.3 to 6.5 !11.8 to 11.6 !5.9 to 7.2
SD 6.5 4.6 6.0 3.4
3DE interobserver
ICC 0.955 0.965 0.867 0.827
COV (%) 7.7 8.0 16.6 9.4
RD (%) 10.3 11.4 23.5 13.3
Bias !12.5 !2.0 !10.6 !4.0
LOA !40.0 to 15.1 !24.0 to 20.1 !33.2 to 12.1 !16.2 to 8.3
SD 14.1 11.3 11.6 6.3
CMRI interobserver
Bias !1.9 !2.80 1.1 0.9
LOA !18.2 to 14.4 !13.1 to 7.5 !9.3 to 11.5 !4.1 to 5.8
SD 8.3 5.2 5.3 2.5
ESV, End-systolic volume; LOA, limits of agreement; RD, relative difference.
Table 5 Interobserver and intraobserver test-retest RV metrics by 3DE
Sonographer 1 Sonographer 2
Variable First (S1.1) Second (S1.2) P* S1.1 vs S1.2 Acquisition P* vs S1.1 P* vs S1.2
EDV (mL) 145 6 63 145 6 62 NS 133 6 59 .003 .003
ESV (mL) 78 6 44 83 6 42 NS 76 6 39 NS NS
SV (mL) 67 6 31 63 6 29 .032 57 6 27 .002 .046
EF (%) 48 6 13 44 6 12 .005 44 6 11 .033 NS
ESV, End-systolic volume.
Data are expressed as mean 6 SD.
*One-way repeated-measures analysis of variance with Bonferroni post hoc test.
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known to be easier in the setting of RV hypertrophy or dilatation for
both magnetic resonance imaging and 3DE41,47 and is reflected by
the higher image quality scores observed with our disease cohorts.
The progressive increase in 3D echocardiographic image quality
over the study duration reflects a significant learning curve with the
technique, as also described in previous studies.38 This is important
clinically, as follow-up studies will vary depending on operator expe-
rience for both acquisition and postprocessing. Few studies so far have
addressed 3D echocardiographic test-retest reproducibility for both
the acquisition and postprocessing stages.22,41 Our interobserver
test-retest study demonstrated a second operator bias for EDV under-
estimation, conferring lower SV and EF measurements. This was a
systematic error likely reflecting relative operator inexperience with
the technique. The susceptibility of 3DE to underestimate RV vol-
umes has been well documented,8 and our data suggest that operator
experience is related to this underestimation.
Furthermore, nonsignificant differences in intraobserver EDV and
ESV nevertheless resulted in significant differences in SV and EF
when the errors in the raw volumes were combined. Given that
small changes in endocardial border delineation are known to
confer significant changes in 3DE-derived volumetric parameters in
the left ventricle,48 this is also likely to be a problem with 3DE recon-
struction of the right ventricle too. This is clinically important because
a change of as little as 10 mL in SV by CMRI is clinically significant in
PH,49 but a change of this magnitude may bemasked by 3DE’s repro-
ducibility error and/or the degradation of accuracy found with poorer
quality 3D echocardiographic data sets. For example, the interob-
server measurement of RV SV by 3DE showed a significant bias
with a standard deviation more than double that of CMRI. Our
CMRI reproducibility data show narrow limits of agreement, with
no major bias between observers, consistent with previous reproduc-
ibility studies of RV quantification by transaxial slices50,51 and
sensitive enough to detect small changes in RV indices on serial
studies.
Limitations
This study was a single-center study based on acquisitions made by
one sonographer with experience using single-beat 3DE for RV
volumetric quantification. As demonstrated by our test-retest repro-
ducibility, results cannot be applied across operators with variable
experience in 3D echocardiographic RV analysis. Patients with ar-
rhythmias were excluded because of the extra variability introduced
by irregular cardiac cycles when comparing modalities. Single-beat
acquisition is advantageous over traditional disk summation
techniques that are limited by stitching artifacts due to irregular R-R
intervals, and this patient group requires further investigation with
the technique.
We found a bias to underestimate cavity size, particularly in control
subjects, but the study was not designed to compare the accuracy of
the technique in patients with large versus small cavity sizes. This
question should be addressed in a separate prospectively designed
analysis of large versus small right ventricles. The sensitivity and
specificity values for 3DE and 2DE to identify CMRI-derived RVEF
< 50% were calculated by applying the ROC cutoff values to the
same patients used to derive them as described previously,38 hence
representing a ‘‘best case’’ scenario. A more appropriate method
would be to identify cut-off values using ROC analysis in a derivation
group, then prospectively evaluate the cutoff values in a separate test
group in whom outcomes could be verified independently. Thus the
diagnostic performance of the cutoff values found in this study needs
to be confirmed independently.
Finally, the study was not designed to provide CMRI test-retest
reproducibility similar to the 3D echocardiographic study design for
acquisition and postprocessing. However, CMRI does not have the
same acquisition window restrictions inherent to transthoracic echo-
cardiography, as contiguous transaxial RV slices of fixed thickness are
acquired from the base of the right heart to the main pulmonary
artery with the patient in the supine position. However, this difference
in technique methodology is a potential source of discrepancy, with
the reference standard of CMRI building volumes frommultiple slices
compared with the full-volume data sets of 3DE.10
CONCLUSIONS
Single-beat full-volume 3DE is a feasible technique for quantifying RV
size and function in acquired right heart pressure and volume
overload. The limits of agreement of 3DE are acceptable compared
with CMRI but may not be sensitive enough to detect small yet clin-
ically significant responses to treatment demonstrated by this modal-
ity.49 The test-retest reproducibility of 3DE suggests a significant
learning curve that needs to be considered, and thus results cannot
necessarily be extrapolated to less experienced operators.
Nevertheless, 3DE showed incremental benefit over conventional
2D echocardiographic measures, suggesting an important role in as-
sessing acquired RV pathology. Future work should focus on
improving spatial resolution to optimize RV endocardial delineation,
in particular for adequate visualization of the RVOT in nondilated
right ventricles.
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RIGHT VENTRICULAR FUNCTION
Accuracy and Test-Retest Reproducibility
of Two-Dimensional Knowledge-Based Volumetric
Reconstruction of the Right Ventricle in Pulmonary
Hypertension
Daniel S. Knight, BSc (Hons), MBBS, MRCP, Johannes P. Schwaiger, MD, Sylvia Krupickova, MD, PhD,
Joseph Davar, FRCP, MD, PhD, Vivek Muthurangu, MD, MRCPCH, and
J. Gerry Coghlan, MD, FRCP, London, United Kingdom
Background:Right heart function is the key determinant of symptoms and prognosis in pulmonary hyperten-
sion (PH), but the right ventricle has a complex geometry that is challenging to quantify by two-dimensional
(2D) echocardiography. A novel 2D echocardiographic technique for right ventricular (RV) quantitation in-
volves knowledge-based reconstruction (KBR), a hybrid of 2D echocardiography–acquired coordinates
localized in three-dimensional space and connected by reference to a disease-specific RV shape library.
The aim of this study was to determine the accuracy of 2D KBR against cardiacmagnetic resonance imaging
in PH and the test-retest reproducibility of both conventional 2D echocardiographic RV fractional area
change (FAC) and 2D KBR.
Methods: Twenty-eight patients with PH underwent same-day echocardiography and cardiac magnetic reso-
nance imaging. Two operators performed serial RV FAC and 2D KBR acquisition and postprocessing to
assess inter- and intraobserver test-retest reproducibility.
Results: Bland-Altman analysis (mean bias 6 95% limits of agreement) showed good agreement for
end-diastolic volume (3.5 6 25.0 mL), end-systolic volume (0.9 6 19.9 mL), stroke volume (2.6 6 23.1 mL),
and ejection fraction (0.4 6 10.2%) measured by 2D KBR and cardiac magnetic resonance imaging. There
were no significant interobserver or intraobserver test-retest differences for 2D KBR RV metrics, with accept-
able limits of agreement (interobserver end-diastolic volume, !0.9 6 21.8 mL; end-systolic volume,
!1.3 6 25.8 mL; stroke volume, !0.2 6 24.2 mL; ejection fraction, 0.7 6 14.4%). Significant test-retest vari-
ability was observed for 2D echocardiographic RV areas and FAC.
Conclusions: Two-dimensional KBR is an accurate, novel technique for RV volumetric quantification in PH,
with superior test-retest reproducibility compared with conventional 2D echocardiographic RV FAC. (J Am
Soc Echocardiogr 2015;28:989-98.)
Keywords: Transthoracic echocardiography, Right ventricular function, Pulmonary hypertension, Reproduc-
ibility of results, Magnetic resonance imaging
Right ventricular (RV) function is the key symptomatic and prognostic
determinant in pulmonary hypertension (PH).1 Cardiac magnetic
resonance imaging (CMRI) is the gold standard for volumetric quan-
tification of the right ventricle,2 but cardiac ultrasound is a compara-
tively cheaper and more widely available modality. However, the
anatomy and complex geometry of the right ventricle confer signifi-
cant limitations to two-dimensional (2D) echocardiography
(2DE).3,4 Fractional area change (FAC), for example, is a simple
measure of RV size and function that visualizes only one 2D plane
of this complex chamber.5 Three-dimensional echocardiography
(3DE) has shown promise for RV volumetric analysis in PH6-8 but
requires operator experience for acquisition and postprocessing
beyond that of 2DE, with lower spatial and temporal resolution,
typically leading to underestimation of RV volumes.9
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A novel 2D echocardiographic
technique for volumetric RV
quantitation involves knowledge-
based reconstruction (KBR). This
hybrid approach uses the benefits
of conventional 2DE in conjunc-
tion with a reference library of
RV shapes to reconstruct a 3D
RV polygon. The feasibility and
accuracy of 2D KBR has been
demonstrated in a small PHpopu-
lation,10 but the ability to accu-
rately identify changes in RV
function in response to treatment
is also of clinical and prognostic
significance.2,11 This will depend
on the acquisition and
postprocessing elements of 2D
KBR that both contribute to its variability. We therefore sought to
provide further validation data for 2D KBR RV quantification in PH
and to investigate the test-retest reproducibility of this novel technique
compared with FAC.
METHODS
Study Population
We performed a prospective cross-sectional study that enrolled 28
patients in sinus rhythm with no contraindications to magnetic reso-
nance imaging who presented for diagnosis and/or follow-up of PH
(diagnosed by right heart catheterization as a mean pulmonary artery
pressure > 25 mm Hg and a pulmonary capillary wedge pressure <
15 mm Hg12). All participants underwent comprehensive 2D trans-
thoracic echocardiography and CMRI on the same day (median
scan interval, 116 min; interquartile range, 104–150 min). The etiol-
ogies of PH were idiopathic (n = 5), connective tissue disease associ-
ated (n = 14), chronic thromboembolic disease (n = 8) and
portopulmonary (n = 1). Exclusion criteria were arrhythmia and
known independent left-sided cardiac disease unrelated to PH.
The study complied with the Declaration of Helsinki. The institu-
tional research ethics committee approved the study, and informed
written consent was obtained from all participants.
Two-Dimensional Echocardiography and KBR
Image Acquisition. All patients underwent comprehensive 2D and
Doppler transthoracic echocardiography in the left lateral decubitus
position using the Philips iE33 echocardiographic system (Philips
Medical Systems, Andover, MA) with an S5-1 transducer (frequency
bandwidth, 1–5 MHz). A standard clinical protocol for all examina-
tions was followed in conjunction with American Society of
Echocardiography guidelines for chamber quantification.5,13
A magnetic localizer was attached to the S5-1 transducer by a
molded plastic sheath. The magnetic localizer was connected to a
dedicated console, from which a mechanical arm with an attached
magnetic field generator hung over the patient (Figure 1;
VentriPoint Diagnostics Ltd, Seattle, WA). The localizer mounted on
the ultrasound transducer detects orthogonal magnetic fields from
the generator hanging over the patient, and in this manner the ultra-
sound probe position is localized in 3D space at the point of any 2D
acquisition. A cushioned wedge was placed on the echocardiography
couch to ensure that the metallic couch apparatus did not interfere
with the magnetic field, and patients were instructed to remain
entirely stationary in the left lateral decubitus position for the duration
of a study acquisition. The ultrasound depth required to visualize all
relevant structures was determined before commencing the study
and remained fixed throughout.
Seven 2D transthoracic echocardiographic views were obtained
in all subjects: parasternal long axis, parasternal short axis at the
papillary muscle and apical levels, parasternal RV inflow, parasternal
RV outflow including pulmonary valve hinge points and infundib-
ulum, apical four chamber, and an off-axis RV apical view. The 2D
KBR acquisition from each view consists of a 2-sec period (usually
containing two or three heartbeats) acquired during end-
expiratory breath-holds. The electrocardiograph was connected to
the echocardiographic system via the dedicated 2D KBR console,
and the console images were reproduced from the echocardio-
graphic system’s video output and digitized at 30 frames/sec.
Image quality was subjectively graded on a 5-point scale from
0 (very poor) to 4 (perfect).14
Postprocessing: RV FAC. End-diastolic and end-systolic frames
were assigned by visual identification of the largest and smallest RV
four-chamber cavity areas, respectively, on the 2D KBR console.
These frames were exported to the open-source OsiriX Digital
Imaging and Communications in Medicine software for the measure-
ment of RV FAC by tracing the RVendocardium in both frames and
using the formula [(end-diastolic area ! end-systolic area)/end-dia-
stolic area] " 100.
Postprocessing: 2D KBR. The largest and smallest RV four-
chamber cavity areas were visually identified as end-diastole and
end-systole, respectively, on the 2D KBR console, with the software
subsequently assigning the same time interval between these frames
to all other views. On the 2D KBR console, a series of anatomic RV
landmarks were identified on the 2D echocardiography images
(Figures 2A–2G) in the end-diastolic frames and subsequently in
the end-systolic frames. A minimum of 26 points was plotted for
each of the end-diastolic and end-systolic data sets. RV endocardial
points were placed at the junction between trabeculations and
myocardium. The plotted anatomic landmarks with their respective
3D spatial coordinates were then submitted via the Internet to a
secure remote server for remote processing by a proprietary 2D
KBR algorithm. The algorithm interpolates between the plotted
points by referencing against a catalogue of RV shapes generated
by CMRI from patients with known diagnoses of PH.
End-diastolic and end-systolic 3Dmodels of the right ventricle were
reviewed in a systematic fashion. Intersections between the borders of
the 3D model and the original 2D scan plane were inspected to
ensure concordance between 2D images and 3D reconstructions
(Figures 2A–2G), and marked points were checked for alignment
with the surface of the 3D model. Where significant deviations be-
tween the reconstructed model and either the plotted points and/
or 2D echocardiographic endocardial borders existed, points were re-
plotted and the algorithm was rerun. Where significant border versus
2D image misalignment suggested a shift in patient position or an
inadequate breath-hold, all points from that 2D view were removed,
and the erroneous 2D echocardiographic view was excluded from
the 2D KBR reconstruction. A maximum of one view of the seven
required in the data acquisition protocol could be excluded for any
given study because of a change in patient position or an inadequate
breath-hold. If this problem was encountered in more than one of the
seven required views, the entire study was excluded from the final
analysis.
Abbreviations
CMRI = Cardiac magnetic
resonance imaging
FAC = Fractional area change
KBR = Knowledge-based
reconstruction
PH = Pulmonary hypertension
RV = Right ventricular
3DE = Three-dimensional
echocardiography
2D = Two-dimensional
2DE = Two-dimensional
echocardiography
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The final check entailed inspection of the nested view of end-
diastolic and end-systolic models to verify alignment of the tricuspid
and pulmonary annular planes (Figure 2H). The final 2D KBR poly-
gon was assessed for precision by subjectively scoring on a 5-point
scale depending on the proximity of intersections of the plotted
landmarks with the reconstructed polygon: 4 (all points intersect),
3 (three or fewer points significantly deviate from polygon), 2
(five or fewer points significantly deviate from polygon), 1 (seven
or fewer points significantly deviate from polygon), and 0 (poor
agreement).
FAC and 2D KBR Test-Retest Reproducibility. All subjects un-
derwent serial 2D echocardiographic acquisition and postprocessing
by two independent sonographers (D.S.K. and J.P.S.), as described
previously.15 The two sonographers had similar experience in 2D
transthoracic echocardiography (>4 years each) and received the
same vendor training for the 2D KBR system. Sonographer 1
(D.S.K.) obtained a 2D KBR data set, after which sonographer 2
(J.P.S.) independently obtained a 2D KBR data set. Sonographer 1
then acquired a second 2D KBR data set. The sonographers, who
were blinded to each other’s results and the results from CMRI, per-
formed postprocessing of their own data sets for FAC and 2D KBR.
Data sets analyzed for intraobserver test-retest reproducibility were
postprocessed separately at time intervals of >2 weeks.
CMRI
Image Acquisition. All CMRI images were acquired using a 1.5-T
magnetic resonance scanner (Avanto; Siemens Healthcare,
Erlangen, Germany) using a 12-element phased-array coil for signal
reception and the body coil for signal transmission. A vector electro-
cardiographic system was used for cardiac gating. In all patients, ven-
tricular volumes and great vessel flow were measured as previously
described.7 Volumetric RV data were obtained using real-time radial
k-t sensitivity-encoded imaging of contiguous transaxial slices.16
Real-time radial k-t sensitivity-encoded imaging allows the collection
of high–spatiotemporal resolution, real-time images during free
breathing and is part of the standard clinical CMRI work flow at
our institution in the pediatric PH population.17
Postprocessing. All image postprocessing was performed using
‘‘in-house’’ plugins for the open-source OsiriX Digital Imaging and
Communications in Medicine software.16,18,19 Endocardial RV
borders were traced manually at end-diastole and end-systole, the
time points of which were identified by the largest and smallest RV
cavity areas, respectively. The inclusion of RV trabeculations was
the same as that performed in echocardiographic postprocessing.
Ventricular stroke volume was the difference between the end-
diastolic volume and end-systolic volume, and ejection fraction was
calculated as (stroke volume/end-diastolic volume) " 100.
Statistical Analysis
Statistical analysis was performed using SPSS version 22.0 (IBM
Corporation, Armonk, NY) and Prism version 6.0b for Mac
(GraphPad Software, Inc, La Jolla, CA). All continuous data were nor-
mally distributed and expressed as mean 6 SD. Systematic differ-
ences between measurements were evaluated with Student’s paired
t test (two tailed). P values < .05 were considered to indicate statistical
significance. Intermodality agreement was studied using the Bland-
Altman method, whereby the mean difference was presented as
the bias and 95% limits of agreement around the bias expressed as
the mean difference 6 1.96 SDs.20
Differences between test-retest measurements were analyzed us-
ing one-way repeated-measures analysis of variance, with the
Bonferroni post hoc test identifying which specific means differed.
The Greenhouse-Geisser correction was used if the assumption of
sphericity had been violated. Test-retest variability was expressed us-
ing intraclass correlation coefficients, relative differences and coeffi-
cients of variation. The intraclass correlation coefficient was
quantified by the two-way random-effects model with absolute agree-
ment. An intraclass correlation coefficient > 0.85 was considered
excellent. Relative differences were calculated by taking the absolute
difference between two observations divided by the mean of the
repeated observations and expressed as a percentage. Coefficients
of variation were calculated as the SD of the difference between
two acquisitions divided by their mean value and expressed as a per-
centage.21 A coefficient of variation# 10%was considered excellent.
Figure 1 Two-dimensional KBR apparatus: a localizing transducer (A) attached by a molded plastic sheath to a conventional 2D
echocardiographic probe (B) detects orthogonal magnetic fields emitted by the generator (C) attached to the mechanical arm that
hangs over the patient. Here in the 2D KBR calibration module, the die on the screen (D) represents the 2D echocardiographic probe,
which moves synchronously with any movement of the 2D echocardiographic probe. Note the cushioned wedge in the background
that is placed on the echocardiography couch to ensure that the metallic apparatus underneath couch does not interfere with detec-
tion of the magnetic fields.
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Figure 2 Postprocessed 2DKBRdata from a participant with pulmonary hypertension. All of the required 2D echocardiographic scan
planes in end-diastole are displayed: (A) parasternal long-axis (PLAX), (B) PLAX RV inflow, (C) PLAX RV outflow including infundib-
ulum and pulmonary valve hinge points, (D) parasternal short-axis (PSAX) at midcavity (papillary muscle) level, (E) PSAX apical level,
(F) four-chamber RV, (G) off-axis RV apical view (note how the RV apex rides over the left ventricular apex). The differently colored
cross-hairs represent user-defined plots for different RV structures; for example, red crosses are plotted along the RV endocardium,
turquoise crosses along the RV side of the interventricular septum, a yellow cross at the RV apex, orange crosses at the pulmonary
valve annulus, and purple crosses at the tricuspid valve annulus. The yellow border tracings are superimposed projections of the 2D
KBRRV reconstruction onto the original 2D echocardiographic scan data, also showing how the polygon extends beyond the original
2D echocardiographic image sector. Landmarks can be checked and repositioned by the user if required, and the 2D KBR algorithm
subsequently rerun. A final check is the nested view (H) of end-diastolic and end-systolic polygons to ensure alignment of the
tricuspid and pulmonary valve orifices.
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RESULTS
Population Characteristics and 2D KBR Technical Data
The clinical characteristics of the 28 participants are presented in
Table 1, all of whom had adequate 2D echocardiographic windows
for the specified protocol. Participants’ heart rates recorded on the
2D echocardiographic loop acquired first were similar to those re-
corded on the 2D echocardiographic loop acquired last (P = .90).
Image acquisition for one data set took on the order of approximately
5min per patient, with 2D KBR postprocessing and analysis taking no
longer than about 15 min. Good mean subjective scores were
observed for 2D echocardiographic image acquisition (2.9 6 0.9)
and 2D KBR reconstruction (3.2 6 0.7), with moderate correlation
between the two scores (r = 0.54, P = .003).
RV Quantification by 2D KBR versus CMRI
RV volumes and ejection fractions for all participants measured by 2D
KBR showed no significant differences with CMRI (Table 2), with no
significant bias and clinically acceptable limits of agreement (Figure 3).
Test-Retest Intraobserver and Interobserver
Reproducibility
One patient moved in the first data set acquisition, one patient moved
in the third data set acquisition, and two patients moved in both the
second and third data set acquisitions. The 2D KBR data sets for these
four individuals were therefore excluded from the final test-retest
reproducibility analysis because of significant movement artifact.
Good reproducibility metrics and acceptable limits of agreement
were observed for the 24 intra- and interobserver 2D KBR test-
retest studies (Table 3, Figure 4). There were no significant differences
for RV volumes or ejection fraction between serial 2D KBR studies,
but significant intra- and interobserver test-retest variability was
demonstrated for serial RV areas and FAC (Table 4).
DISCUSSION
This study demonstrates the feasibility and accuracy of 2D KBR for
RV quantification in PH and provides the first test-retest reproduc-
ibility data for this technique. These results suggest a role for 2D
KBR in serial follow-up studies of this patient population. The sources
of variability at the acquisition and postprocessing stages of 2D KBR
have been tested in an approach more akin to clinical practice, with
no significant differences demonstrated between serial interobserver
and intraobserver test-retest studies. By comparison with conven-
tional RV FAC, 2D KBR has incremental benefit in quantifying RV
function through superior test-retest reproducibility.
Two-dimensional KBR is an emerging technique that has been vali-
dated in congenital heart disease populations22-24 and more recently
in a small population of patients with PH.10 The utility of applying a
hybrid knowledge-based approach to 2DE of the right ventricle is re-
flected by the known differences in RV shapes that are encountered
not only in congenital and acquired disease but also among different
subtypes of PH.25 Moreover, algorithms for RV reconstruction by
conventional 3DE are typically based on generic healthy adult RV
shapes rather than taking into account differences in congenital pop-
ulations or subtle changes in volume- and pressure-overload states.26
The reconstruction of a 3D model from 2D landmark coordinates
makes the use of the piecewise smooth subdivision surface technique,
with gaps between the user-defined points filled by a catalogue regis-
tration method that is well validated in vitro.27,28 The piecewise
smooth subdivision surface technique itself also has greater
accuracy over the conventional Beutel method for RV volume
reconstruction in vivo by 3DE.22
Our limits of agreement are clinically acceptable compared with
the gold standard of CMRI, slightly more favorable than those ob-
tained previously in idiopathic PH,10 and similar to previous work
in children following surgical repair of tetralogy of Fallot.22 A potential
explanation for these differences might be our quantification of RV
volumes by CMRI using a transaxial stack of RV slices rather than
the short-axis stack approach. This has the advantage of avoiding par-
tial voluming of the basal RV slices that is of particular relevance in PH
because of the relative preservation of longitudinal over radial func-
tion.29 A transaxial slice orientation facilitates the identification of
the inflow and outflow components of the right ventricle and ulti-
mately confers better reproducibility for RV volumetric quantification
by CMRI.30-32 The 2D KBR hardware used in our study also differs
from that in previous studies in terms of the position of the
magnetic field generator either above or underneath the patient
bed. Our equipment used a magnetic field generator suspended
Table 1 Clinical characteristics of study population (n = 28)
Variable Value
Age (y) 54 6 13
Women 20 (71%)
Height (cm) 165 6 11
Weight (kg) 71 6 18
Body surface area (m2) 1.8 6 0.3
Heart rate (beats/min) 79 6 13
Mean PASP on RHC (mm Hg) 47 6 12
Pulmonary vasodilators
Endothelin antagonists 11 (39%)
PDE5 antagonists 18 (64%)
Oral prostanoid 1 (4%)
Inhaled prostanoid 1 (4%)
RV EDV (mL/m2) 98 6 26
RV ESV (mL/m2) 59 6 23
RV EF (%) 41 6 11
EDV, End-diastolic volume; EF, ejection fraction; ESV, end-systolic
volume; PASP, pulmonary artery systolic pressure; PDE5, phospho-
diesterase 5; RHC, right heart catheterization.
Data are expressed as mean 6 SD or as number (percentage). RV
volumes are derived from cardiac magnetic resonance imaging.
Table 2 RV volumes and EF by 2D KBR versus CMRI
Measurement 2D KBR CMRI P*
RV EDV (mL) 179 6 66 176 6 61 .16
RV ESV (mL) 107 6 47 106 6 47 .63
RV SV (mL) 73 6 27 70 6 26 .26
RV EF (%) 42 6 10 41 6 11 .66
EDV, End-diastolic volume; EF, ejection fraction; ESV, end-systolic
volume; SV, stroke volume.
Data are expressed as mean 6 SD; n = 27 (one patient excluded
because of movement artifact during 2D KBR study).
*Paired Student’s t test.
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directly above the patient’s chest. However, the magnetic field
generator location above or below the echocardiography couch
should not theoretically affect the spatial detection of the 2D
echocardiographic probe localizer.
To our knowledge, this is the first study designed to assess the test-
retest reproducibility of 2D KBR. Importantly, the 2D KBR tech-
nique showed no significant differences for interobserver or intraob-
server test-retest reproducibility, whereas FAC had significant test-
retest variability. The only previous study of test-retest reproduc-
ibility of 2D echocardiographic RV area metrics, to our knowledge,
had a comparable intraobserver test-retest coefficient of variation for
RV FAC of 16.5%.33 The reproducibility of FAC postprocessing
alone (not including variability in image acquisition) has also been
shown to have significant interobserver bias and wide limits of agree-
ment in children after surgical repair of tetralogy of Fallot compared
with 2D KBR.22 The test-retest reproducibility of 2D KBR RV volu-
metric quantification is also improved compared with that previ-
ously demonstrated by 3DE in either congenital heart disease15 or
acquired PH.7
The superior reproducibility of 2D KBR compared with conven-
tional 2DE and that previously reported for 3DE may be accounted
for by several reasons. First, FAC and 3DE require good endocardial
delineation to trace the RV border, whereas 2D KBR requires the user
to define single points along the endocardium rather than the border
in its entirety. Second, in contrast to 2D FAC, the 3D spatial localiza-
tion of the 2D echocardiographic probe compensates for the acquisi-
tion variability in transthoracic windows among operators.34
Postprocessing reproducibility is also likely to be enhanced by the
KBR process, with our protocol mandating review of the recon-
structed models relative to the original 2D echocardiographic pic-
tures. Landmarks are adjusted to ensure acceptable agreement
between the raw 2D echocardiographic images and the KBR
polygons, thus conferring an element of reproducibility through the
KBR algorithm itself. KBR also differs from 3DE by using a shape-
specific reconstruction algorithm rather than a generic adult-based
algorithm,26 hence taking account of the impact of the underlying dis-
ease process conferred upon RV morphology.
Compared with 3DE, the use of 2D echocardiographic technology
for data acquisition also has methodologic advantages.
Fundamentally, spatial and temporal resolutions of 2DE are higher
than those of 3DE. Underestimation of RV volumes is a known
Figure 3 Bland-Altman analysis of bias (black solid line) and 95% limits of agreement (red dashed line) for 2D KBR versus CMRI quan-
tification of right ventricular end-diastolic volume (EDV), end-systolic volume (ESV), stroke volume (SV), and ejection fraction (EF);
n = 27 (one patient excluded because of movement artifact during 2D KBR study).
Table 3 Test-retest reproducibility results for 2DKBR and 2D
echocardiographic RV metrics
Variable
Intraobserver Interobserver
ICC COV (%) RD (%) ICC COV (%) RD (%)
2D KBR
RV EDV 0.985 3.0 4.2 0.986 3.9 5.5
RV ESV 0.987 4.3 6.1 0.960 7.7 10.9
RV SV 0.953 8.3 11.7 0.856 11.7 16.5
RV EF 0.919 6.4 9.0 0.758 10.5 14.8
2DE
RV EDA 0.885 9.0 12.7 0.394 25.0 35.4
RV ESA 0.931 9.3 13.2 0.440 31.0 43.9
RV FAC 0.784 18.1 25.6 0.619 20.8 29.4
COV, Coefficient of variation; EDA, end-diastolic area; EDV, end-
diastolic volume; EF, ejection fraction; ESA, end-systolic area;
ESV, end-systolic volume; ICC, intraclass correlation coefficient;
RD, relative difference; SV, stroke volume.
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limitation of 3DE due to the inferior spatial resolution, conferring
blurred endocardial borders and thus a visually smaller RV cavity.9
In particular, the contribution from the RV outflow tract is known
to be an important determinant of the overall accuracy of RV vol-
umes.35 However, accurate visualization of this region can be techni-
cally difficult by 3DE.7,36 The 2D KBR acquisition protocol includes
dedicated imaging of the RV outflow tract by 2DE, affording higher
spatial resolution when imaging this region that may contribute to
more accurate volumetric quantification (Figure 5). Furthermore,
given that echocardiography of the right ventricle has inherent acqui-
sition difficulties due to its anterior position in the chest wall, complex
geometry, thin walls, and heavy trabeculations,3,4 our subjective
image scoring suggests that the requirement for the identification of
landmarks rather than the entirety of a cardiac border still permits
adequate reconstruction despite cases of poor-quality transthoracic
2D echocardiographic windows.
However, subtle changes in RV function may nevertheless be
masked by the margins of error demonstrated in the study. CMRI
data demonstrates that a change in RV stroke volume in PH of as little
as 10 mL can be regarded as clinically significant,11 and therefore 2D
KBR may not be able to differentiate minor variations in RV volumes
from the variance in reproducibility. CMRI does not have the same
acquisition window restrictions and variability inherent to transtho-
racic echocardiography, with data sets consisting of contiguous
fixed-thickness RV slices acquired from the base of the right heart
to the main pulmonary artery with the patient in the supine position.
A further consideration with respect to the use of 2D KBR in the serial
evaluation of patients is that a change in RV volume might confer a
change in cavity shape, which could also have implications for the
application of the KBR algorithm to follow-up studies.
A disadvantage of 2D KBR is the requirement for several 2D
planes to be acquired over separate cardiac cycles. Image acquisition
over several cardiac cycles with potential beat-to-beat variability is also
a limitation shared by traditional disk summation 3DE and by CMRI,
but not with single-beat full-volume 3DE. However, no significant dif-
ferences were found in heart rates between the start and end of our
studies. Acquiring several 2D echocardiographic planes also requires
reproducible breath-holding and a stable patient position throughout
Figure 4 Bland-Altman analysis of bias (black solid line) and 95% limits of agreement (red dashed line) for interobserver 2D KBR test-
retest reproducibility of right ventricular end-diastolic volume (EDV), end-systolic volume (ESV), stroke volume (SV), and ejection frac-
tion (EF); n = 25 (three patients excluded because of movement artifact during 2D KBR study). S1, Sonographer 1; S2, sonographer 2.
Table 4 Interobserver and intraobserver test-retest
reproducibility of RV volumes and EF by 2D KBR and RV
areas and FAC by 2DE
Variable
Sonographer
1.1 Sonographer 2
Sonographer
1.2 P*
2D KBR
RV EDV (mL) 184 6 68 185 6 65 180 6 66 .17
RV ESV (mL) 110 6 49 111 6 45 111 6 48 .80
RV SV (mL) 74 6 27 74 6 30 69 6 27 .15
RV EF (%) 41 6 10 41 6 11 40 6 10 .39
2DE
RV EDA (cm2) 23 6 6 32 6 7 23 6 7 <.001
RV ESA (cm2) 15 6 6 22 6 6 16 6 6 <.001
RV FAC (%) 36 6 15 31 6 10 34 6 14 .05
EDA, end-diastolic area; EDV, end-diastolic volume; EF, ejection
fraction; ESA, end-systolic area; ESV, end-systolic volume.
Data are expressed as mean6 SD; n = 24 for 2D KBR (four patients
excluded because of movement artifact), n = 27 for FAC (one patient
had an unanalyzable four-chamber image that precluded FAC but
not 2D KBR).
*One-way repeated measures analysis of variance.
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the study. Repeated breath-holding is also conventionally associated
with CMRI, but we used a real-time, high–spatiotemporal resolution
sequence as per our institution protocol for PH imaging that allows
free breathing and the rapid acquisition of ventricular volumes.16
Once image acquisition for a 2D KBR study has commenced, the
operator is unable to maneuver the patient to optimize transthoracic
echocardiographic windows. Therefore, an optimal patient position
for parasternal and apical views must be decided upon before
commencing 2D KBR data acquisition. These optimal breath-hold
and positional constraints may confer difficulty when applied to
acutely unwell individuals, and hence 2D KBR is more likely to be
practically applicable in the stable outpatient setting. It should also
be remembered that although global volumetric indices of RV func-
tion are highly prognostic, they do not account for the heterogeneity
in RVregional function in different disease states, as shown by 2D and
3D echocardiographic deformation imaging.37,38 Finally, 2D KBR
includes the RV trabeculations together with the blood volume,
which may in turn affect the accuracy of volumetric indices.
However, this is also a limitation shared with 3D echocardiographic
techniques and has been shown by CMRI to improve
reproducibility metrics compared with excluding trabeculations
from the RV cavity volume.39
Limitations
Our study represents a single-center experience with a small partici-
pant sample size. However, we have supported the validation data
for 2D KBR obtained by previous single-center studies using similar
sample sizes,10,22,23 and a total of 84 2D echocardiographic studies
were performed in our study for test-retest reproducibility purposes.
The increase in excluded studies with successive repeated scans
was due more to the serial 2D echocardiographic scan acquisition
protocol for test-retest reproducibility rather than the 2D KBR tech-
nique itself. Only one of 28 patients moved in the first 2D echocardio-
graphic data set image acquisition. Therefore, this limitation is unlikely
to be so prevalent for individual clinical scans, and the study analysis
times would allow the reacquisition of a second data set within a
scheduled clinical echocardiographic examination.
Patients with arrhythmia were specifically excluded from this
study, but patients with atrial fibrillation, for example, would require
a different approach to 2D KBR post-processing. In atrial fibrillation,
the end-diastolic frame for each view would have to be manually
selected by visually determining the largest RV cavity size. This could
theoretically affect the border alignment of the reconstructed poly-
gon, as different cardiac cycles in separate views will inherently
have different end-diastolic volumes because of the variability of irreg-
ular R-R intervals. Several reconstructions could be performed on the
same data set by selecting different cardiac cycles for each reconstruc-
tion, with the resulting 2D KBR RV metrics averaged over the num-
ber of cardiac cycles analyzed. However, the accuracy and
Figure 5 Demonstration of the interaction between the recon-
structed 2D knowledge-based reconstruction polygon with a
four-chamber view 2D echocardiographic scan plane. The re-
constructed polygon can be rotated in any direction (here
through 90# from top to bottom, indicated by the curved arrow).
Any original 2D echocardiographic acquisition can be dis-
played (here, the four-chamber view) and viewed in relation
to the polygon by clicking on one of the dots. In this way, the
reconstructed polygon can be inspected to ensure accurate
alignment with the original 2D echocardiographic data. From
this view, it is also readily appreciable how much of the right
ventricle, predominantly the outflow portion, is neglected in a
standard four-chamber view used to derive fractional area
change.
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reproducibility of this approach using 2D KBR in atrial fibrillation re-
quires further investigation.
Finally, CMRI reproducibility data were not acquired in a test-
retest format that allowed comparison of the acquisition and postpro-
cessing variability of this technique. However, as detailed above, the
acquisition stage of CMRI consists of a set acquisition of cross-
sectional, fixed-thickness, contiguous craniocaudal slices that include
the entirety of the heart with the patient supine. Therefore CMRI
fundamentally has less potential for acquisition variability compared
with 2DE, which has imaging windows obtained from different rib
spaces acquired in nonuniform patient positions.
CONCLUSIONS
Novel 2DKBR is a feasible and clinically reproducible technique for
RV volumetric quantification in PH, with superior test-retest repro-
ducibility compared with 2D echocardiographic FAC for quantifying
RV function. It offers the benefits of using operator experience with
conventional 2DE for image acquisition and uses algorithmic recon-
struction that takes into account the heterogeneity in shape of the
RV cavity in different disease states. The applicability of 2D KBR to
serial follow-up studies for assessing the response to treatment should
be the focus for further work in advancing this novel echocardiogra-
phy technique.
ACKNOWLEDGMENT
We are grateful to Dr James Willis for providing reproducibility data
for RV FAC.
REFERENCES
1. Chin KM, Kim NH, Rubin LJ. The right ventricle in pulmonary hyperten-
sion. Coron Artery Dis 2005;16:13-8.
2. van Wolferen SA, Marcus JT, Boonstra A, Marques KM, Bronzwaer JG,
Spreeuwenberg MD, et al. Prognostic value of right ventricular mass, vol-
ume, and function in idiopathic pulmonary arterial hypertension. Eur
Heart J 2007;28:1250-7.
3. Ho SY, Nihoyannopoulos P. Anatomy, echocardiography, and normal
right ventricular dimensions. Heart 2006;92(Suppl 1):i2-13.
4. Mertens LL, FriedbergMK. Imaging the right ventricle–current state of the
art. Nat Rev Cardiol 2010;7:551-63.
5. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD,
Chandrasekaran K, et al. Guidelines for the echocardiographic assessment
of the right heart in adults: a report from the American Society of Echocar-
diography endorsed by the European Association of Echocardiography, a
registered branch of the European Society of Cardiology, and the Cana-
dian Society of Echocardiography. J Am Soc Echocardiogr 2010;23:
685-713. quiz 86–8.
6. Grapsa J, O’Regan DP, Pavlopoulos H, Durighel G, Dawson D,
Nihoyannopoulos P. Right ventricular remodelling in pulmonary arterial hy-
pertensionwith three-dimensional echocardiography: comparisonwith car-
diac magnetic resonance imaging. Eur J Echocardiogr 2010;11:64-73.
7. Knight DS, Grasso AE, Quail MA, Muthurangu V, Taylor AM,
Toumpanakis C, et al. Accuracy and reproducibility of right ventricular
quantification in patients with pressure and volume overload using
single-beat three-dimensional echocardiography. J Am Soc Echocardiogr
2015;28:363-74.
8. Morikawa T, Murata M, Okuda S, Tsuruta H, Iwanaga S, Murata M, et al.
Quantitative analysis of right ventricular function in patients with pulmo-
nary hypertension using three-dimensional echocardiography and a
two-dimensional summation method compared to magnetic resonance
imaging. Am J Cardiol 2011;107:484-9.
9. Shimada YJ, ShiotaM, Siegel RJ, Shiota T. Accuracy of right ventricular vol-
umes and function determined by three-dimensional echocardiography in
comparison with magnetic resonance imaging: a meta-analysis study. J Am
Soc Echocardiogr 2010;23:943-53.
10. Bhave NM, Patel AR, Weinert L, Yamat M, Freed BH, Mor-Avi V, et al.
Three-dimensional modeling of the right ventricle from two-dimensional
transthoracic echocardiographic images: utility of knowledge-based recon-
struction in pulmonary arterial hypertension. J Am Soc Echocardiogr 2013;
26:860-7.
11. van Wolferen SA, van de Veerdonk MC, Mauritz GJ, Jacobs W, Marcus JT,
Marques KM, et al. Clinically significant change in stroke volume in pulmo-
nary hypertension. Chest 2011;139:1003-9.
12. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA,
et al. Guidelines for the diagnosis and treatment of pulmonary hyperten-
sion: the Task Force for the Diagnosis and Treatment of Pulmonary Hyper-
tension of the European Society of Cardiology (ESC) and the European
Respiratory Society (ERS), endorsed by the International Society of Heart
and Lung Transplantation (ISHLT). Eur Heart J 2009;30:2493-537.
13. LangRM,BierigM,DevereuxRB, Flachskampf FA, Foster E, Pellikka PA, et al.
Recommendations for chamber quantification: a report from the American
Society of Echocardiography’s Guidelines and Standards Committee and the
Chamber Quantification Writing Group, developed in conjunction with the
European Association of Echocardiography, a branch of the European Soci-
ety of Cardiology. J Am Soc Echocardiogr 2005;18:1440-63.
14. Kjaergaard J, Petersen CL, Kjaer A, Schaadt BK, Oh JK, Hassager C. Eval-
uation of right ventricular volume and function by 2D and 3D echocardi-
ography compared to MRI. Eur J Echocardiogr 2006;7:430-8.
15. van der Zwaan HB, Geleijnse ML, Soliman OI, McGhie JS, Wiegers-
Groeneweg EJ, Helbing WA, et al. Test-retest variability of volumetric right
ventricular measurements using real-time three-dimensional echocardiog-
raphy. J Am Soc Echocardiogr 2011;24:671-9.
16. Muthurangu V, Lurz P, Critchely JD, Deanfield JE, Taylor AM, HansenMS.
Real-time assessment of right and left ventricular volumes and function in
patients with congenital heart disease by using high spatiotemporal resolu-
tion radial k-t SENSE. Radiology 2008;248:782-91.
17. Moledina S, Pandya B, Bartsota M, Mortensen KH, McMillan M, Quyam S, et al.
Prognostic significance of cardiacmagnetic resonance imaging in childrenwith pul-
monary hypertension. Circ Cardiovasc Imaging 2013;6:407-14.
18. Odille F, Steeden JA, Muthurangu V, Atkinson D. Automatic segmenta-
tion propagation of the aorta in real-time phase contrast MRI using
nonrigid registration. J Magn Reson Imaging 2011;33:232-8.
19. Rosset A, Spadola L, Ratib O. OsiriX: an open-source software for navi-
gating in multidimensional DICOM images. J Digit Imaging 2004;17:
205-16.
20. Bland JM, Altman DG. Statistical methods for assessing agreement be-
tween two methods of clinical measurement. Lancet 1986;1:307-10.
21. Tamborini G, Marsan NA, Gripari P, Maffessanti F, Brusoni D, Muratori M,
et al. Reference values for right ventricular volumes and ejection fraction
with real-time three-dimensional echocardiography: evaluation in a large
series of normal subjects. J Am Soc Echocardiogr 2010;23:109-15.
22. Dragulescu A, Grosse-Wortmann L, Fackoury C, Mertens L. Echocardio-
graphic assessment of right ventricular volumes: a comparison of different
techniques in children after surgical repair of tetralogy of Fallot. Eur Heart J
Cardiovasc Imaging 2012;13:596-604.
23. Dragulescu A, Grosse-Wortmann L, Fackoury C, Riffle S,WaissM, Jaeggi E,
et al. Echocardiographic assessment of right ventricular volumes after sur-
gical repair of tetralogy of Fallot: clinical validation of a new echocardio-
graphic method. J Am Soc Echocardiogr 2011;24:1191-8.
24. Kutty S, Li L, Polak A, Gribben P, Danford DA. Echocardiographic
knowledge-based reconstruction for quantification of the systemic right
ventricle in young adults with repaired D-transposition of great arteries.
Am J Cardiol 2012;109:881-8.
25. Leary PJ, Kurtz CE, Hough CL, Waiss MP, Ralph DD, Sheehan FH. Three-
dimensional analysis of right ventricular shape and function in pulmonary
hypertension. Pulm Circ 2012;2:34-40.
Journal of the American Society of Echocardiography
Volume 28 Number 8
Knight et al 997
26. Schattke S, Wagner M, Hattasch R, Schroeckh S, Durmus T, Schimke I,
et al. Single beat 3D echocardiography for the assessment of right ventric-
ular dimension and function after endurance exercise: intraindividual
comparison with magnetic resonance imaging. Cardiovasc Ultrasound
2012;10:6.
27. Hubka M, Bolson EL, McDonald JA, Martin RW, Munt B, Sheehan FH.
Three-dimensional echocardiographic measurement of left and right ven-
tricular mass and volume: in vitro validation. Int J Cardiovasc Imaging
2002;18:111-8.
28. Wong SP, Johnson RK, Sheehan FH. Rapid and accurate left ventricular
surface generation from three-dimensional echocardiography by a catalog
based method. Rapid LV surface generation by three-dimensional echo.
Int J Cardiovasc Imaging 2003;19:9-17.
29. Kind T, Mauritz GJ, Marcus JT, van de Veerdonk M, Westerhof N, Vonk-
Noordegraaf A. Right ventricular ejection fraction is better reflected by
transverse rather than longitudinal wall motion in pulmonary hyperten-
sion. J Cardiovasc Magn Reson 2010;12:35.
30. Alfakih K, Plein S, Bloomer T, Jones T, Ridgway J, Sivananthan M. Com-
parison of right ventricular volume measurements between axial and
short axis orientation using steady-state free precession magnetic reso-
nance imaging. J Magn Reson Imaging 2003;18:25-32.
31. Fratz S, Schuhbaeck A, Buchner C, Busch R, Meierhofer C, Martinoff S,
et al. Comparison of accuracy of axial slices versus short-axis slices for
measuring ventricular volumes by cardiac magnetic resonance in patients
with corrected tetralogy of Fallot. Am J Cardiol 2009;103:1764-9.
32. Atalay MK, Chang KJ, Grand DJ, Haji-Momenian S, Machan JT,
Sheehan FH. The transaxial orientation is superior to both the short axis
and horizontal long axis orientations for determining right ventricular vol-
ume and ejection fraction using Simpson’s method with cardiac magnetic
resonance. ISRN Cardiol 2013;2013:268697.
33. Willis J, Augustine D, Shah R, Stevens C, Easaw J. Right ventricular
normal measurements: time to index? J Am Soc Echocardiogr 2012;
25:1259-67.
34. Legget ME, Leotta DF, Bolson EL, McDonald JA, Martin RW, Li XN, et al.
System for quantitative three-dimensional echocardiography of the left
ventricle based on a magnetic-field position and orientation sensing sys-
tem. IEEE Trans Biomed Eng 1998;45:494-504.
35. Horton KD, Meece RW, Hill JC. Assessment of the right ventricle by echo-
cardiography: a primer for cardiac sonographers. J Am Soc Echocardiogr
2009;22:776-92. quiz 861–2.
36. van der Zwaan HB, Helbing WA, McGhie JS, Geleijnse ML,
Luijnenburg SE, Roos-Hesselink JW, et al. Clinical value of real-time
three-dimensional echocardiography for right ventricular quantification
in congenital heart disease: validation with cardiac magnetic resonance
imaging. J Am Soc Echocardiogr 2010;23:134-40.
37. Dragulescu A, Grosse-Wortmann L, Redington A, Friedberg MK,
Mertens L. Differential effect of right ventricular dilatation on myocardial
deformation in patients with atrial septal defects and patients after tetral-
ogy of Fallot repair. Int J Cardiol 2013;168:803-10.
38. Morcos M, Sheehan FH. Regional right ventricular wall motion in tetral-
ogy of Fallot: a three dimensional analysis. Int J Cardiovasc Imaging
2013;29:1051-8.
39. Winter MM, Bernink FJ, Groenink M, Bouma BJ, van Dijk AP,
Helbing WA, et al. Evaluating the systemic right ventricle by CMR: the
importance of consistent and reproducible delineation of the cavity. J Car-
diovasc Magn Reson 2008;10:40.
998 Knight et al Journal of the American Society of Echocardiography
August 2015
 Appendix 3  
 
223 
 
 
 
 
 
 
APPENDIX 3 
J. Steeden, D. Knight, S. Bali, D. Atkinson, A. Taylor and V. Muthurangu 
 
Self-navigated tissue phase mapping using a golden-angle spiral 
acquisition – proof of concept in patients with pulmonary 
hypertension. 
 
Magnetic Resonance in Medicine, 2014, 71(1), 145-55. 
 
 Appendix 4  
 
235 
 
 
 
 
 
 
APPENDIX 4 
D. Knight, J. Steeden, S. Moledina, A. Jones, G. Coghlan and V. 
Muthurangu 
 
Left ventricular diastolic dysfunction in pulmonary hypertension 
predicts functional capacity and clinical worsening: a tissue phase 
mapping study. 
 
Submitted with revisions. 
 
 Appendix 5  
 
272 
 
 
 
 
 
 
APPENDIX 5 
M. Quail, J. Steeden, D. Knight, P. Segers, A. Taylor and V. Muthurangu 
 
Development and validation of a novel method to derive central 
aortic systolic pressure from the MR aortic distension curve. 
 
Journal of Magnetic Resonance Imaging, 2014, 40(5), 1064-70. 
 
 Appendix 6  
 
280 
 
 
 
 
 
 
APPENDIX 6 
M. Quail, D. Knight, J. Steeden, L. Taelman, S. Moledina, A. Taylor, P. 
Segers, G. Coghlan and V. Muthurangu 
 
Noninvasive pulmonary artery wave intensity analysis in pulmonary 
hypertension. 
 
American Journal of Physiology – Heart and Circulatory Physiology, 
2015, 308(12), H1603-11. 
 
 Appendix 7  
 
290 
 
 
 
 
 
 
APPENDIX 7 
G. Kowalik, D. Knight, J. Steeden, O. Tann, F. Odille, D. Atkinson, A. 
Taylor and V. Muthurangu 
 
Assessment of cardiac time intervals using high temporal resolution 
real-time spiral phase contrast with UNFOLDed-SENSE. 
 
Magnetic Resonance in Medicine, 2015, 73(2), 749-56. 
 
